prr.hec.gov.pkprr.hec.gov.pk/jspui/bitstream/123456789/1134/1/2339s.pdf · i table of contents...
TRANSCRIPT
SYNTHESIS OF γ-KETOESTERS VIA ACID CATALYSED RING
OPENING OF SUCCINIC ANHYDRIDE WITH SUBSTITUTED
BENZYL ALCOHOLS
&
PHYTOCHEMICAL STUDIES OF BIOACTIVE COMPOUNDS FROM
CORIANDRUM SATIVUM Linn (UMBELLIFERAE)
BY
MUHAMMAD IQBAL
DEPARTMENT OF CHEMISTRY
GOMAL UNIVERSITY
DERA ISMAIL KHAN, KPK, (PAKISTAN)
2013
SYNTHESIS OF γ-KETOESTERS VIA ACID CATALYSED RING
OPENING OF SUCCINIC ANHYDRIDE WITH SUBSTITUTED
BENZYL ALCOHOLS
&
PHYTOCHEMICAL STUDIES OF BIOACTIVE COMPOUNDS FROM
CORIANDRUM SATIVUM Linn (UMBELLIFERAE)
BY
MUHAMMAD IQBAL
Ph. D
DEPARTMENT OF CHEMISTRY
GOMAL UNIVERSITY
DERA ISMAIL KHAN, KPK, (PAKISTAN)
2013
SYNTHESIS OF γ-KETOESTERS VIA ACID CATALYSED RING OPENING OF
SUCCINIC ANHYDRIDE WITH SUBSTITUTED BENZYL ALCOHOLS
&
PHYTOCHEMICAL STUDIES OF BIOACTIVE COMPOUNDS FROM
CORIANDRUM SATIVUM Linn (UMBELLIFERAE)
A Thesis Submitted
For the fulfilment of the degree
Of
Doctor of Philosophy
In
CHEMISTRY
(Organic Chemistry)
BY
MUHAMMAD IQBAL
DEPARTMENT OF CHEMISTRY
GOMAL UNIVERSITY
DERA ISMAIL KHAN, KPK, (PAKISTAN)
2013
IN THE NAME OF ALLAH
THE MOST MERCIFUL
&
THE MOST GRACIOUS
DEDICATED TO
MY
BELOVED WIFE
AND
CHILDREN
i
TABLE OF CONTENTS
SECTION CONTENTS Page #
TABLE OF CONTENTS i
LIST OF TABLES xiii
LIST OF FIGURES ix
LIST OF HISTOGRAMS & SCHEMES ix
ACKNOWLEDGEMENTS x
ABBREVIATIONS xii
TECHNIQUES xii
ABSTRACT 1
PART-I 4
Chapter 1: INTROUCTION 5
1 INTRODUCTION 6
1.1 General Overview 6
1.2 Benzyl Hydrogen Succinates (Monoesters) 6
1.3 Substituted Benzyl 4-Chloro-4-Ketohexanoates (Acid Chlorides) 8
1.4 γ-Ketoesters (Substituted Benzyl 4-Ketohexanoates) 9
1.5 Estimation of Biological Activity 13
1.5.1 Inhibition zones 14
1.5.2 Minimum inhibitory concentrations (MICs) 14
1.6 Aims and Objectives 16
Chapter 2: RESULTS AND DISCUSSION 17
2. RESULTS AND DISCUSSION 18
2.1 Characterization Monoester 1-56 18
2.2 Characterization of Monoester 30 19
2.3 Characterization of Acid Chlorides (1a-56a) 21
2.3.1 Characterization of 1a 21
2.3.2 Characterization of 30a 22
2.3.3 Characterization of γ-Ketoesters (1b-56b) 23
2.3.4 Characterization of 30b 24
2.4 Characterization of 57-60, 57a-60a and 57b-60b 24
2.5 Biological Activity and Structure Activity Relationship 1-29 25
Chapter 3: EXPERIMENTAL 27
3 EXPERIMENTAL 28
3.1 General Experimental 28
3.1.1 Fungal strains 28
3.1.2 Bacterial strains 29
ii
3.2 General Procedure for the Preparation of Monoesters 1-29 29
3.3 General Procedure for the Preparation of Monoesters 30-56 29
3.4 General Procedure for the Preparation of Monoesters (57-60) 30
3.5 General Procedure for Preparation of Mono-/di-/tri-benzyl) 4-Chloroketobutanoates
(1a-56a)
30
3.6 General Procedure for Alkyl 4-Chloro-4-Ketobutanoates (57a-60a) 30
3.7 Preparation of Diethyl Cadmium Reagent 31
3.8 General Procedure for Preparation of Benzyl-γ-Ketohexanoates (1b-56b) 31
3.9 General Procedure for Alkyl γ-Ketohexanoates (57b-60b) 31
3.10 Biological Activity 32
3.10.1 Measurement of zones of inhibition 32
3.10.2 Measurement of MICs 33
3.10.2.1 Preparation of stock solutions 33
3.10.3 Solutions of working concentrarions 33
3.10.4 Controls 34
3.12 Physical and Spectroscopic Data of Monoesters 1-60 35
3.12.1 2-Methoxybenzyl hydrogen succinate (1) 35
3.12.2 3-Methoxybenzyl hydrogen succinate (2) 35
3.12.3 4-Methoxybenzyl hydrogen succinate (3) 35
3.12.4 2,3-Dimethoxybenzyl hydrogen succinate (4) 36
3.12.5 2, 4-Dimethoxybenzyl hydrogen succinate (5) 36
3.12.6 2,5-Dimethoxybenzyl hydrogen succinate (6) 36
3.12.7 3,4-Dimethoxybenzyl hydrogen succinate (7) 37
3.12.8 3,5-Dimethoxybenzyl hydrogen succinate (8) 37
3.12.9 2-Nirobenzyl hydrogen succinate (9) 37
3.12.10 3-Nirobenzyl hydrogen succinate (10) 38
3.12.11 4-Nirobenzyl hydrogen succinate (11) 38
3.12.12 2-Chlorobenzyl hydrogen succinate (12) 38
3.12.13 3-Chlorobenzyl hydrogen succinate (13) 39
3.12.14 4-Chlorobenzyl hydrogen succinate (14) 39
3.12.15 2-Bromobenzyl hydrogen succinate (15) 39
3.12.16 3-Bromobenzyl hydrogen succinate (16) 40
3.12.17 4-Bromobenzyl hydrogen succinate (17) 40
3.12.18 2-Iodobenzyl hydrogen succinate (18) 40
3.12.19 3-Iodobenzyl hydrogen succinate (19) 41
3.12.20 4-Iodobenzyl hydrogen succinate (20) 41
3.12.21 2-Methylbenzyl hydrogen succinate (21) 41
3.12.22 3-Methylbenzyl hydrogen succinate (22) 42
3.12.23 4-Methylbenzyl hydrogen succinate (23) 42
3.12.24 2-Hydroxybenzyl hydrogen succinate (24) 42
3.12.25 3-Hydroxybenzyl hydrogen succinate (25) 43
3.12.26 4-Hydroxybenzyl hydrogen succinate (26) 43
3.12.27 2-Aminobenzyl hydrogen succinate (27) 43
3.12.28 3-Aminobenzyl hydrogen succinate (28) 44
3.12.29 4-Aminobenzyl hydrogen succinate (29) 44
3.12.30 2,4-Dichlorobenzyl hydrogen succinate (30) 44
3.12.31 2,5-Dichlorobenzyl hydrogen succinate (31) 45
iii
3.12.32 2,6-Dichlorobenzyl hydrogen succinate (32) 45
3.12.33 3,4-Dichlorobenzyl hydrogen succinate (33) 45
3.12.34 3,5-Dichlorobenzyl hydrogen succinate (34) 46
3.12.35 2,3-Difluorobenzyl hydrogen succinate (35) 46
3.12.36 2,4-Difluorobenzyl hydrogen succinate (36) 46
3.12.37 2,5-Difluorobenzyl hydrogen succinate (37) 47
3.12.38 2,6-Difluorobenzyl hydrogen succinate (38) 47
3.12.39 2,4-Dimethylbenzyl hydrogen succinate (39) 47
3.12.40 2,5-Dimethylbenzyl hydrogen succinate (40) 48
3.12.41 3,4-Dimethylbenzyl hydrogen succinate (41) 48
3.12.42 3,5-Dimethylbenzyl hydrogen succinate (42) 48
3.12.43 3,4-Dinitrobenzyl hydrogen succinate (43) 49
3.12.44 3,5-Dinitrobenzyl hydrogen succinate (44) 49
3.12.45 2,6-Diethoxybenzyl hydrogen succinate (45) 49
3.12.46 3,4-Diethoxybenzyl hydrogen succinate (46) 50
3.12.47 3,5-Dihydroxybenzyl hydrogen succinate (47) 50
3.12.48 2,3,4-Trimetxoxybenzyl hydrogen succinate (48) 50
3.12.49 2,4,5-Trimethoxbenzyl hydrogen succinate (49) 51
3.12.50 3,4,5-Trimethoxybenzyl hydrogen succinate (50) 51
3.12.51 3-Methoxy-4-nitrobenzyl hydrogen succinate (51) 51
3.12.52 4-Methoxy-3-nitrobenzyl hydrogen succinate (52) 52
3.12.53 2-Methoxy-5-nitrobenzyl hydrogen succinate (53) 52
3.12.54 2,4,6-Trichlorobenzyl hydrogen succinate (54) 52
3.12.55 2,4,5-Tribromobenzyl hydrogen succinate (55) 53
3.12.56 2,4,6-Trimethylbenzyl hydrogen succinate (56) 53
3.12.57 Isopropyl hydrogen succinate (57) 53
3.12.58 Isobutyl hydrogen succinate (58) 53
3.12.59 Isopentyl hydrogen succinate (59) 53
3.12.60 Benzyl hydrogen succinate (60) 54
3.13 Physical Characteristics of Acid Halides 1a-60a 54
3.13.1 2-Methoxybenzyl 4-chloro-4-ketobutanoate (1a) 54
3.13.2 3-Methoxybenzyl 4-chloro-4-ketobutanoate (2a) 54
3.13.3 4-Methoxybenzyl 4-chloro-4-ketobutanoate (3a) 54
3.13.4 2,3-Dimethoxybenzyl 4-chloro-4-ketobutanoate (4a) 55
3.13.5 2,4-Dimethoxybenzyl 4-chloro-4-ketobutanoate (5a) 55
3.13.6 2,5-Dimethoxybenzyl 4-chloro-4-ketobutanoate (6a) 55
3.13.7 3,4-Dimethoxybenzyl 4-chloro-4-ketobutanoate (7a) 55
3.13.8 3,5-Dimethoxybenzyl 4-chloro-4-ketobutanoate (8a) 56
3.13.9 2-Nitrobenzyl 4-chloro-4-ketobutanoate (9a) 56
3.13.10 3-Nitrobenzyl 4-chloro-4-ketobutanoate (10a) 56
3.13.11 4-Nitrobenzyl 4-chloro-4-ketobutanoate (11a) 57
3.13.12 2-Chlorobenzyl 4-chloro-4-ketobutanoate (12a) 57
3.13.13 3-Chlorobenzyl 4-chloro-4-ketobutanoate (13a) 57
3.13.14 4-Chlorobenzyl 4-chloro-4-ketobutanoate (14a) 57
3.13.15 2-Bromobenzyl 4-chloro-4-ketobutanoate (15a) 58
3.13.16 3-Bromobenzyl 4-chloro-4-ketobutanoate (16a) 58
3.13.17 4-Bromobenzyl 4-chloro-4-ketobutanoate (17a) 58
iv
3.13.18 2-Iodobenzyl 4-chloro-4-ketobutanoate (18a) 58
3.13.19 4-Iodobenzyl 4-chloro-4-ketobutanoate (19a) 59
3.13.20 4-Iodobenzyl 4-chloro-4-ketobutanoate (20a) 59
3.13.21 2-Methylbenzyl 4-chloro-4-ketobutanoate (21a) 59
3.13.22 3-Methylbenzyl 4-chloro-4-ketobutanoate (22a) 60
3.13.23 4-Methylbenzyl 4-chloro-4-ketobutanoate (23a) 60
3.13.24 2-Hydroxybenzyl 4-chloro-4-ketobutanoate (24a) 60
3.13.25 3-Hydroxybenzyl 4-chloro-4-ketobutanoate (25a) 61
3.13.26 4-Hydroxybenzyl 4-chloro-4-ketobutanoate (26a) 61
3.13.27 2-Aminobenzyl 4-chloro-4-ketobutanoate (27a) 61
3.13.28 3-Aminobenzyl 4-chloro-4-ketobutanoate (28a) 62
3.13.29 4-Aminobenzyl 4-chloro-4-ketobutanoate (29a) 62
3.13.30 2,4-Dichlorobenzyl 4-chloro-4-ketobutanoate (30a) 62
3.13.31 2,5-Dichlorobenzyl 4-chloro-4-ketobutanoate (31a) 63
3.13.32 2,6-Dichlorobenzyl 4-chloro-4-ketobutanoate (32a) 63
3.13.33 3,4-Dichlorobenzyl 4-chloro-4-ketobutanoate (33a) 63
3.13.34 3,5-Dichlorobenzyl 4-chloro-4-ketobutanoate (34a) 64
3.13.35 2,3-Difluorobenzyl 4-chloro-4-ketobutanoate (35a) 64
3.13.36 2,4-Difluorobenzyl 4-chloro-4-ketobutanoate (36a) 64
3.13.37 2,5-Difluorobenzyl 4-chloro-4-ketobutanoate (37a) 65
3.13.38 2,6-Difluorobenzyl 4-chloro-4-ketobutanoate (38a) 65
3.13.39 2,4-Dimethylbenzyl 4-chloro-4-ketobutanoate (39a) 65
3.13.40 2,5-Dimethylbenzyl 4-chloro-4-ketobutanoate (40a) 66
3.13.41 3,4-Dimethylbenzyl 4-chloro-4-ketobutanoate (41a) 66
3.13.42 3,5-Dimethylbenzyl 4-chloro-4-ketobutanoate (42a) 66
3.13.43 3,4-Dinitrobenzyl 4-chloro-4-ketobutanoate (43a) 66
3.13.44 3,5-Dinitrobenzyl 4-chloro-4-ketobutanoate (44a) 67
3.13.45 2,6-Diethoxybenzyl 4-chloro-4-ketobutanoate (45b) 67
3.13.46 3,4-Diethoxybenzyl 4-chloro-4-ketobutanoate (46a) 67
3.13.47 3,5-Dihydroxybenzyl 4-chloro-4-ketobutanoate (47a) 68
3.13.48 2,3,4-Trimethoxybenzyl 4-chloro-4-ketobutanoate (48a) 68
3.13.49 2,4,5-Trimethoxbenzyl 4-chloro-4-ketobutanoate (49a) 68
3.13.50 3,4,5-Trimethoxybenzyl 4-chloro-4-ketobutanoate (50a) 69
3.13.51 3-Methoxy-4-nitrobenzyl 4-chloro-4-ketobutanoate (51a) 69
3.13.52 4-Methoxy-3-nitrobenzyl 4-chloro-4-ketobutanoate (52a) 69
3.13.53 2-Methoxy-5-nitrobenzyl 4-chloro-4-ketobutanoate (53a) 70
3.13.54 2,4,6-Trichlorobenzyl 4-chloro-4-ketobutanoate (54a) 70
3.13.55 2,4,5-Tribromobenzyl 4-chloro-4-ketobutanoate (55a) 70
3.13.56 2,4,6-Trimethylbenzyl 4-chloro-4-ketobutanoate (56a) 71
3.13.57 Isopropyl 4-chloro-4-ketobutanoate (57a) 71
3.13.58 Isopropyl 4-chloro-4-ketobutanoate (58a) 71
3.13.59 Isobutyl 4-chloro-4-ketobutanoate (59a) 71
3.13.60 Benzyl 4-chloro-4-ketobutanoate (60a) 71
3.14 Physical Characteristics of γ-Ketoesters 1b-56b 71
3.14.1 2-Methoxybenzyl γ-ketohexanoate (1b) 72
3.14.2 3-Methoxybenzyl γ-ketohexanoate (2b) 72
3.14.3 4-Methoxybenzyl γ-ketohexanoate (3b) 72
v
3.14.4 2,3-Dimethoxybenzyl γ-ketohexanoate (4b) 72
3.14.5 2,4-Dimethoxybenzyl γ-ketohexanoate (5b) 73
3.14.6 2,5-Dimethoxybenzyl γ-ketohexanoate (6b) 73
3.14.7 3,4-Dimethoxybenzyl γ-ketohexanoate (7b) 73
3.14.8 3,5-Dimethoxybenzyl γ-ketohexanoate (8b) 73
3.14.9 2-Nitrobenzyl γ-ketohexanoate (9b) 74
3.14.10 3-Nitrobenzyl γ-ketohexanoate (10b) 74
3.14.11 4-Nitrobenzyl γ-ketohexanoate (11b) 74
3.14.12 2-Chlorobenzyl γ-ketohexanoate (12b) 74
3.14.13 3-Chlorobenzyl γ-ketohexanoate (13b) 75
3.14.14 4-Chlorobenzyl γ-ketohexanoate (14b) 75
3.14.15 2-Bromrobenzyl γ-ketohexanoate (15b) 75
3.14.16 3-Bromrobenzyl γ-ketohexanoate (16b) 75
3.14.17 4-Bromrobenzyl γ-ketohexanoate (17b) 76
3.14.18 2-Iodobenzyl γ-ketohexanoate (18b) 76
3.14.19 3-Iodobenzyl γ-ketohexanoate (19b) 76
3.14.20 4-Iodobenzyl γ-ketohexanoate (20b) 77
3.14.21 2-Methylbenzyl γ-ketohexanoate (21b) 77
3.14.22 3-Methylbenzyl γ-ketohexanoate (22b) 77
3.14.23 4-Methylbenzyl γ-ketohexanoate (23b) 77
3.14.24 2-Hydroxybenzyl γ-ketohexanoate (24b) 78
3.14.25 3-Hydroxybenzyl γ-ketohexanoate (25b) 78
3.14.26 4-Hydroxybenzyl γ-ketohexanoate (26b) 78
3.14.27 2-Aminobenzyl γ-ketohexanoate (27b) 79
3.14.28 3-Aminobenzyl γ-ketohexanoate (28b) 79
3.14.29 4-Aminobenzyl γ-ketohexanoate (29b) 79
3.14.30 2,4-Dichlorobenzyl γ-ketohexanoate (30b) 80
3.14.31 2,5-Dichlorobenzyl γ-ketohexanoate (31b) 80
3.14.32 2,6-Dichlorobenzyl γ-ketohexanoate (32b) 80
3.14.33 3,4-Dichlorobenzyl γ-ketohexanoate (33b) 81
3.14.34 3,5-Dichlorobenzyl γ-ketohexanoate (34b) 81
3.14.35 2,3-Difluorobenzyl γ-ketohexanoate (35b) 81
3.14.36 2,4-Difluorobenzyl γ-ketohexanoate (36b) 82
3.14.37 2,5-Difluorobenzyl γ-ketohexanoate (37b) 82
3.14.38 2,6-Difluorobenzyl γ-ketohexanoate (38b) 82
3.14.39 2,4-Dimethylbenzyl γ-ketohexanoate (39b) 83
3.14.40 2,5-Dimethylbenzyl γ-ketohexanoate (40b) 83
3.14.41 3,4-Dimethylbenzyl γ-ketohexanoate (41b) 83
3.14.42 3,5-Dimethylbenzyl γ-ketohexanoate (42b) 84
3.14.43 3,4-Dinitrobenzyl γ-ketohexanoate (43b) 84
3.14.44 3,5-Dinitrobenzyl γ-ketohexanoate (44b) 84
3.14.45 2,6-Diethoxybenzyl γ-ketohexanoate (45b) 85
3.14.46 3,4-Diethoxybenzyl γ-ketohexanoate (46b) 85
3.14.47 3,5-Dihydroxybenzyl γ-ketohexanoate (47b) 85
3.14.48 2,3,4-Trimetxoxybenzyl γ-ketohexanoate (48b) 86
3.14.49 2,4,5-Trimethoxbenzyl γ-ketohexanoate (49b) 86
3.14.50 3,4,5-Trimethoxybenzyl γ-ketohexanoate (50b) 86
vi
3.14.51 3-Methoxy-4-nitrobenzyl γ-ketohexanoate (51b) 86
3.14.52 4-Methoxy-3-nitrobenzyl γ-ketohexanoate (52b) 87
3.14.53 2-Methoxy-5-nitrobenzyl γ-ketohexanoate (53b) 87
3.14.54 2,4,6-Trichlorobenzyl γ-ketohexanoate (54b) 87
3.14.55 2,4,5-Tribromobenzyl γ-ketohexanoate (55b) 88
3.14.56 2,4,6-Trimethylbenzyl γ-ketohexanoate (56b) 88
3.14.57 Isopropyl γ-ketohexanoate (57b) 88
3.14.58 Isobutyl γ-ketohexanoate (58b) 89
3.14.59 Isopentyl γ-ketohexanoate (59b) 89
3.14.60 Benzyl γ-ketohexanoate (60) 89
BIBLIOGRAPHY 129
PART-II 141
Chapter 1: INTRODUCTION 142
1 Introduction 143
1.1 General Introduction 143
1.2 The Umbelliferae 145
Chapter 2: RESULTS AND DISCUSSION 147
2 RESULTS AND DISCUSSION 148
2.1 Essential Oil 148
2.2 Isolates 149
2.2.1 1-Oxo-11β,21β-dihydroxyoleane (1) 149
2.2.2 1-Oxo-11β-hydroxy-21β-O-acetyloleane (2) 152
2.2.3 1-Oxo-11β-hydroxy-21β-O-angeloyloleane (3) 153
2.2.4 1-Oxo-11β-O-angeloyl-21β-O-acetyloleane (4) 154
2.2.5 1-Oxo-11β, 21β-O-dibenzoyloleane (5) 155
2.2.6 28-β-D-glucopyranosyl 2α,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (6) 157
2.2.7 28-β-D-glucopyranosyl 2β,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (7) 159
2.2.8 28-β-D-glucopyranosyl 2α,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (8) 160
2.2.9 28-β-D-glucopyranosyl 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (9) 161
2.2.10 28-β-D-glucopyranosyl 2β,3β,19β,24-tetrahydroxy-12-ene-oleaenoate (10) 162
2.2.11 28-β-D-glucopyranosyl 2α-O-acetyl,3α,19α,24-trihydroxy-12-eneoleaenoate (11) 163
2.2.12 28-β-D-glucopyranosyl 3α-O-acetyl,2α,19α,24-triahydroxy-12-eneoleaenoate (12) 165
2.2.13 28-β-D-glucopyranosyl 19α-O-acetyl,2α,3α,24-trihydroxy-12-eneoleaenoate (13) 166
2.3 Biological Activity 167
2.3.1 Antibacterial and antifungal activity 167
2.3.2 Anticancer activity 167
Chapter 3: EXPERIMENTAL 169
3 EXPERIMENTAL 170
3.1 General Experimental Procedure 170
3.2 Microorganisms 170
vii
3.2.1 Fungi and bacteria 170
3.2.2 Cancer cells 171
3.3 Collection of Plant Material 171
3.4 Hydrodistillation of Essential Oil from Seeds 172
3.5 GC Analysis of Essential Oil of C. sativum 172
3.6 Extraction 172
3.6.1 Isolation of compounds 172
3.6.2 Crude seed extract, solvent fractionation and isolation of 6-13 177
3.7 Physical and Spectroscopic Data of Isolates 178
3.7.1 1-Oxo-11β,21β-dihydroxyoleane (1) 178
3.7.2 1-Oxo-11β-hydroxy-21β-O-acetyloleane (2) 178
3.7.3 1-Oxo-11β-hydroxy-21β-O-angeloyloleane (3) 179
3.7.4 1-Oxo-11β-O-angeloyl-21β-O-acetyloleane (4) 179
3.7.5 1-Oxo-11β, 21β-O-dibenzoyloleane (5) 179
3.7.6 28-β-D-Glucopyranosyl, 2α,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (6) 180
3.7.7 28-β-D-Glucopyranosyl, 2β,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (7) 180
3.7.8 28-β-D-Glucopyranosyl, 2α,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (8) 180
3.7.9 28-β-D-Glucopyranosyl, 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (9) 181
3.7.10 28-β-D-Glucopyranosyl, 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (10) 181
3.7.11 28-β-D-Glucopyranosyl, 2α-O-acetyl,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (11) 181
3.7.12 28-β-D-Glucopyranosyl, 3α-O-acetyl,2α,19α,24-tetrahydroxy-12-ene-oleaenoate (12) 181
3.7.13 28-β-D-Glucopyranosyl, 19α O-acetyl,2α,3α,24-tetrahydroxy-12-ene-oleaenoate (13) 182
3.8 Biological Activities 182
3.8.1 Antifungal and antibacterial activity 182
3.8.2 Cytotoxicity 184
3.9 Statistical Analysis 184
BIBLIOGRAPHY 210
PUBLISHED WORK 218
viii
LIST of TABLES
PART-1
Table Title Page #
1 Physical characteristics of 1a-20a 91
2 Physical characteristics of 1b-20b 93
3 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 1-20 95
4 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 21-40 96
5 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 41-56 97
6 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 1-14 98
7 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 15-28 99
8 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 29-42 100
9 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 43-56 101
10 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 1a-28a 102
11 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 29a-56a 103
12 13
C-NMR (75 MHz, CDCl3, δ) of 1a-28a 104
13 13
C-NMR (75 MHz, CDCl3, δ) of 29a-56a 105
14 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 1b-27b 106
15 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 28b-56b 107
16 13
C-NMR (75 MHz, CDCl3, δ) of 1b-19b 108
17 13
C-NMR (75 MHz, CDCl3, δ) of 20b-38b 109
18 13
C-NMR (75 MHz, CDCl3, δ) of 39b-56b 110
19 Yield, mps/bps and Elemental Analysis of 57-60 and 57a-60a 111
20 Yield and bps of 57b-60b for comparison 112
21 Spectroscopic data of 57-60, 57a-60a and 57b-60b 113
22 Spectroscopic data of 59b-60b 114
23 Inhibition zones of monoesters 1-29 against fungi and bacteria 115
24 MICs of monoesters 1-29 against fungi and bacteria 116
PART-II
1 Natural product as anticancer drugs 186
2 Quantitative analysis of EO of C. sativum Linn 191
3 1H-NMR (C5D5N, 300 MHz) of compounds 1-5 isolated from C. sativum L. Seeds 192
4 13
C-NMR (DEPT, C5D5N, 75 MHz) of compounds 1-5 isolated from C. sativum L.
Seeds
193
5 Inhibition zones of 1-5 isolated from C. sativum against bacteria 194
6 Inhibition zones of 1-5 isolated from C. sativum against fungi 195
7 MICs of 1-5 isolated from C. sativum against bacterial strains 196
8 MICs of 1-5 from C. sativum against fungal strains 197
9 MBCs of 1-5 from C. sativum against bacterial strains 198
10 MFCs of 1-5 from C. sativum Seeds against fungal strains 199
11 1H-NMR (300 MHz, C5D5N) data of 6-9 isolated from C. sativum 200
12 1H-NMR (300 MHz, C5D5N) data of 10-13 isolated from C. sativum 201
13 13
C-NMR (75 MHz, C5D5N) data of 6-13 isolated from C. sativum 202
14 IC50 values (µM) of Compounds 1-13 isolated from C. sativum L. for various cell
lines
203
ix
LIST OF FIGURES
Figure Title Page#
1 General structures for various krtoesters 118
2 Preparation of monoesters (1-60), acid chlorides (1a-60a) and γ-ketoesters 119
3 Atom numbering in compounds for assignment of spectral data 121
4 Tetrahedral intermediate from reaction of RCdCl with CH3COCl 122
5 Proposed mechanism for ketone formation from acid chlorides and diethyl
cadmium 123
6 1H (
13C) NMR and 2DNMR: (i) COSY-45
0 and HOHAHA Bold-bond (ii)
HMBC (iii) NOESY (iv) HMQC for compound 1.
124
7 Presentation of 2D NMR interactions in 30 125
8 Presentation of 2D NMR interactions in 1b 126
9 Presentation of 2D NMR in 30b 127
10 Fragmentation pattern of compound 1 127
PART-II
1 FTIR of essential oils obtained from C. sativum 205
2 COSY and HOHAHA; HMBC Interaction in 1-5 206
3 NOESY Interaction in 1-5 207
4 COSY-45°, HOHAHA and HMBC in 6-13 208
5 ROESY Interaction 6-13 209
LIST OF HISTOGRAMS
1 Zone of inhibition (mm) of essential oil and other subfractions against
fungi
187
2 Zone of inhibition of (mm) essential oil and other subfractions against
bacteria
188
3 MIC (μg) of essential oil and other subfractions against fungi 189
4 MIC (μg) of essential oil and other subfractions against bacteria 190
SCHEMES
1 Extraction of compounds 1-5 175
2 Extraction of compounds 6-13 176
x
ACKNOWLEDGEMENTS
All admiration and prayer is purely for the Omnipotent, the most Merciful, the
Compassionate, and the Omniscient Al-Mighty ALLAH, whose clemency resulted into my
success. The ALLAH, Who created me, bestowed me with sound health and faultless body
and enabled me to perform and compose my research work in the form of thesis. I wish to pay
homage to the most perfect personality of the world Hazrat MUHAMMAD (PBUH), who
enlightened our minds to recognize our Creator.
I am highly indebted to my learned and able supervisor Professor Dr. Imam Bakhsh
Baloch for his valuable guidance, untiring working habit, brotherly behaviour and methodical
understanding of the subject of organic chemistry. I am extremely thankful to Professor Dr
Musa Kaleem Baloch, for his valuable discussions suggestions and instructions throughout
my career in general and during my Ph. D research in particular. My special thanks are for the
Chairman Department of Chemistry, Professor Dr Azim Khan Khattak for his extended
support and facilities during my research work. My special thanks go to Professor Dr Sher
khan Sadozai for his moral support during my career. I am extremely grateful to all my
talented teachers and colleagues for technical and moral support. I am also thankful to all my
friends, laboratory and office staff for their support and encouragement during my Ph. D
work.
I am highly obliged to my parent Organization “Gomal University Dera Ismail Khan”
the only existence of it in Dera Ismail Khan city provided me not only with the basic and
advanced knowledge of organic chemistry but also honour, respect, and job.
My special thanks are for those who extended moral support during completion of Ph. D
thesis.
xi
My prayers and thanks are due for my parents (Late), brothers, sisters, wife and
children whose moral, financial and inspiring support resulted in achieving this goal.
In the last I would like to acknowledge the cooperation and moral support of my eldest
brother, “A. W. Malik Pricipal (R) Govt College of Technology” throughout my life.
Muhammad Iqbal
xii
ABBREVIATIONS
Ac Acetyl
Aq Aqueous
Ar Aryl
n-Bu n-Butyl
C Concentration
CHCl3 Chloroform
CH2Cl2 Dichloromethane
DMSO Dimethyl sulphoxide
EtOAc Ethyl acetate
EIMS Electron impact mass spectrum
ESIMS Electrospray ionization mass spectrum
EtOH Ethanol
t-BuOH tert-Butanol
Et Ethyl
FABMS Fast atom bombardment spectrum
G Gram(s)
M+ Molecular ion
Me Methyl
MHz Megahertz
Min Minute(s)
mL milliliter(s)
Mm millimole(s)
m. p. melting point
m/z mass to charge ratio (in mass spectrometry)
Ph Phenyl
i-Pr Isopropyl
Rf Retention factor (in Chromatography)
Rt Room temperature
S Second (s)
THF Tetrahydrofuran
TLC Thin layer chromatography
xiii
TECHNIQUES
BB Broad (decoupled) band
CC Column chromatography
COSY Correlated spectroscopy
DEPT Distortionless enhancement by polarization
transfer
EI-MS Electron impact mass spectrum
FAB-MS Fast atom bombardment mass spectrometry
GC/MS Gas chromatography mass spectrometry
HMBC Heteronuclear multiple bond connectivity
HMQC Heteronuclear multiple quantum coherence
HOHAHA Homonuclear Hartmann-Hahn Spectroscopy
HR-EIMS High resolution electron impact mass spectrum
IR Infrared spectrophotometry
NMR Nuclear magnetic resonance
NOESY Nuclear overhauser effect spectroscopy
ROESY Rotating Frame Overhouser Enhancement
Spectroscopy
RP-HPLC Reverse Phase High Performance
Chromatography
TLC Thin layer chromatography
UV Ultraviolet
1
ABSTRACT
The thesis consists of two parts. The part-I deals with the synthesis of γ-ketoesters using succinic
anhydride as a starting material. The part-II is about extraction, isolation, purification and
characterization of the chemical constituents from Coriandrum sativum Linn (Umbelliferae).
It is an established fact that γ-ketoesters and their precursors are valuable synthons in synthetic
organic chemistry. These intermediates have potential applications in the preparation of
compounds of significant importance. In view of the important applications of γ-ketoesters, a
three-step reaction approach has been employed for their synthesis via acid catalyzed ring
opening of succinic anhydride with substituted benzyl alcohols.
Step-1: Sixty (1-60) new monoesters of succinic acid were prepared using succinic anhydride
and alcohols and toluene as a solvent. The catalyst employed was p-toluene sulfonic acid.
Step-2: In this step the prepared monoesters on treatment with thionyl chloride were converted to
corresponding acid chlorides (1a-60a).
Step-3: Finally, using diethyl cadmium reagent, acid chlorides obtained in the step-2 were
converted into corresponding novel γ-ketohexanoates (1b-60b). Diethyl cadmium was prepared
by employing ethyl magnesium bromide and cadmium bromide.
The final products were characterized by elemental analysis and spectroscopic techniques such as
UV, IR, NMR (1H and
13C) 1D and 2D, COSY-45°, DEPT, HMQC, HMBC, NOE, ROESY,
NOESY, mass spectrometry etc.
Monoesters (1-29) were screened for biological activity against three fungi and three bacteria
following disk diffusion protocol for inhibition zones and agar dilution method for minimum
inhibitory concentrations. Their structure activity relationship is also discussed.
2
All of the monoesters except nitro substituted were found to be active against fungi and bacteria.
In Part-II seeds of Coriandrum sativum Linn (Umbelliferae) were hydrodistilled for essential oil
and the obtained oil was analyzed by gas chromatograogy for its components. β-Linalool with
retention time 16.575 min and %age 79.86 was identified as major component by GC-MS. The
obtained essential oil was subjected to antifungal and antibacterial activity. Inhibition zones,
minimum inhibitory concentrations (MICs) against fungi and bacteria were assessed. Results of
these experiments showed that the essential oil was active against investigated microbes.
The whole plant (seeds, leaves, stems, flowers) was extracted in 95% aqueous MeOH. The
methanolic extract on solvent fractionation and repeated column chromatography on silica gel
afforded a bio-active fraction. The fraction on repeated chromatotrax preparative TLC yielded
most active fraction which under HPLC RP-18 fractionation afforded thirteen (1-13) compounds.
According to our knowledge, since compounds 1-5 have not been reported earlier from plant
kingdom and hence can be declared as new entities. The obtained compounds 1-13 were
subjected to antifungal and antibacterial activity. Inhibition zones, minimum inhibitory
concentrations (MICs) against fungi and bacteria were assessed. For isolates (6-13), cytotoxicity
against cancer cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW-480) was probed. IC50 of
compounds 6-13 against human cancer cell lines HL-60 were also assessed. Compounds (1-3, 6-
13) displayed antimicrobial and cytotoxicity against used human cell lines.
Among the tetra-hydroxysaponins (6-9) displayed IC50 =1.37± 0.02, 1.29 ± 0.02, 1.28 ± 0.02, and
1.07 ± 0.02, respectively, and compounds 10-13 displayed significant activity with IC50=1.27±
0.02, 1.02 ± 0.02, 1.02 ± 0.02, and 0.87 ± 0.02, respectively, standard (acarbose) showed IC50
0.82 µM.
3
Structure and relative configuration of the compounds 1-13 was established after recording and
analysis of spectroscopic data such as IR, 1D-NMR and 2D NMR (COSY-45, HOHAHA,
HMQC, HMBC and ROESY) and mass measurements. The data revealed that isolated
compounds are oleane triterpenoids and named as: 1-Oxo-11,21-dihydroxyoleane (1), 1-Oxo-11-
hydroxy-21-O-acetyloleane (2), 1-Oxo-11-hydroxy-21-O-angeloyloleane (3), 1-Oxo-11-O-angelo
yl-21-O-acetyloleane (4), 1-Oxo-11,21-O-dibenzoyloleane (5), 28-β-D-Glucopyranosyl 2α,3α,
19α,24-tetrahydroxy-12-ene-oleaenoate (6), 28-β-D-Glucopyranosyl 2β,3α,19α,24-tetrahydroxy-
12-ene-oleaenoate (7), 28-β-D-Glucopyranosyl 2α,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (8),
28-β-D-Glucopyranosyl 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (9), 28-β-D-Glucopyrano-
syl 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (10), 28-β-D-Glucopyranosyl 2α-O-acetyl
,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (11), 28-β-D-Glucopyranosyl 3α-O-acetyl,2α,19α,24-
tetrahydroxy-12-ene-oleaenoate (12) and 28-β-D-Glucopyranosyl 19α-O-acetyl,2α,3α,24-tetrahy-
droxy-12-ene-oleaenoate (13).
4
PART-I
SYNTHESIS OF γ-KETOESTERS
VIA
ACID CATALYSED RING OPENING
OF
SUCCINIC ANHYDRIDE
WITH
SUBSTITUTED BENZYL ALCOHOLS
5
CHAPTER-1
INTRODUCTION
6
1. INTROUCTION
1.1. General Overview
It was believed that a vital force, which could only be present in living organisms, was essential
for the synthesis of organic compounds (Kinne-Saffran and Kinne, 1999). Consequently, the
scientists believed that organic compounds could only be synthesized in living organisms like
plants and animals (Kinne-Saffran and Kinne, 1999). However, during early nineteenth century,
Wohler synthesized urea by heating ammonium cyanate and resulted in a revolution in the
synthetic organic chemistry (Kinne-Saffran and Kinne, 1999). The synthesis of urea not only led
to the termination of the so called “Vital Force Theory” but also delivered a new foundation to
synthetic organic chemistry and opened a new gateway for multitude of organic compounds.
After that, the scientists focused all their efforts to synthesize new organic compounds and
resulted the synthesis of astonishing and marvelous compounds and drugs.
In fact, the syntheses of valuable compounds from simple and easily available starting materials
have been the goal of the scientists. Dicarboxylic acids on esterification with alcohols could give
monoesters as well as diesters. Succinic anhydride is another compound that has enjoyed many
applications in the synthesis of monoesters. It is an excellent starting material and is readily
available in pure form and has been used in the synthesis of mono and di acid derivatives
(Izquierdo et al., 2011, Ronsheim et al., 2002). These are key intermediates in the synthesis of
valuable compounds of industrial, agricultural, medicinal and economic importance (Hilgenkamp
and Zercher, 2001)
1.2. Benzyl Hydrogen Succinates (Monoesters)
Monoesters can be derived from acid anhydrides, esterification of dicarboxylic acids and
hydrolysis of diesters (Huang et al., 2005, Williams et al., 2001, 2002).
7
Succinic anhydride is one of the several useful starting materials that provide monoesters when
treated with alcohols (Huang et al., 2005). The chemistry of succinic anhydride and succinic acid
has numerous applications in the preparation of daily life products (Williams et al., 2001, 2002).
Polymers of butylene with succinic acid and copolymer with succinic and adipic acid were
biodegradable (Maeda et al., 2005). Succinic anhydride on reaction with magnesium diethoxide
and ethylene oxide had been converted to a succinic acid-ethylene oxide polymer (Maeda et al.,
1997). These are also used in magnetic resonance imaging, gene transfection, tissue sealing and
drug delivery system (Luman et al., 2004). Monoesters are associated with amphiphilic and
lyotropic liquid crystal properties (Marchal et al., 2008; Nardello et al., 2006).
Monoesters are used in the preparation of isoprenoid building blocks (Ostermeier et al., 2003).
Using p-toluenesulphonic acid (TsOH) and D-glucose monoesters of succinc acid and ethanol
were prepared (Zhang et al., 2010). Other significant work in this respect is conversion of
succinic anhydride to monoesters on treatment with alcohols (van Rudloff, 1956).
Monoesters of succinates have been used as synthon in the preparation of flavonoids, terpenoids,
alkaloids, glycosides, vitamin K, vitamins, α-tocopherol, mammalian dolichols, archaic
membrane lipids, (S)-26-hydroxycholesterol, (-)-invictolide (Hekking et al., 2008; Jiang et al.,
2007). Monoesters from succinic anhydride are used as resolving agents ( Maeda et al., 1997).
Natural derivatives of succinic acid like dehydroandrographolide has been employed in in vitro
anti-HIV activities. Esters with diterpene alcohols displayed significant activity against HIV,
tumour and enzyme inhibition (Fujimaki, 1998). The derivatives of succinic acid with diterpenols
are even more biologically active against HIV, antitumor and in enzyme inhibition (Fujimaki,
1998; Vraka et al., 2006; Basak et al, 1999; Matsumura et al., 2000). Polymers formed with
glycerol are used as antiseptic (Vraka et al., 2006; Basak et al, 1999). The mnoesters also have
8
an effect on the chlorophyll contents and consequently on growth of plants (Todorov et al.,
1992). Some of them display phosphodiesterase inhibitory activity.
1.3. Substituted Benzyl 4-Chloro-4-Ketohexanoates (Acid Chlorides)
Acid chlorides are very reactive and synthetically useful compounds (Inoue et al., 2001). They
have been described as key intermediates in the homologation of carboxylic acids via Arndt
Eistert synthesis. Their use in Friedel-Crafts acylation of aromatic compounds to give ketones is
well recognized (Kobayashi et al., 1998; Yeung et al., 2002; Matsunami et al., 2007).
Acid chlorides have been frequently used in the synthesis of ketones on treatment with
organometallic reagents (von Rudloff, 1958). Numerous compounds of synthetic importance like
alkyl, aryl substituted heterocyclics, carbohydrates, amino acids and amides have been prepared
from acid chloride and zinc. Acid halides have been used as an acylating agent for several
triphenylphosphonium ylides (Meshram et al., 1998).
In another study 1-alkyl-2-methyleneaziridines and acid halides in non-polar solvents afforded
good yield of ring-opened en-amides as final products (Ennis et al., 2000). The selenoesters,
useful intermediates in the synthesis of natural products, were prepared by acid chlorides (Chen
and Zhang, 2000). The reaction of acid chlorides and diarylselenides catalyzed by Sm/CrCl3
afforded selenoesters (Liu and Zhang, 1999). Excellent yield of N, N-dimethyl amides were
obtained on reaction of acid chlorides with dimethylformamide (Lee et al., 2000; Sirinivasan and
Manisankar, 2010). Aliphatic, alicyclic, aromatic and heterocyclic acid chlorides have been
transformed into corresponding amides (Lee et al., 2000; Sirinivasan and Manisankar, 2010). An
excellent synthetic application of acid chlorides or acid anhydrides has been made in SmI2
catalyzed regioselective ring opening of three, four and five membered cyclic ethers (Kwon et al.,
2002).
9
Some alkoxy substituted acid chlorides readily under went acid catalyzed decarbonylation and
resulted in the formation of alkyl chloromethyl ethers.
Baruah and coworkers have successfully prepared β,γ-unsaturated ketones by treating acid
chlorides with allyl and crotyl bromide using finely divided cadmium as a catalyst and
tetrahydrofuran as a solvent (Baruah et all, 1996). Using organozinc reagents, ketones have been
synthesized from acid chlorides derived from aliphatic, cyclic and aromatic carboxylic acids in
the presence of palladium complexes as catalyst (Grey, 1983). Acid chlorides with organotin
compounds in the presence of Pd complex gave cross coupling reaction and yielded ketones.
Acid chlorides and alkyl boronic acids using palladium complex of triphenyphosphene and
CsCO3 as catalyst yielded ketones (Haddach and McCarthy, 1999). Acid chlorides are a good
source of acylsilanes (Geng et al., 1999). The above mentioned facts about synthetic utility of the
acid chlorides concluded beyond any doubt that these are intermediates of high synthetic utility in
the synthetic organic chemistry.
Therefore, a number of techniques have been proposed to synthesise such acid chlorides. Ruggli
and Maeder synthesized acid chlorides by treating carboxylic acid with oxaloyl chloride and
phosphorous oxychloride. Cason used thionyl chloride to transform monoesters into acid
chlorides. Carboxylic acids on treatment with cyanuric chloride (C3N3Cl3) in triethyl amine give
good yield of corresponding acid chlorides.
1.4. γ-Ketoesters (Substituted Benzyl 4-Ketohexanoates)
The name “ketoester” has been specified to bifunctional open and closed chain compounds
having ketone and ester functionality. The relative position of these two functions in the structure
of esters has been exploited to classify them into various categories. In α-ketoesters, the ketone
and ester functions are at adjacent positions (Agami et al., 2003) (Fig. 1a) and in β-ketoesters, the
10
ketone function is at 3 and ester at 1 position (Agami et al., 2003) (Fig. 1b). Bi-functional
compounds with a keto group at 4 and ester at 1 position are called 4-ketoester or gamma-
ketoester (γ- ketoesters, Fig. 1c). Both open chain and closed chain γ-ketoesters with varying size
of chain and ring have been synthesized. In the last decades, the agricultural, pharmaceutical and
medicinal importance of these esters has attracted the scientists (Ballini et al., 1998; Chaudhuri et
al., 2010). The ketoesters having ketone functionality at positions 5 and 6 are called δ and ω-
ketoesters, respectively (Ballini et al., 1998; Enders et al., 1997; King et al., 1996) (Fig. 1d).
γ-Ketoesters are used in the preparation of furans (Huang et al., 2005), benzotropolones (Kamal
et al., 2003), alkoxythiophenes (Sonpatki et al., 2001) and other heterocyles (Csende and Stajer,
2000). Their applications as intermediates in the preparation of cyclopentenone, natural flavor
(Starodubtseva, et al., 2008) and useful building blocks of pharmaceutical interests. Moreover,
ketoesters can be converted to various important compounds like butyrolactone, its dimer
(Williams et al., 2002) chiral γ-hydroxyesters (Benincori et al., 2004; Williams et al., 2001), γ-
hydroxycarboxylic acids (Csende and Stajer, 2000) and chiral auxiliaries (Romo and Meyers,
1991). The γ-ketoesters could be reduced to γ-hydroxyesters, which on subsequent hydrolysis
lead to γ-hydroxyl butyric acid (GHBA), a metabolite of γ-amino butyric acid present in
mammalian brain and used in the treatment of daytime sleepiness and cataplexy associated with
narcolepsy (Hog et al., 2008). Ketoesters can be reduced to corresponding secondary alcohols
using Cp2TiCl2 or Zn dust and water (Barrero et al., 2003). Presence of two functional groups in
ketoesters renders these compounds to own multifarious applications and their derivatives are
used in pharmaceutical and agrochemical industries (Nakamura et al., 2003; Pohmakotr et al.,
2007; Chaudhuri et al., 2010; Osawa et al., 2003). For example, the γ- ketoesters have been
catalytically reduced to chiral γ-hydroxyester and lactone derivatives by using RuCl3-BINAP-
11
HCl (Starodubtseva et al., 2008) and (COD) Ru(2-methylallyl)2-BINAP-HCl (Turova et al.,
2009). The γ- and δ-ketoesters and acids have also been reduced using yeasts to chiral hydroxyl
esters/acids which were further transformed to chiral lactones (Forzato et al., 2001; Benincori et
al., 2004). Their reduction to chiral hydroxyl esters has also been achieved by double
nucleophilic trifluoromethylation reactions (Singh et al., 2001). Chiral reduction of γ-ketoesters,
δ-ketoesters and lactones to corresponding optically active 1,4- and 1,5-diols by employing
Lipase from Pseudomonas cepacia have been reported (Kamal et al., 2003). These derivatives are
important synthons of some biologically active compounds like sex hormones and pheromones,
anti-asthma drugs, isoquinolines, lactam antibiotics, enzyme inhibitors, additives in food, and
perfumes (Huang et al., 2005; Starodubtseva et al., 2008; Heiss et al., 2001; Itoh et al., 2002;
Kizaki et al., 2001; Arends and Sheldon, 2004; Tojo and Fernández, 2006; Yamamoto et al.,
2002a, 2002b; Nanduri et al., 2001).
Keeping in view the importance of ketoesters and their derivatives numerous methods have been
put forward for their synthesis (Cason, 1946). Their synthesis by the reaction of aldehydes and
dimethyl maleate has also been reported (Starodubtseva et al., 2008). Reaction of methyl (or
ethyl) ester of 2,2,2-trifluoroacetic acid, dimethyl succinate and sodium in dry ether led to the
synthesis of γ-ketoesters which were further transformed to heterocyclic compounds (Wan et al.,
2009). Chiral 2-substituted γ-ketoesters have been prepared by the reaction of aryldiazoacetates
and enamines in the presence of copper and rhodium complex as catalysts in good yield (Zhao et
al., 2005). Synthesis of a number of γ-ketoesters has also been described by the reaction of
conjugated unsaturated ketones and α-nitrocycloalkanones (Ballini et al., 1998). Reaction of
aryldiazoacetates and enamines afforded γ-ketoesters via substituted enamines as intermediates
(Yan et al., 2004). These have also been prepared by a method involving cross coupling between
12
the monoester monochloride of succinic and glutaric acid and suitable Grignard compounds in
the presence of CuI (Benincori et al., 2004). Some other methods of practical worth for the
synthesis of γ-ketoesters include rearrangement of γ-hydroxy-α,β-unsaturated ketones in xylene
(Giardina et al., 2001). Kashima and coworkers prepared γ-ketoesters by the reaction of the
Grignard reagent and N-acylpyrazoles (Kashima et al., 2001). In aprotic solvents cyanide ion
catalyzed condensation of aromatic and heterocyclic aldehydes to α, β-unsaturated ketones,
esters, and nitriles resulted in the formation of corresponding γ-diketones, 4-oxo carboxylic
esters, and 4-oxo nitriles. (Ballini and Petrini, 2004). 4-Oxoesters were successfully prepared by
applying Nef reaction in which nitro group was converted to carbonyl yielding required esters
(Ballini and Petrini, 2004). Cowling and Mann prepared γ-ketoesters from oxyallyls and 2π-
systems (1, 1-dimethoxyethene). A good yield of γ-ketoesters was obtained by homologation of
aldehydes with methyl 5-triphenylphosphoranylidenelevulinate. γ-ketoesters were also obtained
by the reaction of bisdithiane, n-butyl lithium and alkyl or aryl halide in hexane. These have been
prepared from diethyl succinate via acetylation, hydrolysis, decarboxylation and esterification.
Formation of γ-diketones or γ-ketoesters from primary nitro alkanes with α, β-unsaturated
ketones or α, β-unsaturated esters, in the presence of two equivalents of 1, 8-Diazabicyclo [5.4.0]
undec-7-ene (DBU) have been reported (Ballini et al., 2002). Such compounds have been
synthesized from 3, 4-epoxyesters by treating with alcohols to get open chain 4-alkoxy-3-
hydroxyesters on treatment with BF3 (Izquierdo et al., 2011). The preparation of γ-ketoesters has
also been reported from the reaction of β-ketoesters and EtZnCH2I (Ronsheim et al., 2002). The
reaction of β-diketone with EtZnCH2I has been used to prepare γ-ketoesters (Hilgenkamp and
Zercher, 2001). Enamines and ethyldiazoacetate (EDA) in the presence of rhodium and copper
complex afforded γ-ketoesters (Huang et al., 2005). The γ-ketoesters have been prepared from the
13
esters having triple bond in acid part by addition of water in the presence of NaAuCl4 (Wang et
al., 2009). The γ-ketoesters were prepared from substituted γ -lactones and γ-lactone dimers using
Smarium iodide (SmI2) (Williams et al., 2001, 2002).
The revealed literature concluded that most of the techniques involved in synthesis are complex
in nature, require very expensive transition metal complexes, their ions or oxides as catalyst and
toxic solvents which may not be environment friendly (Starodubtseva et al., 2008; Forzato et al.,
2001; Benincori et al., 2004; Poliakoff et al., 2002; Arends and Sheldon, 2004; Tojo and
Fernández, 2006; Bandgar et al., 2005; Csende, 2002; Hilgenkamp and Zercher, 2001; Kashima
et al., 2001; Wang et al., 2009; Williams et al., 2001, 2002; Huang et al., 2005). Keeping in view
these facts some of the scientists came with anaerobic oxidation of hydroxyl esters to get
ketoesters. However, this technique faced criticism on the grounds that it is difficult to control
and to obtain a well-defined product ( Poliakoff et al., 2002).
The above aspects prompted us to synthesise several useful compounds (1-60, 1a-60a and 1b-
60b) by following a three-step reaction using diethyl ether as solvent and diethyl cadmium as
ethylating agent.
1.5. Estimation of Biological Activity
The prime objective of the scientists is to synthesize compounds having biological or chemical
applications. A compound is said to be biologically active if it possesses the ability to affect
(positive or negative) microorganisms, plants, animals or human beings on their exposure to it
(Andrew, 2001; Singh et al., 2011).
Though, all of the synthesized compounds do not display bio-activity but some of the synthesized
compounds have excellent biological activity and are used in many areas of health related
problems including various types of cancer (Ragavan et al., 2012). Therefore, it is necessary to
14
estimate the biological activity of the synthesized compounds to assess their applications or
utility. A technique commonly employed for the estimation of bioactivity of a compound is
treating certain pathogenic bacteria and fungi with it and comparing its activity to a standard drug
(EUCAST Documents, 2000, 2012; Doern, 2000). In estimating bioactivity the following
important parameters are measured.
1.5.1. Inhibition zones
Inhibition zones are qualitative measures of the biological activity of compounds against
microorganisms. The inhibition zone of a bioactive compound is defined as the diameter (mm) of
a clear circular zone (without any symptoms of growth of microorganism) around the filter paper
disk that was impregnated with the solution of the compound, placed on an appropriate
supportive media inoculated with the microorganism and incubated overnight. The inhibition
zones are directly related to the activity of the compound under consideration. The larger the
value of inhibition zone, the greater will be activity of the compound. Inhibition zone against
fungi and bacteria can be measured by employing either disk diffusion (EUCAST Definitive
Document, 2000) or agar well diffusion techniques (Khan et al., 2006).
1.5.2. Minimum inhibitory concentrations (MICs)
The second parameter which is of prime interest in estimating the bioactivity of the compounds is
minimum inhibitory concentration. It is a quantitative measurement of bioactivity which is
defined as the least or minimum quantity in mg/L (μg/mL) of a compound when added to a media
inhibits the growth of overnight culture of bacteria or fungi. The MICs values give information
about the activity of the compounds; low values correspond to high activities and vice versa. The
reported methods for the estimation of MICs of the compounds include agar dilution, agar well
dilution, broth dilution techniques and E-tests (Sen and Batra, 2012; Wanger et al., 1995; Clancy
15
and Ngyugen, 1999; Lozano-Chiu et al., 1998; Pfaller et al., 1998; (EUCAST Definitive
Document, 2000, 2012; Clinical Laboratory Standards Institute by Wayne 2006).
16
1.6. Aim and Objectives
Keeping in view the importance of γ-ketoesters and shortcomings pointed out in the techniques
involved in the synthesis of such compounds our aim was to synthesise these important
compounds by establishing a simple technique and investigate biological activity of the
synthesized compounds. For this purpose the following steps were taken;
a. Preparation of biologically active monoesters from succinic anhydride
b. Conversion of monoesters to acid chlorides
c. Preparation of γ-ketoesters from acid chlorides
d. Structural characterization of prepared compounds by various spectroscopic methods.
e. Biological activity of the synthesized monoesters
17
CHAPTER-2
RESULTS AND DISCUSSION
18
2. RESULTS AND DISCUSSION
The esterification of the alkyl, mono-, di-, and tri-substituted benzyl alcohols with succinic
anhydride afforded novel alkyl, mono-, di- and trisubstituted benzyl hydrogen succinates (1-60)
in good yield (Fig. 2). The TLC results and 1H-NMR data of the crude reaction mixture proved
that the esterification gave single product with reasonable high selectivity.
The structure of 1-60, 1a-60a, 1b-60b compounds were established by different spectroscopic
(UV, IR, NMR, and MS) techniques. The physical and spectroscopic data of compounds are
presented (Tables 1-22). The antimicrobial activities of monoesters 1-29 are presented in tables
23 and 24.
2.1. Characterization Monoester 1-56
Monoester 1 was obtained as colorless amorphous solid, m.p. 55-57 °C in 71% yield. The UV
spectrum of 1 displayed a peak at 253 nm (3.5) due to the presence of an aryl chromophore. The
IR spectrum displayed a broad band at 3412 for O-H, 1729 &1717 for C=O and 1210 cm-1
for C-
O. Presence of an aromatic moiety in 1 was evident from the peaks observed at 3023 cm-1
and
1495 cm-1
for Ar-H at and C=C, respectively.
1H-NMR spectrum displayed multiplet in the low-field region, at δ 6.93-7.22 due to aromatic
protons (Table 3). Two peaks at δ 2.85 (d, J = 6.8 Hz, 2H) and δ 2.75 (d, J = 6.8 Hz, 2H) were
assigned to methylene groups between acid and ester functions. Two singlets at δ 3.81 and δ 5.06
were due to protons of OCH3 and methylene (O-CH2) respectively. Presence of the carboxylic
acid functionality was also verified by peak at δ 12.41 which disappeared on addition of D2O.
13C-NMR spectrum of compound 1 displayed twelve peaks for twelve carbon atoms
corresponding to molecular formula C12H14O5 (Table 3). DEPT 13
C-NMR displayed one CH3,
three CH2, two C (carbonyl), four CH (aromatic) and two C atom (aromatic). Further, the
19
chemical shift of three carbons showed that these are attached to three oxygen atom. The 2D-
NMR (1H-
1H) spectra of 1 (COSY-45° and HOHAHA) disclosed two spin systems i.e., i) CH-CH
and ii) CH2-CH2 and were verified by the HMQC technique (Fig. 6).
Esterification in 1 was further confirmed by HMBC (Fig. 6) in which the CH2 resonating at δ
5.06 and the CH2 at δ 2.75 displayed interactions with aryl C-1,2 and the carbonyl group of ester
function (δ 172.7), respectively. In the same spectrum there was another interaction between the
methylene proton (δ 2.85) and the acidic carbon (δ 173.9) (Fig. 6). In the NOE 2D-NMR (1H-
1H)
spectrum, interactions were observed between two CH2 protons resonating at δ 2.75 adjacent to
the C=O group. Interaction between CH2 (δ 2.75) and C=O (δ 172.7) was also observed. The
mass fragmentation pattern of 1 is presented in Fig. 10. In the light of all the spectral evidence,
the formation of 1 was confirmed. Similarly, the structures of compounds (2-56) were established
in this way.
Final structural proof was obtained from elemental analysis that gave molecular formula
C12H14O5 (238.24): C, 60.50%; H, 5.92%; Found: C, 60.34%; H, 5.70%.
2.2. Characterization of Monoester 30
Monoester 30 was obtained as colorless, amorphous solid, m.p. 71-73 °C and yield 60% (3.33 g).
The UV spectrum of 30 showed a peak at 259 nm indicating the presence of an aryl
chromophore. In IR spectrum, the 30 displayed a broad band at 3386 cm-1
for OH. Presence of
aromatic moiety was evident by Ar-H peaks in the aromatic region at 3083 cm-1
. Peaks 1510 and
1473 cm-1
were assigned to aromatic C=C bonds. The significant and most important peak at
1722 cm-1
was assigned to carboxylic group (COOH) while peak at 1773 cm-1
was attributed to
ester group. Peaks at 1247, 1123 and 1022 cm-1
were due to C-O stretching. Presence of C-Cl
bond was revealed by the peaks near 723 cm-1
.
20
The 1
H-NMR spectrum of compound 30 displayed a multiplet in the low-field region, at δ 7.36-
7.87 for three aromatic protons (Table 4). Two peaks at δ 2.93 (d, J = 6.8 Hz, 2H) and δ 2.82 (d,
J = 6.8 Hz, 2H) were assigned to methylene groups. Singlet at δ 5.24 for 2H was due to protons
of oxymethylene (O-CH2). Presence of the carboxylic acid protons was also verified by proton
resonating at δ 11.82 which disappeared on addition of D2O. 13
C-NMR spectrum displayed
eleven peaks for eleven carbon atoms corresponding to molecular formula C11H10Cl2O4 (Table 8).
Broad band (BB) and DEPT 13
C-NMR displayed three CH2, two C (carbonyl), four CH
(aromatic) and four C atom. 13
C-NMR spectrum, of 30 displayed two low field singlets at δ 171.3
and 176.9 and were assigned to carboxylic (C=O) and ester (C=O) carbons, respectively. In the
same NMR two triplets at δ 32.2 and 33.2 were assigned to two methylene groups flanked by
ester and acid functions whereas CH2O carbon gave a triplet as δ 65.8. 13
C-NMR spectrum also
displayed three singlets at δ 137.6, 135.8, 131.4, two doublets at δ131.4d, 128.9 and a singlet at δ
134.1 were due to six aromatic carbons.
COSY-45° and HOHAHA revealed spin systems; i) CH-CH and ii) CH2-CH2 verified by the
HMQC technique (Fig. 7). The molecular formula was confirmed by observing (M+) ion peak in
HR-MS at m/z 277.10. Analytical data afforded C, 47.73%; H, 3.42%, Cl, 25.66% for molecular
formula C11H10Cl2O4. Calculated % are C, 47.68%; H, 3.64 % and Cl 25.59%.
In HMBC (Fig. 7) CH2 resonating at δ 2.93 and δ 2.82 displayed interactions with acid (C=O)
and ester (C=O). A oxymethylene group (CH2O) resonated at δ 5.24 showed interaction with aryl
C-1 and CO2 (δ 171.3) (Fig. 7). In the spectrum, interactions were observed between two CH2
protons resonated at δ 2.82. All above mentioned facts proved the formation of 30. Similarly, the
structures of compounds (2-56) were established in this way.
In the DEPT (13
C-NMR) spectrum, compound 30 displayed eleven peaks for eleven carbon atoms
21
corresponding to molecular formula C11H10Cl2O4. DEPT 13
C-NMR displayed three CH2, three
CH (aromatic) and five C atoms.
Further, the chemical shift of two carbons showed that these are attached to two oxygen atoms.
The 2D-NMR (1H-
1H) spectra of 30 (COSY-45° and HOHAHA) disclosed two fragments: i) CH-
CH and ii) CH2-CH2 and were verified by the HMQC technique (Fig. 7). Esterification was
further confirmed by HMBC in which the CH2 resonating at δH 5.24 and the CH2 at δH 2.82
displayed interactions with aryl C-1,2 and the carbonyl group of ester function (δC 171.3) ,
respectively. In the same spectrum there was another interaction between the methylene proton
(δH 2.85) and the acidic carbon (δC 176.9) (Fig. 7). In the ROESY 2D-NMR (1H-
1H) spectrum,
interactions were observed between two CH2 protons resonating at δH 2.82 adjacent to the C=O
group. Interaction between CH2 (δH 2.82) and C=O (δC 171.3) was also observed. In the light of
all the spectral evidence, the formation of 30 was confirmed. The structures of synthesized (31-
56) compounds were established in this way.
2.3. Characterization of Chlorides 1a-56a
In the present study sixty (1a-60a) acid halides were prepared from sixty monoesters (1-60).
Their formation was confirmed by taking physical data and spectroscopic data analysis (Tables 1-
22). Compounds 1a, 30a and 57a were considered as representatives of all the acid halides and
their structural characterization is discussed in detail.
2.3.1. Characterization of 1a
The principal change on transforming 11a is the replacement of hydroxyl group (OH) by a
chloride (Cl). Therefore, the absence of OH peak in the IR spectrum of 1a was the strong
evidence supporting the formation of 1a. The IR spectrum of 1a showed no OH peak for the
initial monoester 1. The two new peaks observed (723 cm-1
and 1792 cm-1
) were assigned to C-Cl
22
and Cl-C=O, respectively, confirming the formation of 1a. In the 13
C-NMR spectra, a peak at δ
175.6 supported the formation of 1a; this was also verified by HMBC spectrum, in which the
proton resonating at δ 2.74, displayed interactions with carbon resonating at δ 175.6, was
attributed to COCl (Fig. 2). Others 1H- and
13C-NMR assignments were also in accordance with
the structure of 1a (Table 10 and 12). In the high resolution electron impact MS (HRMS)
spectrum, 1a displayed a molecular ion peak [M+] at m/z 256.6823 (calc. 256.6813)
corresponding to C12H13ClO4. Chemical analysis data of 1a supported the molecular formula
C12H13ClO4.
2.3.2. Characterization of 30a
The compound 30a was obtained as viscous oil in 78% yield (1.91 g). Its HR-MS spectrum
indicated [M+] at m/z 295.54 corresponding to molecular formula C11H9Cl3O3. Its UV spectrum
in ethanol absorbed at λmax 257.9 nm (log ε 3.7). The main difference in the IR spectra of 30 and
30a was the absence of OH peak for the initial monoester 30. Three aromatic protons (Ar-H, 3H)
displayed in the IR spectra a peak at 3086. Two peaks at 1721 and 1777 cm-1
in the IR spectra of
30a were assigned to ester (C=O) and acid chloride (1777, Cl-C=O), respectively. IR spectrum
30a showed peaks for double bonds of benzyl ring at 1610, 1478 cm-1
(C=C). Ether linkage was
confirmed by the presence of bands at 1262, 1144, 1021 cm-1
(C-O). The C-Cl bond formation
was evident from a peak at 720 cm-1
, indicating the formation of C-Cl bond.
Formation of 30a was verified by 1H-NMR and
13C-NMR (Table 11 and 13). In the
13C-NMR
spectra, a peak at δ 176.3 was indicative Cl-C=O bond. In its 1H-NMR spectra compound 30a
displayed four peaks due to four different groups of protons. Peaks at δ 2.91(t, J=6.8 Hz) and
2.67 (t, J= 6.8 Hz) were attributed to two methylene groups. A singlet at δ 5.06 was due to CH2O
group. In 13
C-NMR 30a revealed eleven peaks for eleven different carbons (Table 13). The peaks
23
at δ 138.2, 132.3, 131.4, 133.2, 126.3 and 128.5 were for aromatic carbons. Two peaks at δ 38.5
and 28.4 were due to two methylene groups between ester and acid chloride. The assignment was
also verified by HMBC spectrum, in which the proton resonating at δ 2.67, displayed interactions
with carbon resonating at δ 176.3, was attributed to COCl. In the high resolution electron impact
HR-EIMS spectrum, 30a displayed a molecular ion peak at (295.55), calculated for C11H9Cl3O3
(295.55): C, 44.70%; H, 3.07%; Cl, 35.99%; Found: C, 44.68%; H, 3.11%; Cl 35.88%. The
structure of the remaining compounds (2a-56a) was established in the same way.
2.3.3. Characterization of 1b-56b
Our γ-ketoesters differ from those previously reported, mainly in the nature of R, R1, and R
2 (Fig.
1c). In almost all reported examples, R3 is an alkyl or an un-substituted benzyl
(Fig. 1c), whereas
in our case R is ethyl, R1 and R
2 are H, and R
3 is alkyl, mono-, di- or tri-substituted benzyl group
(1b-56b) (Figs. 1 and 2), isopropyl (57b), isobutyl (58b), isopentyl (59b) and benzyl (60b). The
carbon atoms in monoesters (1-60), acid chlorides (1a-60a) and ketoesters (1b-60b) are
numbered for spectral data assignment (Fig. 3).
Based on mechanism suggested by Bansal (1996) for reaction of dimethyl cadmium with acid
halides, we proposed the mechanism of ketohexanoates formation from the reaction of diethyl
cadmium with acid chlorides. Both dimethyl and diethyl cadmium have similarity in structure
and reactivity. This mechanism is further supported by Roberts and Caserio (1964), who reported
the formation of a tetrahedral intermediate from the reaction of RCdCl and CH3COCl (Fig. 4).
Proposed mechanism for the reaction of diethyl cadmium with acid halide is given in Fig. 5.
Conversion of 1a into 1b was established by the HR-EIMS displaying a molecular ion peak at
m/z 250.2905 for C14H18O4 (calc. 250.2903). 1D (1H-NMR and
13C-NMR) spectra similarly
supported the predicted formation of 1b (Fig. 1, Tables 2, 14 and 16). Its formation was further
24
verified by the presence of an ethyl moiety by displaying peaks at δ 1.05 (t, 3H, J = 7.4 Hz, C-6)
and 2.55 (q, 2H, J = 7.4 Hz, C-5) and 13
C-NMR peaks at 7.7 (C-6) and 36.1 (C-5). Formation of
1b was further established by 2D NMR techniques (Figs. 8).
2.3.4. Characterization of 30b
Compound 30b was obtained as viscous oil (yield 78%, 1.91 g). Its HR-EIMS showed molecular
ion (M+) peak at m/z 289.15 with relative intensity 33%. It exhibited UV-VIS absorption band in
ethanol solvent at λmax 258.5 nm (log ε 3.72) and was assigned to aromatic chromophore.
The compound 30b in IR displayed bands at 3076 (Ar-H), 1728 (CO2Ar), 1767 (C=O), 1615,
1479 (C=C), 1267, 1148, 1023 (C-O), 722 (C-Cl) cm-1
. The assignments are compatible with the
structure of 30b. Two additional peaks other than 30a at 1.05 (t, 7.4 Hz), 2.46 (q, 7.4 Hz) and
corresponding peaks in 13
C-NMR at 7.8 and 36.3 were assigned to newly introduced ethyl group
(Tables 15 and 17). Two signals in the 1H-NMR (Table 15) of 30b at δ 2.46 (q, 7.4 Hz) and 2.91
(t, 6.8 Hz) were assigned to two methylenes. A low field singlet at δ 5.06 was assigned to CH2O
protons. In the 13
C-NMR spectra (Table 17) of 30b, the other assignments are; δ 209.4 (C-4, C=O
of ketone, δ 32.3 (C-3, CH2), δ 29.1 (C-2, CH2), δ 171.8 (C-1, C=O of ester), δ 62.9 (C-1ʹʹ,
CH2O), δ 137.5 (C-1ʹ), δ 131.2 (C-2 ʹ), δ 129.3 (C-3 ʹ), δ 133.6 (C-4ʹ), δ 126.8 (C-5 ʹ) and δ 128.6
(C-6ʹ). Finally the structure of 30b was also confirmed by analytical data that led to the
calculation of molecular formula C13H14Cl2O3 (289.15): C, 54.00; H, 4.88; Cl, 24.52; Found: C,
54.05; H, 4.89; Cl, 24.51%. Formation of 30b was also confirmed by 2D NMR techniques (Fig.
9).
2.4. Characterization of 57-60, 57a-60a and 57b-60b
Reaction of succinic anhydride with isopropyl, isobutyl, isopentyl and benzyl alcohols led to
alkyl hydrogen succinates 57-60 which upon treatment with thionylchloride afforded the
25
corresponding 4-alkoxy-4-ketobutanoyl chlorides 57a-60a (Fig. 2). Reaction of 57a-60a with
diethyl cadmium, ethyl magnesium bromide or the corresponding Gilman reagent converted these
compounds to alkyl γ-ketohexanoates 57b-60b. The comparison of the results of the three
organometallic reagents is illustrated in Table-20; the yield was the highest utilizing the cadmium
reagent as compared to others and no side products were formed. The EI-MS spectrum of the
compound showed peak at m/z 57 and was attributed to the loss of keto group from the parent
molecule. The 1H-NMR spectrum of 57b displayed two new peaks at δ 1.08 (t, J = 7.3 Hz, 3H,
Me) and at δ 2.49 (q, J = 7.3 Hz, 2H, CH2CO). Its 13
C-NMR spectrum exhibited two extra peaks
as compared to 57a that were identified as CH3 and CH2 by DEPT-135 13
C-NMR. The 2D NMR
also confirmed the formation of γ-ketoester (57b). The physical, spectroscopic and the literature
data revealed that isobutyl hydrogen succinate (58) and isopentyl hydrogen succinate (59) have
been identified in wine. Benzyl hydrogen succinate (60b), mp 117-119 ºC has been synthesized
in 52% yield by exposure of benzyl β-formyl propionate to air for 30 days. In the series 57b-60b
only benzyl γ-ketohexanoate (60b) is known (Matsunami et al., 2007). This compound was
prepared in low yield (24%) by reaction of benzyl acrylate with excess propanoyl chloride in the
presence of Mg and in DMF as solvent. Our methodology gave 60b in 71% overall yield. The
spectroscopic data of 60b are identical with that reported in the literature (Matsunami et al.,
2007).
2.5. Biological Activity and Structure Activity Relationship 1-29
The results in vitro biological activity of the monoesters 1-29 against three fungi and three
bacteria are denoted in Tables 23 and 24. All of the monoesters were subjected to biological
activities using fungi and bacteria and the compounds showed antifungal/antibacterial activity
against Colletotrichum gloeosporioides, Alternaria brassicicola, Colletotrichum capsici,
26
Klebsiella pneumonia, Escherichia coli and Staphylococcus aureus except nitro substituted (9-
11). So far as structure activity relationships is concerned noticeable low activities of the
compounds having substituents linked through oxygen and having substituent at three position of
benzene ring (Tables 23 and 24). Higher activities were observed for compounds with substituent
at 2 and 4 position of benzene ring. Highest activity was revealed by halogenated monoesters
(12-20) in general and iodinated monoesters in particular (18-20) and was close to ketoconazole
and chloramphenicol standards.
27
CHAPTER-3
EXPERIMENTAL
28
3. EXPERIMENTAL
3.1. General Experimental
All the required chemicals (aryl alcohols, anhydride, p-toluenesulphonic acid anhydrous, toluene,
hexane, benzene, methanol, ethanol, ethyl acetate, diethyl ether, chloroform, sodium sulphate and
sodium bicarbonate) were purchased from Sigma-Aldrich (St. Louis, New York, USA). All the
reagents were of analytical grade and used as such, except toluene. The toluene was dried and
then stored over sodium metal before use. Purity of alcohols and succinic anhydride was checked
by taking IR and NMR spectra. The melting points were determined using Gallenkamp digital
melting point apparatus and are uncorrected.
The UV spectra were recorded in absolute MeOH employing IRMECO UV/VIS Model U-2020
spectrophotometer. IR spectra were obtained on a TENSOR 27 FT-IR spectrophotometer
supplied by Bruker, Ettiligen, Germany. 1H-NMR and
13C-NMR (1D-, 2D-NMR) spectra were
procured in CDCl3 at (1H) 300 MHz, (
13C) 75 MHz using Bruker Biospin, AMX 300 MHz FT
NMR spectrometer; trimethylsilane (TMS) was used as an internal reference. EI-MS were
acquired with a direct insertion probe on a double-focusing Finnigan MAT 112 at 70 eV. HR-
EIMS measurements were made on a JEOL HX 110 spectrometer. Column chromatography was
carried out using silica gel (PF254, mesh size 60-70), E. Merck, Darmstadt Germany; thin layer
chromatography was performed on pre-coated silica gel plate (20 × 20 cm, 0.2 mm thickness)
with UV fluorescence indicator (PF254), E. Merck, Darmstadt, Germany.
3.1.1. Fungal strains
The fungal agents investigated in this study were supplied from Laboratório de Antibiotics,
Universidad Federal de Santa Catarina and included Colletotrichum gloeosporioides, Alternaria
29
brassicicola, Colletotrichum capsici. Ketoconazole was used as standard drug and was
purchased from m/s SMS Pharmaceuticals Ltd., Hyderabad.
3.1.2. Bacterial strains
Bacterial strains included Klebsiella pneumonia NCTC 11228, Escherichia coli ATCC 25922
and Staphylococcus aureus ATCC 25923. Chloramphenicol from Sigma St. Lious, USA was
used as standards.
3.2. General Procedure for the Preparation of Monoesters 1-29
The mono- and disubstitutedbenzyl hydrogen succinates (1-29) were synthesized by adding 15
mmol of corresponding alcohol to succinic anhydride (1.5 g, 15 mmol), anhydrous p-
toluenesulfonic acid (12.5 mg, 0.06 mmol) and toluene (13 g, 15 mL) under nitrogen in a single-
necked round-bottom flask (100 mL), equipped with magnetic stirrer, Dean-Stark trap and a
reflux condenser. The solution was refluxed for 14 h and allowed to cool up to 25 °C. After
cooling, it was poured into saturated aqueous NaHCO3 solution (12.5 mL) and the organic layer
was extracted with hexane (3 × 25 mL). The organic phase was then washed with brine (10 mL),
dried over anhydrous Na2SO4 and the excess of the solvent was removed under vacuum to give a
resinous product. It was then subjected to column chromatography to get pure monoesters (1-29).
3.3. General Procedure for the Preparation of Monoesters 30-56
Monoesters 30-56 were synthesized by above procedure briefly, by mixing 20 mmol of alcohol to
succinic anhydride (20 mmol), anhydrous p-toluenesulfonic acid (0.08 mmol) and toluene (20
mL) under nitrogen atmosphere. The mixture was refluxed for variable times and allowed to cool
up to 25 °C (Table 1). After cooling, it was poured into saturated aqueous NaHCO3 solution (12.5
mL) and the organic layer was extracted with hexane (3 × 25 mL). The organic phase was then
washed with brine (10 mL), dried over anhydrous Na2SO4 and excess of the solvent was removed
30
under vacuum to give a resinous product. The mixture obtained was subjected to separation on
column chromatography using mixture of n-hexane-ethyl acetate (1:0→0:1) to get thirty fractions
(1-30). The fractions (17-22) were combined and re-chromatographed on preparative thin layer
chromatography using n-hexane-ethyl acetate (4:6) as an eluent which yielded colorless
amorphous solid pure compounds (30-56)
3.4. General Procedure for the Preparation of Monoesters (57-60)
Monoesters 57-60 were by adding together succinic anhydride (3.0 g, 30 mmol), anhydrous p-
toluene sulfonic acid (25 mg) and toluene (15 mL) and 30 mmol of the alcohols under nitrogen
were added. After 24 h at reflux, the solution was left to cool at 25 °C then poured into a
saturated aqueous NaHCO3 solution (25 mL) and the aqueous layer was extracted with hexane (3
× 25 mL). The combined organic (toluene and hexanes) layers were washed with brine (20 mL),
dried over anhydrous Na2SO4 and the solvent was removed under vacuum to give a resinous
product, which was subjected to column chromatography to afford the pure monoesters (57-60).
3.5. General Procedure for Preparation of Mono-/di-/tri-benzyl) 4-Chloroketobutanoates
(1a-56a)
Acid chlorides (1a-56a) were prepared by following a standard procedure (Von Rudloff, 1958).
In brief, the required monoester (1-56; 8 mmol) and thionyl chloride (1.64 mL, 22.5 mmol) were
mixed in a round-bottom reaction flask (100 mL) fitted with a reflux condenser. The mixture was
heated to 30-40 °C for different lengths of time (Table 1) and the excess of thionyl chloride was
removed by heating at reduced pressure. The residue was subjected to open column
chromatography on silica gel using a mixture of hexane/ethyl acetate (φr = 4: 1 → 1: 4) as an
eluent to obtain pure compounds 1a-56a.
31
3.6. General Procedure for Alkyl 4-Chloro-4-Ketobutanoates (57a-60a)
Compound 57 (3.6 g, 22.5 mmol) was mixed with thionyl chloride (3.26 mL, 45 mmol), and
warmed at 30-40 °C for 3 hrs. Then the excess of thionyl chloride was removed on a steam bath
under reduced pressure to afford a colorless resin (57a) which was purified by distillation at
reduced pressure.
3.7. Preparation of Diethyl Cadmium Reagent
The diethyl cadmium reagent was prepared from a freshly prepared Grignard solution by
following a standard protocol (Cason, 1946). Briefly, dry CdCl2 (2.15 g, 11.8 mmol) was added
to the Grignard reagent [prepared from ethyl bromide (1.06 g, 11.8 mmol) and magnesium metal
(0.26 g, 11.8 mmol) cooled to 0 °C] in a dry diethyl ether (60 mL), over a period of 10 min with
vigorous stirring. Stirring was continued further for an hour and was used as freshly prepared.
3.8. General Procedure for Preparation of Benzyl γ-Ketohexanoates (1b-56b)
γ-Ketohexanoates (1b-56b) were prepared from acid chlorides (1a-56a), by following a standard
methodology (Cason, 1946). Briefly, 4-benzyloxy-4-ketobutanoyl chloride (5 mmol) was slowly
added to the diethyl cadmium solution. After maintaining reflux for different lengths of time
(Table 2), the mixture was allowed to stand overnight. The material was then poured into a
beaker containing ice and aq. H2SO4 (1 M, 30 mL). The organic layer was extracted with diethyl
ether (3 × 20 mL), washed with an aq. NaHCO3 solution (20 mL) and dried over anhydrous
Na2SO4. After removal of the solvent, the obtained material was subjected to open column
chromatography on silica gel and elution was made with the mixture of hexane/ethyl acetate (φr =
4: 1 → 1: 4) to get pure compounds (1b-56b).
32
3.9. General Procedure for Alkyl γ-ketohexanoates (57b-60b) Preparation
Compound 57b was synthesized by addition of 10 mmol of 57a (1.78 g) over a period of 10
minutes to a solution of diethyl cadmium in diethyl ether. The mixture was refluxed for six hours
and allowed to stand overnight stirring. The reaction mixture was then poured into a beaker (500
mL) containing crushed ice (150 g) and 10% aqueous H2SO4 (30 mL). It was vigorously stirred
for 5 minutes more. The organic layer was extracted with diethyl ether (3 × 20 mL), washed with
50% aqueous NaHCO3 solution (40 mL) and dried over anhydrous Na2SO4. After removal of the
solvent, the obtained material was subjected to column chromatography using an ethyl
acetate/hexane [(1:9) → (2:8) → (3:7)] as eluent. The desired product 57b was obtained after
elution with ethyl acetate/hexane (3:7). Similarly, compounds 58b-60b were prepared by
following the above mentioned procedure.
3.10. Biological Activity
3.10.1. Measurement of zones of inhibition
Biological activity of the monoesters (1-29) in terms of inhibition zones (mm) was determined by
following the disk diffusion method (EUCAST, 2012). Shortly, Mueller-Hinton pre-poured plates
were used for measuring inhibition zones of 1-29 against bacteria and Mueller-Hinton Himedia
(Mueller-Hinton complemented with 5% defibrinated horse blood and 20 mg/L β-NAD) pre-
poured plates against fungi. The 24 hour pre-cultured bacteria and fungi was taken into sterile
saline (0.85-0.90%, 2mL) contained in six test tubes (5 mL) pre-incubated and sterilized at 120
°C for 30 minutes. By adding the saline or inoculum, the densities of the prepared suspensions
was visually adjusted to McFarland standard (0.5) to obtain the suspension having 1-2×108
CFU/mL. It was further diluted to 1:10 to the concentration of 1-2×107 CFU/mL. The inoculum
was applied to pre-poured plates with the help of a sterilized cotton swab. Monoesters (1-29,
33
500µg each) were dissolved in 500 µL of DMSO in six vials. Disk (6mm) were loaded with 200
µg (200µL/disk) of the solution of the monoesters and placed on inoculated petri plates to
allowed to dry for 10 minutes. The plates were then incubated over night at 28 ± 2 °C for fungi
and 35± 2 for bacteria. Diameter was measured using a caliper. Experiment was replicated twice.
3.10.2. Measurement of MICs
Minimum inhibitory concentration (mg/L=μg/mL) of the monoesters (1-29) was determined by
Agar dilution method (EUCAST, 2012). Mueller-Hinton Agar (Oxoid) was used for
antibacterial while Mueller-Hinton Fastidious (Oxoid) for fungi. First of all fourteen sterilized
containers (50 mL) were labeled 128, 56, 32, 16, 8, 4, 2, 1, 0.5, 0.25, a, b, c and d mg/L or
µg/mL; containers a-d were for controls. Three stock solutions A, B, and C of monoesters (1-29)
were then prepared in order to get working solutions in the concentration range of 128-0.25
mg/L.
3.10.2.1. Preparation of stock solutions
Stock solution A was prepared by dissolving monoester 20 mg in 2 mL of diluent DMSO to
obtain over all concentration 10,000 mg/L = 10,000µg/mL.
Stock solution B
To get a stock solution B, with concentration of 1000 mg/L = 1mg/mL = 1000µg/mL, a 100 µL
stock A was added to 900 µL of DMSO.
Stock solution C
To get a stock solution C, with concentration of 100 mg/L=0.1 mg/mL=100µL/mL, a 100 µL
from stock B was added to 900 µL of DMSO
34
3.10.3. Solutions of working concentration
From stock A, 256 µL were transferred to a container labeled 128, 128 µL to the container
labeled 64, 64 µL to the container labeled 32 and 32 µL to container the labeled 16. From stock
solution B, 160 µL were added to the container labeled 8, 80 µL to the container labeled 4, 40 µL
to the container labeled 2. From the stock solution C were moved 200 µL to the container labeled
1, 100 µL to the container labeled 0.5 and 50 µL to the container labeled 0.25.
3.10.4. Controls
Following control containers a-d were included.
a. No antibiotic was added to container labeled “a” it served as antibiotic free growth control.
b. Control “b” was set to ensure that the observed activity was not due to DMSO. In the presence
of DMSO when no monoester was added the fungi and bacteria `showed full growth. Therefore,
any antibacterial or antifungal effect due to DMSO was negated.
c. Control “c” was for chloramphenicol standard antibiotic drug.
d. Control “d” was for ketoconazole standard antifungal drug.
Muller-Hinton nutrient agar (Oxoid, ≈20 mL/container) was prepared in sterilized water
according to manufacturer’s recommendations, cooled to 50 °C and added to all containers
labeled 128-1 and control containers a-d to make the final volume 20 mL in each container. The
concentration of 1-29 in the containers labeled 128-1 then became 128-1 mg/L. Contents were
poured into 90 mm petri dishes, allowed to dry at room temperature for 5-10 minutes. The
inoculua of bacteria and fungi were prepared to have approximately 1-2×108 CFU/mL by
adjusting the turbidity of inoculum to McFarland standard (0.5). One drop of inoculum was
applied to each prepared plate within 15 minutes. The plates were incubated overnight in air at
35±2 °C for bacteria and 28±2 °C for fungi. Least concentration (mg/L or µg/mL) of the
35
monoester that inhibited more than 95% growth of overnight cultured bacteria or fungi was taken
as MIC.
3.12. Physical and Spectroscopic Data of Monoesters 1-60
Physical data; Yield (%), physical state, mps/bps, UU-VIS, IR and Mass/anlytical data for
compounds 1-56 are given below. 1H-, and
13C-NMR data of 1-56 is given in tables 3-9.
3.12.1. 2-Methoxybenzyl hydrogen succinate (1)
Colorless amorphous solid m.p. 55-57 °C; Yield 71%, 2.54 g (10.66
mmol); UV (EtOH) λmax nm (log ε): 253 (3.5); FT-IR (Neat) υmax
(cm-1
): 3412 (OH), 3023 (Ar-H), 1729 (C=O), 1717 (C=O), 1595,
1546, 1429 (C=C), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR (Table 3 and 6, respectively).
Analysis calculated for C12H14O5 (238.24): C, 60.50%; H, 5.92%; Found: C, 60.34%; H, 5.70%.
3.12.2. 3-Methoxybenzyl hydrogen succinate (2)
Colorless amorphous, solid m.p. 49-51 °C; Yield 68%, 2.43 g (10.28
mmol); UV (EtOH) λmaxnm (log ε): 257.3 (3.3); FT-IR (Neat) υmax
(cm-1
): 3300 (OH), 3123 (Ar-H), 1729 (C=O), 1717 (C=O), 1595,
1546 1429 (C=C, Ar-H), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR data are given in tables 3
and 6, respectively; Analysis calculated for C12H14O5 (238.24): C, 60.50%; H, 5.92%; Found: C,
60.36%; H, 5.75%.
3.12.3. 4-Methoxybenzyl hydrogen succinate (3)
Colorless amorphous solid m.p. 56-58 °C; Yield 74%, 2.64 g (11.09
mmol); UV (EtOH) λmax nm (log ε): 256 (3.5); FT-IR (Neat) υmax
(cm-1
): 3366 (OH) 3054 (Ar-H), 1729 (C=O), 1717 (C=O), 1595,
1546, 1429 (C=C, Ar-H), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR data is given in tables 3
36
and 6, respectively; Analysis calculated for C12H14O5 (238.24): C, 60.50%; H, 5.92%; Found: C,
60.23%; H, 5.99%.
3.12.4. 2,3-Dimethoxybenzyl hydrogen succinate (4)
Pale yellow, amorphous solid, m.p. 87-89 °C; Yield 77%, 3.1 g
(11.54 mmol); UV (EtOH) λ max nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3355 (OH) 3068 (Ar-H), 2850 1729
(C=O), 1717 (C=O), 1592, 1538, 1435 (C=C, Ar-H), 1237, 1133, 1041 (C-O); 1H-, and
13C-NMR
data is given in tables 3 and 6, respectively; Analysis calculated for C13H16O6 (268.26): C,
58.20%; H, 6.01%; Found: C, 58.44%; H, 5.81%.
3.12.5. 2, 4-Dimethoxybenzyl hydrogen succinate (5)
Pale yellow, amorphous solid, m.p. 77-79 °C; Yield 78%,
3.14 g (11.69 mmol); UV (EtOH) λ max nm (log ε): 258 (3.5);
FT-IR (Neat) υmax (cm-1
): 3355 (OH), 3090 (Ar-H), 1729
(C=O), 1717 (C=O), 1592, 1538, 1435, (C=C, Ar-H), 1237, 1133, 1041; 1H-, and
13C-NMR data
is given in tables 3 and 6, respectively; Analysis calculated for C13H16O6 (268.26): C, 58.20%; H,
6.01%; Found: C, 58.35%; H, 6.12%.
3.12.6. 2,5-Dimethoxybenzyl hydrogen succinate (6)
Pale yellow, amorphous solid, m.p. 81-84 °C; Yield 74%, 2.97
g (11.09 mmol); UV (EtOH) λmax nm (log ε): 253 (3.5);
FT-IR (Neat) υmax (cm-1
): 3358 (OH) and 3030 (Ar-H), 2850,
1729 (C=O), 1717 (C=O), 1592, 1538, 1435, (C=C, Ar-H), 1237, 1133, 1041; 1H-, and
13C-NMR
data is given in tables 3 and 6, respectively; Analysis calculated for C13H16O6 (268.26): C,
58.20%; H, 6.01%; Found: C, 58.47%; H, 5.96%.
37
3.12.7. 3,4-Dimethoxybenzyl hydrogen succinate (7)
Pale yellow, amorphous solid, m.p. 95-97 °C; Yield 73%,
2.93 g (10.94 mmol); UV (EtOH) λmax nm (log ε): 259 (3.5);
FT-IR (Neat) υmax (cm-1
): 3358 (OH), 3042 (Ar-H), 2850,
1729 (C=O), 1717 (C=O), 1592, 1538, 1435 (C=C, Ar-H), 1237, 1133, 1041; 1H-, and
13C-NMR
data is given in tables 3 and 6, respectively. Analysis calculated for C13H16O6 (268.26): C,
58.20%; H, 6.01%; Found: C, C, 58.18%; H, 6.23%.
3.12.8. 3,5-Dimethoxybenzyl hydrogen succinate (8)
Pale yellow, amorphous solid, m.p. 88-90 °C; Yield 72%,
2.89 g (10.79 mmol); UV (EtOH) λmax nm (log ε): 256 (3.5);
FT-IR (Neat) υmax (cm-1
): 3375 (OH), 3095 (Ar-H), 2850,
1729 (C=O), 1717 (C=O), 1592, 1538, 1435 (C=C, Ar-H),
1237, 1133, 1041(C-O); 1H-, and
13C-NMR data is given in tables 3 and 6, respectively; Analysis
calculated for C13H16O6 (268.26): C, 58.20%; H, 6.01%; Found: C, 58.37%; H, 6.09%.
3.12.9. 2-Nirobenzyl hydrogen succinate (9)
Yellow, amorphous solid m.p. 100-102 °C; Yield 55%, 2.09 g (8.25
mmol); UV (EtOH) λmax nm (log ε): 252 (3.5);
FT-IR (Neat) υmax (cm-1
): 3400 (OH), 3056 (Ar-H), 2860, 1743
(C=O), 1723 (C=O), 1596, 1530, 1441 (C=C, Ar-H), 1375 (NO2), 1244, 1139, 1045; 1H-, and
13C-NMR data is given in tables 3 and 6, respectively; Analysis calculated for C11H11NO6
(253.21): C, 52.18%; H, 4.38, N, 5.33%; Found: C, 52.31%; H, 4.22, N, 5.27%.
38
3.12.10. 3-Nirobenzyl hydrogen succinate (10)
Yellow, amorphous solid, m.p. 65-68 °C; Yield 59%, 2.24 g
(8.85 mmol); UV (EtOH) λmax nm (log ε): 253 (3.5);
FT-IR (Neat) υmax (cm-1
): 3402 (OH), 3080 (Ar-H), 1739
(C=O), 1721 (C=O), 1597, 1539, 1440, (C=C, Ar-H), 1374 (NO2), 1249, 1137, 1044; 1H-, and
13C-NMR data is given in tables 3 and 6, respectively; Analysis calculated for C11H11NO6
(253.21): C, 52.18%; H, 4.38, N, 5.33%; Found: C, 52.31%; H, 4.22, N, 5.27%.
3.12.11. 4-Nirobenzyl hydrogen succinate (11)
Yellow, amorphous solid, m.p. 125-128 °C; Yield 54%, 2.05 g
(8.10 mmol); UV (EtOH) λmax nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3400 (OH), 3072 (Ar-H), 1740
(C=O), 1722 (C=O), 1595, 1535, 1440, (C=C, Ar-H), 1372 (NO2), 12408, 1136, 1045; 1H-, and
13C-NMR data is given in tables 3 and 6, respectively; Analysis calculated for C11H11NO6
(253.21): C, 52.18%; H, 4.38, N, 5.33%; Found: C, 52.24%; H, 4.29, N, 5.21%.
3.12.12. 2-Chlorobenzyl hydrogen succinate (12)
Colorless, amorphous solid, m.p. 69-71 °C; Yield 58%, 2.11 g (8.7
mmol); UV (EtOH) λmax nm (log ε): 251 (3.5);
FT-IR (Neat) υmax (cm-1
): 3410 (OH), 3060 (Ar-H), 1740 (CH2C=O),
1715 (C=O), 1597, 1529, 1497, 1456, (C=C, Ar-H), 1387, 1251, 1237, 1134, 1208, 1094, 1047,
1015 (C-O), 723 (C-Cl); 1H-, and
13C-NMR data is given in tables 3 and 6, respectively;
Analysis calculated for C11H11ClO4 (242.66): C, 54.45%; H, 4.57%; Found: C, 54.77%; H,
4.64%.
39
3.12.13. 3-Chlorobenzyl hydrogen succinate (13)
Colorless, amorphous solid, m.p. 58-59 °C; Yield 58%, 2.11 g
(8.7 mmol); UV (EtOH) λmax nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3415 (OH), 3085 (Ar-H), 1739 (C=O),
1720 (C=O), 1599, 1525, 1452, (C=C, Ar-H), 1248, 1133, 1049 (C-O), 722 (C-Cl); 1H-, and
13C-
NMR data is given in tables 3 and 6, respectively; Analysis calculated for C11H11ClO4 (242.66):
C, 54.45%; H, 4.57%; Found: C, 54.68%; H, 4.54%.
3.12.14. 4-Chlorobenzyl hydrogen succinate (14)
Colorless, amorphous solid, m.p. 70-72 °C; Yield 65%, 2.37 g
(9.75 mmol); UV (EtOH) λmax nm (log ε): 251 (3.5);
FT-IR (Neat) υmax (cm-1
): 3345 (OH), 3048 (Ar-H), 1738 (C=O),
1720 (C=O), 1597, 1529, 1456 (C=C, Ar-H), 1383, 1251, 1134, 1047 (C-O), 723 (C-Cl); 1H-, and
13C-NMR data is given in tables 3 and 6, respectively; Analysis calculated for C11H11ClO4
(242.66): C, 54.45%; H, 4.57%; Found: C, 54.71%; H, 4.58%.
3.12.15. 2-Bromobenzyl hydrogen succinate (15)
Pale brown, amorphous solid, m.p. 100-103 °C; Yield 67%, 2.39 g
(10.06 mmol); UV (EtOH) λmax nm (log ε): 253 (3.5);
FT-IR (Neat) υmax (cm-1
): 3345 (OH), 3084 (Ar-H), 1736 (C=O),
1715 (C=O), 1596, 1527, 1453 (C=C, Ar-H), 1413, 1277, 1254, 1144, 1054 (C-O), 521 (C-Br);
1H-, and
13C-NMR data is given in tables 3 and 7, respectively; Analysis calculated for
C11H11BrO4 (287.11): C, 46.02%; H, 3.86%; Found: C, 46.23%; H, 3.96%.
40
3.12.16. 3-Bromobenzyl hydrogen succinate (16)
Pale brown, amorphous solid, m.p. 77-79 °C; Yield 66%, 2.84 g
(9.89 mmol); UV (EtOH) λmax nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3345 (OH), 3033 (Ar-H), 1738 (C=O), 1717 (C=O), 1598, 1525, 1457,
(C=C, Ar-H), 1250, 1141, 1059, 522 (C-Br); 1H-, and
13C-NMR data is given in tables 3 and 7,
respectively; Analysis calculated for C11H11BrO4 (287.11): C, 46.02%; H, 3.86%; Found: C,
46.12%; H, 3.78%.
3.12.17. 4-Bromobenzyl hydrogen succinate (17)
Pale brown, amorphous solid, m.p. 99-102 °C; Yield 70%, 3.02
g (10.5 mmol); UV (EtOH) λmax nm (log ε): 252 (3.5);
FT-IR (Neat) υmax (cm-1
): 3377 (OH), 3059 (Ar-H), 1737 (C=O),
1714 (CH2C=O), 1598, 1519, 1457, (C=C, Ar-H), 1250, 1144, 1051 (C-O), 521 (C-Br); 1H-, and
13C-NMR data is given in tables 3 and 7, respectively; Analysis calculated for C11H11BrO4
(287.11): C, 46.02%; H, 3.86%; Found: C, 46.14%; H, 3.66%.
3.12.18. 2-Iodobenzyl hydrogen succinate (18)
Brown, amorphous solid, m.p. 120-124 °C; Yield 61%, 3.06 g (9.15
mmol); UV (EtOH) λmax nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3377 (OH), 3024 (Ar-H), 1733 (C=O),
1715 (C=O), 1599, 1521, 1460 (C=C, Ar-H), 1255, 1153, 1054, 487 (C-I); 1H-, and
13C-NMR
data is given in tables 3 and 7, respectively; Analysis calculated for C11H11IO4 (334.11): C,
39.54%; H, 3.32%; Found: C, 39.34%; H, 3.21%.
41
3.12.19. 3-Iodobenzyl hydrogen succinate (19)
Brown, amorphous solid, m.p. 92-94 °C; Yield 62%, 3.11 g (9.31
mmol); UV (EtOH) λmax nm (log ε): 257 (3.5);
FT-IR (Neat) υmax (cm-1
): 3376 (OH), 3059 (Ar-H), 1734
(CH2C=O), 1714 (C=O), 1601, 1524 1462, (C=C, Ar-H), 1253, 1152, 1052 (C-O), 486 (C-I). 1H-,
and 13
C-NMR data is given in tables 3 and 7, respectively; Analysis calculated for C11H11IO4
(334.11): C, 39.54%; H, 3.32%; Found: C, 39.28%; H, 3.27%.
3.12.20. 4-Iodobenzyl hydrogen succinate (20)
Brown, amorphous solid, m.p. 120-131 °C; Yield 65%, 3.26 g
(9.76 mmol); UV (EtOH) λmax nm (log ε): 254 (3.5);
FT-IR (Neat) υmax (cm-1
): 3376 (OH), 3071 (Ar-H), 1739 (C=O),
1718 (C=O), 1600, 1523, 1461 (C=C, Ar-H), 1253, 1151, 1050 (C-O), 486 (C-I); 1H-, and
13C-
NMR data is given in tables 3 and 7, respectively; Analysis calculated for C11H11IO4 (334.11): C,
39.54%; H, 3.32%; Found: C, 39.66%; H, 3.55%.
3.12.21. 2-Methylbenzyl hydrogen succinate (21)
Colorless amorphous solid, m.p. 51-53 °C; Yield 71%, 2.37 g (10.66
mmol); UV (EtOH) λmax nm (log ε): 253 (3.5); FT-IR (Neat) υmax (cm-
1): 3412 (OH), 3023 (Ar-H), 1729 (C=O), 1717 (C=O), 1595, 1546,
1429 (C=C), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR data is given in tables 4 and 7,
respectively; Analysis calculated for C12H14O4 (222.24): C, 64.85%; H, 6.35%; Found: C,
64.95%; H, 6.22%.
42
3.12.22. 3-Methylbenzyl hydrogen succinate (22)
Colorless amorphous solid, m.p. 49-51 °C; Yield 68%, 2.28 g
(10.28 mmol); UV (EtOH) λmax nm (log ε): 257.3 (3.3);
FT-IR (Neat) υmax (cm-1
): 3300 (OH), 3123 (Ar-H), 1729
(C=O), 1717 (C=O), 1595, 1546 1429 (C=C, Ar-H), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR
data is given in tables 4 and 7, respectively; Analysis calculated for C12H14O4 (222.24)
: C, 64.85%; H, 6.35%; Found: C, 64.74%; H, 6.46%.
3.12.23. 4-Methylbenzyl hydrogen succinate (23)
Colorless amorphous solid, m.p. 54.56 °C; Yield 74%, 2.44 g
(11.09 mmol); UV (EtOH) λ max nm (log ε): 256 (3.5);
FT-IR (Neat) υmax (cm-1
): 3366 (OH) 3054 (Ar-H), 1729 (C=O),
1717 (C=O), 1595, 1546, 1429 (C=C, Ar-H), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR data is
given in tables 4 and 7, respectively; Analysis calculated for C12H14O4 (222.24): C, 64.85%; H,
6.35%; Found: C, 64.67%; H, 6.55%.
3.12.24. 2-Hydroxybenzyl hydrogen succinate (24)
Pale yellow, amorphous solid, m.p. 121-123 °C; Yield 55%, 1.87 g
(8.25 mmol); UV (EtOH) λmax nm (log ε): 252 (3.5);
FT-IR (Neat) υmax (cm-1
): 3400-3120 (OH), 3056 (Ar-H), 2860, 1743
(C=O), 1723 (C=O), 1596, 1530, 1441 (C=C, Ar-H), 1244, 1139, 1045; 1H-, and
13C-NMR data
is given in tables 4 and 7, respectively; Analysis calculated for C11H12O5 (224.21): C, 58.93%; H,
5.39%; Found: C, 58.47%; H, 5.77%.
43
3.12.25. 3-Hydroxybenzyl hydrogen succinate (25)
Yellow, amorphous solid, m.p. 102-105 °C; Yield 59%, 1.98 g
(8.85 mmol); UV (EtOH) λmax nm (log ε): 253 (3.5);
FT-IR (Neat) υmax (cm-1
): 3402-3110 (OH), 3080 (Ar-H), 1739
(C=O), 1721 (C=O), 1597, 1539, 1440, (C=C, Ar-H), 1249, 1137, 1044; 1H-, and
13C-NMR data
is given in tables 4 and 7, respectively; Analysis calculated for C11H12O5 (224.21): C, 58.93%; H,
5.39%; Found: C, 58.66%; H, 5.88%.
3.12.26. 4-Hydroxybenzyl hydrogen succinate (26)
Yellow, amorphous solid, m.p. 126-128 °C; Yield 54%, 1.82 g
(8.10 mmol); UV (EtOH) λmax nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3400-3100 (OH), 3072 (Ar-H), 1740 (C=O), 1722 (C=O), 1595, 1535,
1440 (C=C, Ar-H), 12408, 1136, 1045; 1H-, and
13C-NMR data is given in tables 4 and 7,
respectively; Analysis calculated for C11H12O5 (224.21): C, 58.93%; H, 5.39%; Found: C,
58.81%; H, 5.44%.
3.12.27. 2-Aminobenzyl hydrogen succinate (27)
Yellow, amorphous solid, m.p. 115-117 °C; Yield 58%, 1.94 g (8.7
mmol); UV (EtOH) λmax nm (log ε): 251 (3.5);
FT-IR (Neat) υmax (cm-1
): 3410 (NH2 and OH), 3060 (Ar-H), 1740
(CH2CO), 1715 (CO), 1597, 1529, 1497, 1456, (C=C, Ar-H), 1387 (C-N), 1251, 1237, 1134,
1208, 1094, 1047, 1015 (C-O); 1H-, and
13C-NMR data is given in tables 4 and 7, respectively;
Analysis calculated for C11H13O4 (223.23): C, 59.19%; H, 5.87, N, 6.27%; Found: C, 59.29%; H,
5.76, N, 6.18%.
44
3.12.28. 3-Aminobenzyl hydrogen succinate (28)
Yellow, amorphous solid, m.p. 99-102 °C; Yield 58%, 1.94 g
(8.7 mmol); UV (EtOH) λmax nm (log ε): 255 (3.5);
FT-IR (Neat) υmax (cm-1
): 3415 (Broad, NH2 and OH), 3085
(Ar-H), 1739 (C=O), 1720 (C=O), 1599, 1525, 1452, (C=C, Ar-H), 1393 (C-N), 1248, 1133,
1049 (C-O); 1H-, and
13C-NMR data is given in tables 4 and 7, respectively; Analysis calculated
for C11H13O4 (223.23): C, 59.19%; H, 5.87, N, 6.27%; Found: C, 59.51; H, 5.81, N, 6.12%.
3.12.29. 4-Aminobenzyl hydrogen succinate (29)
Yellow, amorphous solid, m.p. 117-120 °C; Yield 65%, 2.18 g
(9.75 mmol); UV (EtOH) λmax nm (log ε): 251 (3.5);
FT-IR (Neat) υmax (cm-1
): 3345 (Broad, intense, NH2 and OH),
3048 (Ar-H), 1738 (C=O), 1720 (C=O), 1597, 1529, 1456 (C=C, Ar-H), 1383 (C-N), 1251, 1134,
1047 (C-O); 1H-, and
13C-NMR data is given in tables 4 and 8, respectively; Analysis calculated
for C11H13O4 (223.23): C, 59.19%; H, 5.87, N, 6.27%; Found: C, 59.46%; H, 5.64, N, 6.48%.
3.12.30. 2,4-Dichlorobenzyl hydrogen succinate (30)
Colorless, amorphous solid, m.p. 71-73 °C; Yield 60%, 3.33 g
(12.0 mmol); UV (EtOH) λmax nm (log ε): 259 (3.4);
FT-IR (Neat) υmax (cm-1
): 3386 (OH), 3063 (Ar-H), 1722 (C=O),
1773 (C=O), 1510, 1473 (C=C), 1247, 1123, 1022 (C-O), 723 (C-Cl); 1H-, and
13C-NMR data is
given in tables 4 and 8, respectively; Analysis calculated for C11H10Cl2O4 (277.10): C, 47.68%;
H, 3.64 %, Cl 25.59%; Found: C, 47.37%; H, 3.42%, Cl, 25.66%.
45
3.12.31. 2,5-Dichlorobenzyl hydrogen succinate (31)
Colorless, amorphous solid, m.p. 79-81 °C; Yield 62%, 3.44 g
(12.4 mmol); UV (EtOH) λmax nm (log ε): 259 (3.5);
FT-IR (Neat) υmax (cm-1
): 3382 (OH), 3060 (Ar-H), 1725 (C=O),
1774 (C=O), 1561, 1423 (C=C), 1247, 1123, 1022 (C-O), 720 (C-Cl); 1H-, and
13C-NMR data is
given in tables 4 and 8, respectively; Analysis calculated for C11H10Cl2O4 (277.10): C, 47.68%;
H, 3.64 %, Cl 25.59; Found: C, 47.44%; H, 3.32%, Cl, 25.64%.
3.12.32. 2,6-Dichlorobenzyl hydrogen succinate (32)
Colorless, amorphous solid, m.p. 77-79 °C; Yield 58%, 3.21 g (11.6
mmol); UV (EtOH) λmax nm (log ε): 258 (3.7); FT-IR (Neat) υmax
(cm-1
): 3385 (OH), 3023 (Ar-H), 1771 (C=O), 1726 (C=O), 1512,
1441 (C=C), 1249, 1111, 1014 (C-O), 724 (C-Cl); 1H-, and
13C-NMR data is given in tables 4
and 8, respectively; Analysis calculated for C11H10Cl2O4 (277.10): C, 47.68%; H, 3.64 %, Cl
25.59; Found: C, 47.35%; H, 3.46%, Cl, 25.75%.
3.12.33. 3,4-Dichlorobenzyl hydrogen succinate (33)
Colorless amorphous solid, m.p. 72-74 °C; Yield 66%, 3.66 g
(13.2 mmol); UV (EtOH) λmax nm (log ε): 259 (3.6); FT-IR
(Neat) υmax (cm-1
): 3375 (OH), 3058 (Ar-H), 1778 (C=O), 1725
(C=O), 1594, 1415 (C=C), 1247, 1123, 1022 (C-O), 721 (C-Cl); 1H-, and
13C-NMR data is given
in tables 4 and 8, respectively; Analysis calculated for C11H10Cl2O4 (277.10): C, 47.68%; H, 3.64
%, Cl 25.59; Found: C, 47.49%; H, 3.71%, Cl, 25.45%.
46
3.12.34. 3,5-Dichlorobenzyl hydrogen succinate (34)
Colorless amorphous solid, m.p. 74-76 °C; Yield 65%, 3.60 g
(13.0 mmol); UV (EtOH) λmax nm (log ε): 259 (3.8);
FT-IR (Neat) υmax (cm-1
): 3379 (OH), 3055 (Ar-H), 1764 (C=O),
1721 (C=O), 1529, 1432 (C=C), 1247, 1123, 1022 (C-O), 723 (C-Cl); 1H-, and
13C-NMR data is
given in tables 4 and 8, respectively; Analysis calculated for C11H10Cl2O4 (277.10): C, 47.68%;
H, 3.64 %, Cl, 25.59; Found: C, 47.53%; H, 3.36%, Cl, 25.61%.
3.12.35. 2,3-Difluorobenzyl hydrogen succinate (35)
Colorless, amorphous solid, m.p. 88-90 °C; Yield 64%, 3.12 g (12.8
mmol); UV (EtOH) λmax nm (log ε): 255 (4.1); FT-IR (Neat) υmax
(cm-1
): 3410 (OH), 3074 (Ar-H), 1770 (C=O), 1729 (C=O), 1601,
1408 (C=C), 1246, 1123, 1014 (C-O), 1155 (C-F); 1H-, and
13C-NMR data is given in tables 4
and 8, respectively; Analysis calculated for C11H10F2O4 (244.19): C, 54.10%; H, 4.13; F, 15.56
%; Found: C, 54.23%; H, 4.25; F, 15.36%.
3.12.36. 2,4-Difluorobenzyl hydrogen succinate (36)
Colorless, amorphous solid, m.p. 90-91 °C; Yield 63%, 3.08 g
(12.6 mmol); UV (EtOH) λmax nm (log ε): 255 (4.2);
FT-IR (Neat) υmax (cm-1
): 3315 (OH), 3069 (Ar-H), 1765 (C=O),
1728 (C=O), 1524, 1471 (C=C), 1236, 1115, 1020 (C-O) 1158 (C-F); 1H-, and
13C-NMR data is
given in tables 4 and 8, respectively; Analysis calculated for C11H10F2O4 (244.19): C, 54.10%; H,
4.13; F, 15.56 %; Found: C, 53.99%; H, 4.24; F, 15.32%.
47
3.12.37. 2,5-Difluorobenzyl hydrogen succinate (37)
Colorless, amorphous solid, m.p. 97-98 °C; Yield 67%, 3.27 g
(13.4 mmol); UV (EtOH) λmax nm (log ε): 256 (3.4); FT-IR (Neat)
υmax (cm-1
): 3422 (OH), 3068 (Ar-H), 1766 (C=O), 1726 (C=O),
1499, 1481 (C=C), 1252, 1121, 1025 (C-O), 1159 (C-F); 1H-, and
13C-NMR data is given in
tables 4 and 8, respectively; Analysis calculated for C11H10F2O4 (244.19): C, 54.10%; H, 4.13; F,
15.56 %; Found: C, 53.98%; H, 4.22; F, 15.44%.
3.12.38. 2,6-Difluorobenzyl hydrogen succinate (38)
Colorless, amorphous solid, m.p. 92-94 °C; Yield 60%, 2.93 g (12.0
mmol); UV (EtOH) λmax nm (log ε): 256 (3.5); FT-IR (Neat) υmax
(cm-1
): 3425 (OH), 3066 (Ar-H), 1764 (C=O), 1727 (C=O), 1499,
1402 (C=C), 1248, 1125, 1008 (C-O), 1155 (C-F); 1H-, and
13C-NMR data is given in tables 4
and 8, respectively; Analysis calculated for C11H10F2O4 (244.19): C, 54.10%; H, 4.13; F, 15.56
%; Found: C, 54.18%; H, 4.18; F, 15.54%.
3.12.39. 2,4-Dimethylbenzyl hydrogen succinate (39)
Colorless, amorphous solid, m.p. 77-79 °C; Yield 68%, 3.21 g
(13.6 mmol); UV (EtOH) λmax nm (log ε): 253 (3.4);
FT-IR (Neat) υmax (cm-1
): 3366 (OH), 3037 (Ar-H), 1756 (C=O),
1730 (C=O), 1505, 1411 (C=C), 1250, 1123, 1009 (C-O); 1H-, and
13C-NMR data is given in
tables 4 and 8, respectively; Analysis calculated for C13H16O4 (236.26): C, 66.09%; H, 6.83%;
Found: C, 66.22%; H, 6.75%.
48
3.12.40. 2,5-Dimethylbenzyl hydrogen succinate (40)
Colorless, amorphous solid, m.p. 84-86 °C; Yield 67%, 3.17 g
(13.4 mmol); UV (EtOH) λmax nm (log ε): 253 (3.6);
FT-IR (Neat) υmax (cm-1
): 3360 (OH), 3040 (Ar-H), 1758 (C=O),
1721 (C=O), 1502, 1485 (C=C), 1245, 1135, 1014 (C-O); 1H-, and
13C-NMR data is given in
tables 4 and 8, respectively; Analysis calculated for C13H16O4 (236.26): C, 66.09%; H, 6.83%;
Found: C, 66.25%; H, 6.74%.
3.12.41. 3,4-Dimethylbenzyl hydrogen succinate (41)
Colorless amorphous solid, m.p. 89-92 °C; Yield 68%, 3.21 g
(13.6 mmol); UV (EtOH) λmax nm (log ε): 253 (3.2); FT-IR
(Neat) υmax (cm-1
): 3369 (OH), 3036 (Ar-H), 1756 (C=O), 1720
(C=O), 1501, 1477 (C=C), 1255, 1110, 1030 (C-O); 1H-, and
13C-NMR data is given in tables 5
and 8, respectively; Analysis calculated for C13H16O4 (236.26): C, 66.09%; H, 6.83%; Found: C,
66.16%; H, 6.81%.
3.12.42. 3,5-Dimethylbenzyl hydrogen succinate (42)
Colorless amorphous solid, m.p. 87-86 °C;Yield 69%, 3.26 g
(13.8 mmol); UV (EtOH) λmax nm (log ε): 253 (3.6); FT-IR
(Neat) υmax (cm-1
): 3372 (OH), 3033 (Ar-H), 1755 (C=O),
1722 (C=O), 1554, 1491 (C=C), 1251, 1120, 1015 (C-O); 1H-, and
13C-NMR data is given in
tables 5 and 8, respectively; Analysis calculated for C13H16O4 (236.26): C, 66.09%; H, 6.83%;
Found: C, 66.20%; H, 6.65%.
49
3.12.43. 3,4-Dinitrobenzyl hydrogen succinate (43)
Pale yellow, amorphous solid, m.p. 108-109 °C; Yield 65%,
3.88 g (13.0 mmol); UV (EtOH) λmax nm (log ε): 266 (3.1);
FT-IR (Neat) υmax (cm-1
): 3475 (OH), 3085 (Ar-H), 1776
(C=O), 1733 (C=O), 1519, 1452 (C=C), 1369 (NO2), 1246, 1123, 1022 (C-O); 1H-, and
13C-
NMR data is given in tables 5 and 9, respectively; Analysis calculated for C11H10N2O8 (298.21):
C, 44.30%; H, 3.38%, N, 9.39; Found: C, 44.46%; H, 3.32%, N, 9.36%.
3.12.44. 3,5-Dinitrobenzyl hydrogen succinate (44)
Pale yellow, amorphous solid, m.p. 112-113 °C; Yield 66%,
3.94 g (13.2 mmol); UV (EtOH) λmax nm (log ε): 266 (3.2);
FT-IR (Neat) υmax (cm-1
): 3466 (OH), 3087 (Ar-H), 1775
(C=O), 1731 (C=O), 1604, 1580, 1410 (C=C), 1378 (NO2), 1249, 1123, 1020 (C-O); 1H-, and
13C-NMR data is given in tables 5 and 9, respectively; Analysis calculated for C11H10N2O8
(298.21): C, 44.30%; H, 3.38%, N, 9.39; Found: C, 44.47%; H, 3.31%, N, 9.37%.
3.12.45. 2,6-Diethoxybenzyl hydrogen succinate (45)
Colorless, amorphous solid, m.p. 104-106 °C; Yield 64%, 3.79 g
(12.8 mmol); UV (EtOH) λmax nm (log ε): 270 (4.05);
FT-IR (Neat) υmax (cm-1
): 3455 (OH), 3086 (Ar-H), 1776 (C=O),
1732 (C=O), 1505, 1496 (C=C), 1250, 1124, 1022 (C-O); 1H-, and
13C-NMR data is given in
tables 5 and 9, respectively; Analysis calculated for C15H20O6 (296.32): C, 60.80%; H, 6.80%;
Found: C, 60.74%; H, 6.65%.
50
3.12.46. 3,4-Diethoxybenzyl hydrogen succinate (46)
Colorless amorphous solid, m.p. 114-116 °C; Yield 67%, 3.97 g
(13.4 mmol); UV (EtOH) λmax nm (log ε): 270 (4.2);
FT-IR (Neat) υmax (cm-1
): 3454 (OH), 3085 (Ar-H), 1775
(C=O), 1731 (C=O), 1506, 1495 (C=C), 1252, 1120, 1021 (C-O); 1H-, and
13C-NMR data is
given in tables 5 and 9, respectively; Analysis calculated for C15H20O6 (296.32): C, 60.80%; H,
6.80%; Found: C, 60.77%; H, 6.68%.
3.12.47. 3,5-Dihydroxybenzyl hydrogen succinate (47)
Colorless, amorphous solid, m.p. 122-123 °C; Yield 70%, 3.36 g
(14.0 mmol); UV (EtOH) λmax nm (log ε): 272 (4.1); FT-IR
(Neat) υmax (cm-1
): 3450 (OH), 3082 (Ar-H), 1774 (C=O), 1730
(C=O), 1507, 1494 (C=C), 1265, 1132, 1025 (C-O); 1H-, and
13C-NMR data is given in tables 5
and 9, respectively; Analysis calculated for C11H12O6 (240.21): C, 55.0%; H, 5.04%; Found: C,
55.16%; H, 4.97%.
3.12.48. 2,3,4-Trimethoxybenzyl hydrogen succinate (48)
Colorless, amorphous solid, m.p. 67-68 °C; Yield 71%, 4.24 g
(14.2 mmol); UV (EtOH) λmax nm (log ε): 272 (3.97);
FT-IR (Neat) υmax (cm-1
): 3450 (OH), 3082 (Ar-H), 1774
(C=O), 1730 (C=O), 1508, 1498 (C=C), 1262, 1135, 1015 (C-O); 1H-, and
13C-NMR data is
given in tables 5 and 9, respectively; Analysis calculated for C14H18O7 (298.29): C, 56.37%; H,
6.08%; Found: C, 56.25%; H, 6.18%.
51
3.12.49. 2,4,5-Trimethoxbenzyl hydrogen succinate (49)
Colorless, amorphous solid, m.p. 94-96 °C; Yield 71%, 4.24 g
(14.2 mmol); UV (EtOH) λmax nm (log ε): 272 (4.15); FT-IR
(Neat) υmax (cm-1
): 3445 (OH), 3078 (Ar-H), 1777 (C=O),
1733 (C=O), 1504, 1498 (C=C), 1260, 1150, 1023 (C-O); 1H-, and
13C-NMR data is given in
tables 5 and 9, respectively; Analysis calculated for C14H18O7 (298.29): C, 56.37%; H, 6.08%;
Found: C, 56.27%; H, 6.17%.
3.12.50. 3,4,5-Trimethoxybenzyl hydrogen succinate (50)
Colorless, amorphous solid, m.p. 78-79 °C; Yield 72%, 4.30 g
(14.4 mmol); UV (EtOH) λmax nm (log ε): 272 (4.26); FT-IR
(Neat) υmax (cm-1
): 3447 (OH), 3079 (Ar-H), 1778 (C=O),
1732 (C=O), 1501, 1492 (C=C), 1256, 1152, 1024 (C-O); 1H-, and
13C-NMR data is given in
tables 5 and 9, respectively; Analysis calculated for C14H18O7 (298.29): C, 56.37%; H, 6.08%;
Found: C, 56.26%; H, 6.16%.
3.12.51. 3-Methoxy-4-nitrobenzyl hydrogen succinate (51)
Light yellow, amorphous solid, m.p. 108-110 °C; Yield 65%,
3.68 g (13.0 mmol); UV (EtOH) λmax nm (log ε): 267 (3.84);
FT-IR (Neat) υmax (cm-1
): 3398 (OH), 3069 (Ar-H), 1779
(C=O), 1730 (C=O), 1601, 1576, 1390 (C=C), 1377 (NO2), 1255, 1135, 1020 (C-O); 1H-, and
13C-NMR data is given in tables 5 and 9, respectively; Analysis calculated for C12H13NO7
(283.07): C, 50.89%; H, 4.63%; N, 4.95%; Found: C, 50.77%; H, 4.73%; N, 4.4.85%.
52
3.12.52. 4-Methoxy-3-nitrobenzyl hydrogen succinate (52)
Light yellow, amorphous solid, m.p. 111-113 °C; Yield 66%,
2.74 g (13.2 mmol); UV (EtOH) λmax nm (log ε): 267 (3.86);
FT-IR (Neat) υmax (cm-1
): 3396 (OH), 3067 (Ar-H), 1777
(C=O), 1728 (C=O), 1607, 1585, 1388 (C=C), 1373 (NO2), 1253, 1133, 1018 (C-O); 1H-, and
13C-NMR data is given in tables 5 and 9, respectively; Analysis calculated for C12H13NO7
(283.07): C, 50.89%; H, 4.63%; N, 4.95%; Found: C, 50.75%; H, 4.78%; N, 4.84%.
3.12.53. 2-Methoxy-5-nitrobenzyl hydrogen succinate (53)
Light yellow, amorphous solid, m.p. 115-117 °C; Yield 64%,
3.63 g (12.8 mmol); UV (EtOH) λmax nm (log ε): 267 (3.99);
FT-IR (Neat) υmax (cm-1
): 3393 (OH), 3064 (Ar-H), 1774
(C=O), 1725 (C=O), 1503, 1484 (C=C), 1372 (NO2), 1249, 1128, 1014 (C-O); 1H-, and
13C-
NMR data is given in tables 5 and 9, respectively; Analysis calculated for C12H13NO7 (283.07):
C, 50.89%; H, 4.63%; N, 4.95%; Found: C, 50.97%; H, 4.80%; N, 4.81%.
3.12.54. 2,4,6-Trichlorobenzyl hydrogen succinate (54)
Colorless, amorphous solid, m.p. 98-100 °C; Yield 58%, 3.61 g
(11.6 mmol); UV (EtOH) λmax nm (log ε): 265 (3.98); FT-IR
(Neat) υmax (cm-1
): 3390 (OH), 3061 (Ar-H), 1779 (C=O), 1728
(C=O), 1612-1390 (C=C), 1248, 1125, 1010 (C-O), 729 (C-Cl); 1H-, and
13C-NMR data is given
in tables 5 and 9, respectively; Analysis calculated for C11H9Cl3O4 (311.55): C, 42.41%; H,
2.91%; Cl, 34.14%; Found: C, 42.49%; H, 2.86%; Cl, 34.22%.
53
3.12.55. 2,4,5-Tribromobenzyl hydrogen succinate (55)
Colorless, amorphous solid, m.p. 106-108 °C; Yield 58%, 5.07 g
(11.4 mmol); UV (EtOH) λmax nm (log ε): 266 (4.2);
FT-IR (Neat) υmax (cm-1
): 3386 (OH), 3078 (Ar-H), 1778 (C=O),
1729 (C=O), 1514, 1491 (C=C), 1257, 1132, 1015 (C-O), 527 (C-Br); 1H-, and
13C-NMR data is
given in tables 5 and 9, respectively; Analysis calculated for C11H9Br3O4 (444.90): C, 29.70%; H,
2.04%; Br, 53.88%; Found: C, 29.62%; H, 2.22%; Br, 53.76%.
3.12.56. 2,4,6-Trimethylbenzyl hydrogen succinate (56)
Colorless, amorphous solid, m.p. 101-102 °C; Yield 60%, 3.0 g
(12.0 mmol); UV (EtOH) λmax nm (log ε): 264 (3.4);
FT-IR (Neat) υmax (cm-1
): 3376 (OH), 3070 (Ar-H), 1775
(C=O), 1727 (C=O), 1612-1392 (C=C), 1254, 1133, 1016 (C-O); 1H-, and
13C-NMR data is given
in tables 5 and 9, respectively; Analysis calculated for C14H18O4 (250.29): C, 67.18%; H, 7.25%;
Found: C, 67.34%; H, 7.11%.
3.12.57. Isopropyl hydrogen succinate (57)
Physical data, yield (%), UU-VIS, IR, Mass/anlytical, 1H-, and
13C-NMR
of 57 is given in tables 19 and 21.
3.12.58. Isobutyl hydrogen succinate (58)
Physical data, yield (%), UU-VIS, IR, Mass/anlytical, 1H-, and
13C-
NMR of 58 is given in tables 19 and 21.
3.12.59. Isopentyl hydrogen succinate (59)
Physical data, yield (%), UU-VIS, IR, Mass/anlytical, 1H-, and
13C-
NMR of 59 is given in tables 19 and 21.
54
3.12.60. Benzyl hydrogen succinate (60)
Physical data, yield (%), UU-VIS, IR, Mass/anlytical, 1H-, and
13C-
NMR of 60 is given in tables 19 and 21.
3.13. Physical characteristics of acid halides 1a-60a
Yield (%), UU-VIS, IR and Mass/anlytical data for compounds 1a-56a are given below. Physical
characteristics of 1a-20a are given in table 1. 1H-, and
13C-NMR data of 57a-60a is given in
tables 19-21.
3.13.1. 2-Methoxybenzyl 4-chloro-4-ketobutanoate (1a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 278 (3.7); MS, m/z (Ir/%):
256.68 (11) (M+); FT-IR (Neat) υmax (cm
-1): 3056 (Ar-H), 1792 (Cl-
C=O), 1737 (C=O), 1595, 1546, (C=C, Ar-H), 1026 (C-O), 723 (C-Cl); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.2. 3-Methoxybenzyl 4-chloro-4-ketobutanoate (2a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 278 (3.7); MS, m/z (Ir/%):
256.68 (13) (M+); IR, ~ /cm
-1: 3057 (Ar-H), 1793 (Cl-C=O), 1738
(C=O), 1592, 1541, (C=C, Ar-H), 1021 (C-O), 721 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 10 and 12).
3.13.3. 4-Methoxybenzyl 4-chloro-4-ketobutanoate (3a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 278 (3.7);
MS, m/z (Ir/%): 256.68 (16) (M+); FT-IR (Neat) υmax (cm
-1):
55
3057 (Ar-H), 1793 (Cl-C=O), 1738 (C=O), 1593, 1542, (C=C, Ar-H), 1023 (C-O), 722 (C-Cl);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.4. 2,3-Dimethoxybenzyl 4-chloro-4-ketobutanoate (4a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 282 (3.7); MS, m/z (Ir/%):
286.70 (17) (M+); FT-IR (Neat) υmax (cm
-1): 3065 (Ar-H), 1797 (Cl-
C=O), 1741 (C=O), 1598, 1547, (C=C), 1027 (C-O), 725 (C-Cl); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 10 and 12).
3.13.5. 2,4-Dimethoxybenzyl 4-chloro-4-ketobutanoate (5a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 282 (3.7);
MS, m/z (Ir/%): 286.70 (18) (M+); FT-IR (Neat) υmax (cm
-1):
3067 (Ar-H), 1799 (Cl-C=O), 1743 (C=O), 1591, 1544, 1431 (C=C), Ar-H), 1245, 1135, 1029
(C-O), 727 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.6. 2,5-Dimethoxybenzyl 4-chloro-4-ketobutanoate (6a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 282 (3.7);
MS, m/z (Ir/%): 286.70 (14) (M+); FT-IR (Neat) υmax (cm
-1):
3069 (Ar-H), 1790 (Cl-C=O), 1747 (C=O), 1594, 1541, 1433 (C=C), Ar-H), 1249, 1131, 1022
(C-O), 724 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.7. 3,4-Dimethoxybenzyl 4-chloro-4-ketobutanoate (7a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 282 (3.7);
56
MS, m/z (Ir/%): 286.70 (19) (M+); FT-IR (Neat) υmax (cm
-1): 3077 (Ar-H), 1799 (Cl-C=O), 1738
(C=O), 1598, 1547, 1431 (C=C), Ar-H), 1241, 1129, 1021 (C-O), 725 (C-Cl); 1H-, and
13C-NMR
(300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.8. 3,5-Dimethoxybenzyl 4-chloro-4-ketobutanoate (8a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 278 (3.4);
MS, m/z (Ir/%): 286.70 (11) (M+); FT-IR (Neat) υmax (cm
-1):
3046 (Ar-H), 1789 (Cl-C=O), 1733 (C=O), 1601, 1548, 1432 (C=C), Ar-H), 1243, 1127, 1019
(C-O), 726 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.9. 2-Nitrobenzyl 4-chloro-4-ketobutanoate (9a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 238 (3.1); MS, m/z (Ir/%):
271.66 (16) (M+); FT-IR (Neat) υmax (cm
-1): 3085 (Ar-H), 1788 (Cl-
C=O), 1734 (C=O), 1602, 1549, 1433 (C=C), Ar-H), 1365 (NO2), 1244, 1128, 1018 (C-O), 724
(C-Cl); 1
H-, and 13
C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.10. 3-Nitrobenzyl 4-chloro-4-ketobutanoate (10a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 238 (3.1);
MS, m/z (Ir/%): 271.66 (14) (M+); FT-IR (Neat) υmax (cm
-1): 3087
(Ar-H), 1786 (Cl-C=O), 1735 (C=O), 1603, 1559, 1443 (C=C), Ar-H), 1371 (NO2), 1255, 1138,
1028 (C-O), 722 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
57
3.13.11. 4-Nitrobenzyl 4-chloro-4-ketobutanoate (11a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 238 (3.1);
MS, m/z (Ir/%): 271.66 (14) (M+);
FT-IR (Neat) υmax (cm-1
): 3083 (Ar-H), 1785 (Cl-C=O), 1734 (C=O), 1601, 1558, and 1441
(C=C), Ar-H), 1375 (NO2), 1251, 1134, and 1025 (C-O), 727 (C-Cl); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.12. 2-Chlorobenzyl 4-chloro-4-ketobutanoate (12a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 260.95 (17) (M+); FT-IR (Neat) υmax (cm
-1): 3053 (Ar-H), 1787 (Cl-C=O), 1738
(C=O), 1603, 1551, 1439 (C=C), Ar-H), 1257, 1138, 1021 (C-O), 721 (C-Cl); 1H-, and
13C-NMR
(300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.13. 3-Chlorobenzyl 4-chloro-4-ketobutanoate (13a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 260.95 (18) (M+); FT-IR (Neat) υmax (cm
-1): 3059 (Ar-
H), 1791 (Cl-C=O), 1736 (C=O), 1605, 1548, 1432 (C=C), Ar-H), 1251, 1132, 1019 (C-O), 726
(C-Cl); 1H-, and
13C-NMR data (Tables 10 and 12).
3.13.14. 4-Chlorobenzyl 4-chloro-4-ketobutanoate (14a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 260.95 (15) (M+); FT-IR (Neat) υmax (cm
-1): 3061
58
(Ar-H), 1789 (Cl-C=O), 1737 (C=O), 1606, 1549, 1436 (C=C), Ar-H), 1252, 1131, 1018 (C-O),
724 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.15. 2-Bromobenzyl 4-chloro-4-ketobutanoate (15a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 305.76 (12) (M+); FT-IR (Neat) υmax (cm
-1): 3063 (Ar-
H), 1788 (Cl-C=O), 1739 (C=O), 1602, 1575, 1431 (C=C), Ar-H), 1258, 1139, 1028 (C-O), 722
(C-Cl), 521 (C-Br); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.16. 3-Bromobenzyl 4-chloro-4-ketobutanoate (16a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 305.76 (15) (M+); FT-IR (Neat) υmax (cm
-1): 3064 (Ar-
H), 1786 (Cl-C=O), 1729 (C=O), 1599, 1567, 1443, (C=C), Ar-H), 1253, 1144, 1024, 723 (C-
Cl), 523 (C-Br); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.17. 4-Bromobenzyl 4-chloro-4-ketobutanoate (17a)
Physical characteristics, yields (%) and analytical data are given
in table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 305.76 (13) (M+); FT-IR (Neat) υmax (cm
-1): 3061
(Ar-H), 1787 (Cl-C=O), 1731 (C=O), 1598, 1569, 1441 (C=C), Ar-H), 1257, 1142, 1021, 725 (C-
Cl), 525 (C-Br); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.18. 2-Iodobenzyl 4-chloro-4-ketobutanoate (18a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 278 (3.7);
59
MS, m/z (Ir/%): 352.65 (12) (M+); FT-IR (Neat) υmax (cm
-1): 3075 (Ar-H), 1791 (Cl-C=O), 1736
(C=O), 1593, 1561, 1446 (C=C), Ar-H), 1261, 1147, 1025, 723 (C-Cl), 487 (C-I); 1H-, and
13C-
NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.19. 3-Iodobenzyl 4-chloro-4-ketobutanoate (19a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 278 (3.7);
MS, m/z (Ir/%): 352.65 (11) (M+); FT-IR (Neat) υmax (cm
-1): 3077 (Ar-
H), 1793 (Cl-C=O), 1738 (C=O), 1595, 1562, 1448 (C=C), Ar-H), 1263, 1148, 1026, 723 (C-Cl),
485 (C-I); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.20. 4-Iodobenzyl 4-chloro-4-ketobutanoate (20a)
Physical characteristics, yields (%) and analytical data are given in
table 1; UV-VIS (MeOH), λmax/nm (log ɛ): 268 (4.1);
MS, m/z (Ir/%): 352.65 (15) (M+); FT-IR (Neat) υmax (cm
-1): 3064 (Ar-H), 1786 (Cl-C=O), 1729
(C=O), 1599, 1567, 1443, (C=C), Ar-H), 1253, 1144, 1024, 723 (C-Cl), 523 (C-Br); 1H-, and
13C-
NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12).
3.13.21. 2-Methylbenzyl 4-chloro-4-ketobutanoate (21a)
Yield 76 %, 1.82 g (6.16 mmol), viscous oil; MS, m/z (Ir/%): 240 (22)
(M+); UV-VIS (MeOH), λmax/nm (log ɛ): 258.5. (3.64); FT-IR (Neat)
υmax (cm-1
): 3083 (Ar-H), 1731 (C=O), 1779 (Cl-C=O), 1596, 1543,
1422 (C=C), 1243, 1122, 1020 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables
10 and 12); Analysis calculated for C12H13ClO3 (240.68): C, 59.88%; H, 5.44%; Cl, 14.73%;
Found: C, 59.67%; H, 5.53%; Cl14.78%.
60
3.13.22. 3-Methylbenzyl 4-chloro-4-ketobutanoate (22a)
Yield 75 %, 1.46 g (6.08 mmol), viscous oil; MS, m/z (Ir/%): 240.87
(22) (M+); UV-VIS (EtOH), λmax nm (log ε): 259.9 (3.47);
FT-IR (Neat) υmax (cm-1
): 3099 (Ar-H), 1732 (C=O), 1782 (Cl-C=O),
1599, 1556 1435 (C=C, Ar-H), 1243, 1134, 1022 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 10 and 12); Analysis calculated for C12H13ClO3 (240.68): C, 59.88%; H, 5.44%;
Cl, 14.73%; Found: C, 59.65%; H, 5.59%; Cl 14.77%.
3.13.23. 4-Methylbenzyl 4-chloro-4-ketobutanoate (23a)
Yield 77 %, 1.50 g (6.24 mmol), viscous oil;
MS, m/z (Ir/%): 240.67 (22) (M+); UV-VIS (EtOH) λ max nm (log
ε): 263.4 (3.68); FT-IR (Neat) υmax (cm-1
): 3076 (Ar-H), 1728 (C=O), 1786 (Cl-C=O), 1598,
1547, 1434 (C=C, Ar-H), 1243, 1132, 1022 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 10 and 12); Analysis calculated for C12H13ClO3 (240.68): C, 59.88%; H, 5.44%;
Cl, 14.73%; Found: C, 59.78%; H, 5.55%; Cl 14.71%.
3.13.24. 2-Hydroxybenzyl 4-chloro-4-ketobutanoate (24a)
Yield 75 %, 1.47 g (6.08 mmol), viscous oil;
MS, m/z (Ir/%): 242.66 (23) (M+);
UV-VIS (EtOH) λmax nm (log ε):
257.8 (3.63); FT-IR (Neat) υmax (cm-1
): 3365-3122 (OH), 3076 (Ar-
H), 1745 (C=O), 1791 (Cl-C=O), 1599, 1538, 1443 (C=C, Ar-H), 1240, 1133 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12); Analysis calculated for C11H11ClO4
(242.65): C, 54.45%; H, 4.57%; Cl, 14.61%; Found: C, 54.57%; H, 4.66%; Cl 14.55%.
61
3.13.25. 3-Hydroxybenzyl 4-chloro-4-ketobutanoate (25a)
Yield 76 %, 1.49 g (6.16 mmol), viscous oil; MS, m/z (Ir/%): 242.64
(23) (M+); UV-VIS (EtOH) λmax nm (log ε): 259.5 (3.45);
FT-IR (Neat) υmax (cm-1
): 3376-3118 (OH), 3096 (Ar-H), 1738 (C=O),
1783 (CO-Cl), 1618, 1554, 1448, (C=C, Ar-H), 1242, 1134, 1041 (C-O); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 10 and 12); Analysis calculated for C11H11ClO4 (242.65): C,
54.45%; H, 4.57%; Cl, 14.61%; Found: C, 54.56%; H, 4.64%; Cl 14.56%.
3.13.26. 4-Hydroxybenzyl 4-chloro-4-ketobutanoate (26a)
Yield 77 %, 1.51 g (6.24 mmol), viscous oil; MS, m/z (Ir/%):
242.64 (23) (M+); UV-VIS (EtOH) λmax nm (log ε): 256.7 (3.72);
FT-IR (Neat) υmax (cm-1
): 3355-3120 (OH), 3078 (Ar-H), 1748 (C=O), 1781 (Cl-C=O), 1614,
1545, 1446 (C=C, Ar-H), 1224, 1133, 1040 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 10 and 12); Analysis calculated for C11H11ClO4 (242.65): C, 54.45%; H, 4.57%;
Cl, 14.61%; Found: C, 54.59%; H, 4.67%; Cl 14.63%.
3.13.27. 2-Aminobenzyl 4-chloro-4-ketobutanoate (27a)
Yield 72%, 1.41 g (5.84 mmol), viscous oil; MS, m/z (Ir/%): 241.66
(21) (M+); UV-VIS (EtOH) λmax nm (log ε): 257.8 (3.92); FT-IR
(Neat) υmax (cm-1
): 3215 (NH2), 3088 (Ar-H), 1742 (C=O), 1788 (Cl-
C=O), 1607, 1532, 1499, 1458, (C=C, Ar-H), 1384 (C-N), 1257, 1231, 1130, 1202, 1098, 1042,
1012 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12); Analysis
calculated for C11H12ClNO3 (241.67): C, 54.67%; H, 5.00%; Cl, 14.67%; N, 5.80; Found: C,
54.64%; H, 4.92%; Cl 14.68%; N, 5.78%.
62
3.13.28. 3-Aminobenzyl 4-chloro-4-ketobutanoate (28a)
Yield 71%, 1.39 g (5.76 mmol), viscous oil; MS, m/z (Ir/%): 241.66
(21) (M+); UV-VIS (EtOH) λmax nm (log ε): 258.7 (3.76);
FT-IR (Neat) υmax (cm-1
): 3215 (Broad, NH2), 3097 (Ar-H), 1738
(C=O), 1787 (Cl-C=O), 1592, 1520, 1442, (C=C, Ar-H), 1391 (C-N), 1246, 1135, 1045 (C-O);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 10 and 12); Analysis calculated for
C11H12ClNO3 (241.67): C, 54.67%; H, 5.00%; Cl, 14.67%; N, 5.80; Found: C, 54.65%; H,
4.91%; Cl 14.69%; N, 5.77%.
3.13.29. 4-Aminobenzyl 4-chloro-4-ketobutanoate (29a)
Yield 78%, 1.53 g (6.32 mmol), viscous oil; MS, m/z (Ir/%):
241.68 (24) (M+); UV-VIS (EtOH) λmax nm (log ε): 256.2 (3.6);
FT-IR (Neat) υmax (cm-1
): 3232 (Broad, intense, NH2), 3085 (Ar-
H), 1739 (C=O), 1779 (Cl-C=O), 1607, 1592, 1458 (C=C, Ar-H), 1382 (C-N), 1263, 1154, 1020
(C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated
for C11H12ClNO3 (241.67): C, 54.67%; H, 5.00%; Cl, 14.67%; N, 5.80; Found: C, 54.65%; H,
4.91%; Cl 14.69%; N, 5.77%.
3.13.30. 2,4-Dichlorobenzyl 4-chloro-4-ketobutanoate (30a)
Yield 65 %, 1.53 g (5.2 mmol), viscous oil; MS, m/z (Ir/%):
295.54 (25) (M+); UV-VIS (EtOH) λmax nm (log ε): 257.9 (3.7);
FT-IR (Neat) υmax (cm-1
): 3086 (Ar-H), 1721 (C=O), 1777 (Cl-
C=O), 1610, 1478 (C=C), 1262, 1144, 1021 (C-O), 720 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H9Cl3O3 (295.55): C, 44.70%; H,
3.07%; Cl, 35.99%; Found: C, 44.68%; H, 3.11%; Cl 35.88%.
63
3.13.31. 2,5-Dichlorobenzyl 4-chloro-4-ketobutanoate (31a)
Yield 66%, 1.56 g (5.28 mmol), viscous oil; MS, m/z (Ir/%):
295.54 (22) (M+); UV-VIS (EtOH) λmax nm (log ε): 262.5 (3.5);
FT-IR (Neat) υmax (cm-1
): 3087 (Ar-H), 1724 (C=O), 1776 (Cl-
C=O), 1609, 1433 (C=C), 1266, 1138, 1027 (C-O), 721 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H9Cl3O3 (295.55): C, 44.70%; H,
3.07%; Cl, 35.99%; Found: C, 44.69%; H, 3.03%; Cl 35.89%.
3.13.32. 2,6-Dichlorobenzyl 4-chloro-4-ketobutanoate (32a)
Yield 64%, 1.51 g (5.12 mmol), viscous oil; MS, m/z (Ir/%): 295.55
(27) (M+); UV-VIS (EtOH) λmax nm (log ε): 265.4 (3.9);
FT-IR (Neat) υmax (cm-1
): 3083 (Ar-H), 1778 (Cl-C=O), 1727 (C=O),
1607, 1442 (C=C), 1248, 1121, 1011 (C-O), 726 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C11H9Cl3O3 (295.55): C, 44.70%; H, 3.07%;
Cl, 35.99%; Found: C, 44.68%; H, 3.02%; Cl 35.91%.
3.13.33. 3,4-Dichlorobenzyl 4-chloro-4-ketobutanoate (33a)
Yield 67%, 1.58 g (5.36 mmol), viscous oil; MS, m/z (Ir/%):
295.54 (21) (M+); UV-VIS (EtOH) λmax nm (log ε): 254.5 (3.7);
FT-IR (Neat) υmax (cm-1
): 3066 (Ar-H), 1777 (Cl-C=O), 1726
(C=O), 1611, 1444 (C=C), 1255, 1132, 1029 (C-O), 724 (C-Cl); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H9Cl3O3 (295.55): C, 44.70%;
H, 3.07%; Cl, 35.99%; Found: C, 44.67%; H, 3.09%; Cl 35.92%.
64
3.13.34. 3,5-Dichlorobenzyl 4-chloro-4-ketobutanoate (34a)
Yield 67%, 1.58 g (5.36 mmol), viscous oil; MS, m/z (Ir/%):
295.56 (24) (M+); UV-VIS (EtOH) λmax nm (log ε): 266.4 (3.9);
FT-IR (Neat) υmax (cm-1
): 3095 (Ar-H), 1765 (Cl-C=O), 1722
(C=O), 1608, 1444 (C=C), 1248, 1129, 1022 (C-O), 727 (C-Cl); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H9Cl3O3 (295.55): C, 44.70%;
H, 3.07%; Cl, 35.99%; Found: C, 44.71%; H, 3.05%; Cl 35.93%.
3.13.35. 2,3-Difluorobenzyl 4-chloro-4-ketobutanoate (35a)
Yield 68%, 1.43 g (5.44 mmol), viscous oil; MS, m/z (Ir/%): 262.75
(22) (M+); UV-VIS (EtOH) λmax nm (log ε): 258.5 (4.2);
FT-IR (Neat) υmax (cm-1
): 3088 (Ar-H), 1776 (Cl-C=O), 1728 (C=O),
1606, 1478 (C=C), 1252, 1126, 1010 (C-O), 1150 (C-F); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C11H9ClF2O3 (262.64): C, 50.30%; H,
3.45%; Cl, 13.50%; F, 14.47; Found: C, 50.28%; H, 3.47%; Cl, 13.52%; F, 14.44%.
3.13.36. 2,4-Difluorobenzyl 4-chloro-4-ketobutanoate (36a)
Yield 68%, 1.43 g (5.44 mmol), viscous oil; MS, m/z (Ir/%):
262.66 (22) (M+); UV-VIS (EtOH) λmax nm (log ε): 263.2 (4.0);
FT-IR (Neat) υmax (cm-1
): 3098 (Ar-H), 1766 (Cl-C=O), 1729
(C=O), 1594, 1476 (C=C), 1239, 1119, 1026 (C-O) 1151 (C-F); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H9ClF2O3 (262.64): C, 50.30%;
H, 3.45%; Cl, 13.50%; F, 14.47; Found: C, 50.29%; H, 3.46%; Cl, 13.49%; F, 14.46%.
65
3.13.37. 2,5-Difluorobenzyl 4-chloro-4-ketobutanoate (37a)
Yield 71%, 1.49 g (5.68 mmol), viscous oil; MS, m/z (Ir/%):
262.63 (22) (M+); UV-VIS (EtOH) λmax nm (log ε): 258.4 (3.5);
FT-IR (Neat) υmax (cm-1
): 3099 (Ar-H), 1767 (Cl-C=O), 1727
(C=O), 1599, 1486 (C=C), 1258, 1122, 1025 (C-O), 1153 (C-F); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H9ClF2O3 (262.64): C, 50.30%;
H, 3.45%; Cl, 13.50%; F, 14.47; Found: C, 50.28%; H, 3.47%; Cl, 13.48%; F, 14.49%.
3.13.38. 2,6-Difluorobenzyl 4-chloro-4-ketobutanoate (38a)
Yield 64%, 1.34 g (5.12 mmol), viscous oil; MS, m/z (Ir/%): 262.64
(22) (M+); UV-VIS (EtOH) λmax nm (log ε): 257.7 (3.9);
FT-IR (Neat) υmax (cm-1
): 3088 (Ar-H), 1765 (Cl-C=O), 1726 (C=O),
1597, 1406 (C=C), 1245, 1120, 1008 (C-O), 1157 (C-F); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C11H9ClF2O3 (262.64): C, 50.30%; H,
3.45%; Cl, 13.50%; F, 14.47; Found: C, 50.31%; H, 3.47%; Cl, 13.49%; F, 14.46%.
3.13.39. 2,4-Dimethylbenzyl 4-chloro-4-ketobutanoate (39a)
Yield 68%, 1.38 g (5.44 mmol), viscous oil; MS, m/z (Ir/%):
254.69 (22) (M+); UV-VIS (EtOH) λmax nm (log ε): 262.5 (3.5);
FT-IR (Neat) υmax (cm-1
): 3097 (Ar-H), 1775 (Cl-C=O), 1731
(C=O), 1605, 1435 (C=C), 1254, 1123, 1008 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C13H15ClO3 (254.71): C, 61.30%; H, 5.94%;
Cl, 13.92%; Found: C, 61.28%; H, 5.95%; Cl, 13.94%.
66
3.13.40. 2,5-Dimethylbenzyl 4-chloro-4-ketobutanoate (40a)
Yield 69%, 1.40 g (5.52 mmol), viscous oil; MS, m/z (Ir/%):
254.70 (22) (M+); UV-VIS (EtOH) λmax nm (log ε): 266.8 (3.8);
FT-IR (Neat) υmax (cm-1
): 3088 (Ar-H), 1767 (Cl-C=O), 1722
(C=O), 1602, 1487 (C=C), 1244, 1136, 1012 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C13H15ClO3 (254.71): C, 61.30%; H, 5.94%;
Cl, 13.92%; Found: C, 61.31%; H, 5.98%; Cl, 13.97%.
3.13.41. 3,4-Dimethylbenzyl 4-chloro-4-ketobutanoate (41a)
Yield 70%, 1.89 g (5.6 mmol), viscous oil; MS, m/z (Ir/%):
254.70 (24) (M+); UV-VIS (EtOH) λmax nm (log ε): 268.3 (3.8);
FT-IR (Neat) υmax (cm-1
): 3088 (Ar-H), 1775 (Cl-C=O), 1721
(C=O), 1601, 1478 (C=C), 1259, 1125, 1010 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C13H15ClO3 (254.71): C, 61.30%; H, 5.94%;
Cl, 13.92%; Found: C, 61.29%; H, 5.93%; Cl, 13.93%.
3.13.42. 3,5-Dimethylbenzyl 4-chloro-4-ketobutanoate (42a)
Yield 72%, 1.46 g (5.76 mmol), viscous oil; MS, m/z (Ir/%):
254.72 (25) (M+); UV-VIS (EtOH) λmax nm (log ε): 264.4 (3.8);
FT-IR (Neat) υmax (cm-1
): 3098 (Ar-H), 1774 (Cl-C=O), 1724
(C=O), 1632, 1494 (C=C), 1256, 1123, 1018 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C13H15ClO3 (254.71): C, 61.30%; H, 5.94%;
Cl, 13.92%; Found: C, 61.32%; H, 5.93%; Cl, 13.92%.
3.13.43. 3,4-Dinitrobenzyl 4-chloro-4-ketobutanoate (43a)
Yield 63%, 1.59 g (5.04 mmol), pale yellow viscous oil;
67
MS, m/z (Ir/%): 316.64 (29) (M+); UV-VIS (EtOH) λmax nm (log ε): 272.3 (3.5); FT-IR (Neat)
υmax (cm-1
): 3114 (Ar-H), 1779 (Cl-C=O), 1732 (C=O), 1517, 1450 (C=C), 1364 (NO2), 1242,
1120, 1020 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and 13); Analysis
calculated for C11H9ClN2O7 (316.65): C, 41.72; H, 2.86; Cl, 11.20; N, 8.85; Found: C, 41.71; H,
2.87; Cl, 11.21; N, 8.84%.
3.13.44. 3,5-Dinitrobenzyl 4-chloro-4-ketobutanoate (44a)
Yield 65%, 1.64 g (5.2 mmol), pale yellow viscous oil;
MS, m/z (Ir/%): 316.66 (27) (M+); UV-VIS (EtOH) λmax nm (log
ε): 271.8 (3.7); FT-IR (Neat) υmax (cm-1
): 3104 (Ar-H), 1776 (Cl-
C=O), 1730 (C=O), 1605, 1582, 1413 (C=C), 1373 (NO2), 1248, 1122, 1025 (C-O);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for
C11H9ClN2O7 (316.65): C, 41.72; H, 2.86; Cl, 11.20; N, 8.85; Found: C, 41.73; H, 2.87; Cl,
11.19; N, 8.87%.
3.13.45. 2,6-Diethoxybenzyl 4-chloro-4-ketobutanoate (45a)
Yield 67%, 1.68 g (5.36 mmol), viscous oil; MS, m/z (Ir/%): 314.75
(19) (M+); UV-VIS (EtOH) λmax nm (log ε): 272.5 (4.07); FT-IR
(Neat) υmax (cm-1
): 3105 (Ar-H), 1778 (Cl-C=O), 1733 (C=O), 1612,
1491 (C=C), 1253, 1125, 1020 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables
11 and 13); Analysis calculated for C15H19ClO5 (314.76): C, 57.24; H, 6.08; Cl, 11.26; Found: C,
57.25; H, 6.03; Cl, 11.25%.
3.13.46. 3,4-Diethoxybenzyl 4-chloro-4-ketobutanoate (46a)
Yield 69%, 1.74 g (5.52 mmol), viscous oil; MS, m/z (Ir/%):
314.77 (21) (M+); UV-VIS (EtOH) λmax nm (log ε): 272.2 (4.4);
68
FT-IR (Neat) υmax (cm-1
): 3354 (OH), 3077 (Ar-H), 1777 (Cl-C=O), 1732 (C=O), 1606, 1475
(C=C), 1249, 1124, 1022 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and
13); Analysis calculated for C15H19ClO5 (314.76): C, 57.24; H, 6.08; Cl, 11.26; Found: C, 57.23;
H, 6.06; Cl, 11.27.
3.13.47. 3,5-Dihydroxybenzyl 4-chloro-4-ketobutanoate (47a)
Yield 74%, 1.55 g (6.0 mmol), viscous oil; MS, m/z (Ir/%):
258.65 (31) (M+); UV-VIS (EtOH) λmax nm (log ε): 273.6 (3.9);
FT-IR (Neat) υmax (cm-1
): 3250 (OH), 3066 (Ar-H), 1779 (Cl-
C=O), 1731 (C=O), 1515, 1490 (C=C), 1261, 1130, 1021 (C-O); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H11ClO5 (258.66): C, 51.08; H,
4.29; Cl, 13.71; Found: C, 51.08; H, 4.29; Cl, 13.71%.
3.13.48. 2,3,4-Trimethoxybenzyl 4-chloro-4-ketobutanoate (48a)
Yield 72%, 1.85 g (5.84 mmol), viscous oil; MS, m/z (Ir/%):
316.72 (25) (M+); UV-VIS (EtOH) λmax nm (log ε): 275.3
(3.98); FT-IR (Neat) υmax (cm-1
): 3097 (Ar-H), 1774 (Cl-C=O),
1731 (C=O), 1618, 1499 (C=C), 1267, 1131, 1012 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C14H17ClO6 (316.73): C, 53.09; H,
5.41; Cl, 11.19; Found: C, 53.10; H, 5.40; Cl, 11.20%.
3.13.49. 2,4,5-Trimethoxbenzyl 4-chloro-4-ketobutanoate (49a)
Yield 74%, 1.90 g (6.0 mmol), viscous oil; MS, m/z (Ir/%):
316.74 (24) (M+); UV-VIS (EtOH) λmax nm (log ε): 273.9
(4.16); FT-IR (Neat) υmax (cm-1
): 3087 (Ar-H), 1778 (Cl-C=O),
1731 (C=O), 1604, 1493 (C=C), 1266, 1154, 1020 (C-O); 1H-, and
13C-NMR (300 MHz, 75
69
MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C14H17ClO6 (316.73): C, 53.09; H,
5.41; Cl, 11.19; Found: C, 53.11; H, 5.42; Cl, 11.18%.
3.13.50. 3,4,5-Trimethoxybenzyl 4-chloro-4-ketobutanoate (50a)
Yield 75%, 1.92 g (6.08 mmol), viscous oil; MS, m/z (Ir/%):
316.74 (22) (M+); UV-VIS (EtOH) λmax nm (log ε): 276.8
(4.22); FT-IR (Neat) υmax (cm-1
): 3076 (Ar-H), 1777 (Cl-C=O),
1731 (C=O), 1504, 1488 (C=C), 1257, 1155, 1023 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C14H17ClO6 (316.73): C, 53.09; H,
5.41; Cl, 11.19; Found: C, 53.08; H, 5.39; Cl, 11.21%.
3.13.51. 3-Methoxy-4-nitrobenzyl 4-chloro-4-ketobutanoate (51a)
Yield 66%, 1.61 g (5.36 mmol), light yellow viscous oil; MS,
m/z (Ir/%): 301.69 (29) (M+); UV-VIS (EtOH) λmax nm (log ε):
268.7 (3.86); FT-IR (Neat) υmax (cm-1
): 3083 (Ar-H), 1778 (Cl-
C=O), 1730 (C=O), 1621, 1575, 1392 (C=C), 1374 (NO2), 1250, 1134, 1022 (C-O); 1H-, and
13C-
NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C12H12ClNO6
(301.68): C, 47.78; H, 4.01; Cl, 11.75; N, 4.64; Found: C, 47.77; H, 4.03; Cl, 11.74; N, 4.65%.
3.13.52. 4-Methoxy-3-nitrobenzyl 4-chloro-4-ketobutanoate (52a)
Yield 64%, 1.54 g (5.12 mmol), light yellow viscous oil;
MS, m/z (Ir/%): 301.69 (25) (M+); UV-VIS (EtOH) λmax nm
(log ε): 269.8 (3.84); FT-IR (Neat) υmax (cm-1
): 3077 (Ar-H),
1783 (Cl-C=O), 1726 (C=O), 1618, 1584, 1386 (C=C), 1372 (NO2), 1251, 1132, 1016 (C-O); 1H-
, and 13
C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for
70
C12H12ClNO6 (301.68): C, 47.78; H, 4.01; Cl, 11.75; N, 4.64; Found: C, 47.76; H, 3.99; Cl,
11.79; N, 4.63%.
3.13.53. 2-Methoxy-5-nitrobenzyl 4-chloro-4-ketobutanoate (53a)
Yield 68%, 1.64 g (5.44 mmol), light yellow viscous oil; MS,
m/z (Ir/%): 301.67 (22) (M+); UV-VIS (EtOH) λmax nm (log ε):
268.7 (3.96); FT-IR (Neat) υmax (cm-1
): 3069 (Ar-H), 1785 (Cl-
C=O), 1724 (C=O), 1512, 1482 (C=C), 1370 (NO2), 1245, 1123, 1010 (C-O); 1H-, and
13C-NMR
(300 MHz, 75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C12H12ClNO6 (301.68):
C, 47.78; H, 4.01; Cl, 11.75; N, 4.64; Found: C, 47.79; H, 3.98; Cl, 11.76; N, 4.65%.
3.13.54. 2,4,6-Trichlorobenzyl 4-chloro-4-ketobutanoate (54a)
Yield 63%, 1.66 g (5.04 mmol), viscous oil; MS, m/z (Ir/%):
329.98 (33) (M+); UV-VIS (EtOH) λmax nm (log ε): 267.8 (3.95);
FT-IR (Neat) υmax (cm-1
): 3086 (Ar-H), 1779 (Cl-C=O), 1729 (C=O), 1616-1395 (C=C), 1250,
1126, 1015 (C-O), 733 (C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 11 and
13); Analysis calculated for C11H8Cl4O3 (329.99): C, 40.04; H, 2.44; Cl, 42.97; Found: C, 40.08;
H, 2.43; Cl, 42.96%.
3.13.55. 2,4,5-Tribromobenzyl 4-chloro-4-ketobutanoate (55a)
Yield 64%, 2.37 g (5.12 mmol), viscous oil; MS, m/z (Ir/%):
463.36 (34) (M+); UV-VIS (EtOH) λmax nm (log ε): 268.6 (4.21);
FT-IR (Neat) υmax (cm-1
): 3090 (Ar-H), 1781 (Cl-C=O), 1728
(C=O), 1516, 1493 (C=C), 1256, 1132, 1018 (C-O), 529 (C-Br); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 11 and 13); Analysis calculated for C11H8Br3ClO3 (463.34): C, 28.51;
H, 1.74; Br, 51.74; Cl, 7.65; Found: C, 28.52; H, 1.73; Br, 51.76; Cl, 7.63%.
71
3.13.56. 2,4,6-Trimethylbenzyl 4-chloro-4-ketobutanoate (56a)
Viscous oil: Yield 71%, 1.52 g (5.68 mmol): MS, m/z (Ir/%):
268.73 (37) (M+); UV-VIS (EtOH) λmax nm (log ε): 267.6 (3.43);
FT-IR (Neat) υmax (cm-1
): 3084 (Ar-H), 1778 (Cl-C=O), 1726
(C=O), 1614-1397 (C=C), 1258, 1135, 1010 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 11 and 13); Analysis calculated for C14H17ClO3 (268.74): C, 62.57; H, 6.38; Cl,
13.19; Found: C, 62.58; H, 6.37; Cl, 13.20%.
3.13.57. Isopropyl 4-chloro-4-ketobutanoate (57a)
Physical data, yield (%), UV-VIS, IR, mass/anlytical, 1H-, and
13C-NMR
data for compound 57a is given in tables 19 and 21.
3.13.58. Isobutyl 4-chloro-4-ketobutanoate (58a)
Physical data, yield (%), UU-VIS, IR, mass/anlytical, 1H-, and
13C-
NMR data for compound 58a is given in tables 19 and 21.
3.13.59. Isopentyl 4-chloro-4-ketobutanoate (59a)
Physical data, yield (%), UU-VIS, IR, mass/anlytical, 1H-, and
13C-
NMR data for compound 59a is given in tables 19 and 21.
3.13.60. Benzyyl 4-chloro-4-ketobutanoate (60a)
Physical data, yield (%), UU-VIS, IR, mass/anlytical, 1H-, and
13C-
NMR data for compound 60a is given in tables 19 and 21.
3.14. Physical Characteristics of γ-Ketoesters 1b-56b
Yield (%), UU-VIS, IR and Mass/anlytical data for compounds 1b-56b are given below. Some
of the physical characteristics of 1b-20b are given in Table 2. 1H-, and
13C-NMR data of 1b-56b
is given in tables 14-18.
72
3.14.1. 2-Methoxybenzyl γ-ketohexanoate (1b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 271.3 (3.3); MS, m/z (Ir/%): 250.29 (23) (M+)
FT-IR (Neat) υmax (cm-1
): 3057 (Ar-H), 1749 (C=O), 1717 (CO2Ar),
1595, 1546, 1429, (C=C), Ar-H), 1239, 1127, 1026 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 14 and 16).
3.14.2. 3-Methoxybenzyl γ-ketohexanoate (2b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 271.6 (3.5). MS, m/z (Ir/%): 250.29 (29) (M+); FT-IR
(Neat) υmax (cm-1
): 3065 (Ar-H), 1725 (C=O), 1714 (CO2Ar), 1592,
1545, 1431 (C=C), 1230, 1128, 1025 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3):
(Tables 14 and 16).
3.14.3. 4-Methoxybenzyl γ-ketohexanoate (3b)
Physical characteristics are given in Table 2;
UV-VIS (MeOH), λmax/nm (log ɛ): 271.1 (3.6);
MS, m/z (Ir/%): 250.29 (25) (M+). FT-IR (Neat) υmax (cm
-1):
3069 (Ar-H), 1747 (C=O), 1722 (CO2Ar), 1596, 1543, 1430 (C=C), 1243, 1129, and 1023 (C-O);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.4. 2,3-Dimethoxybenzyl γ-ketohexanoate (4b)
Physical characteristics are given in Table 2;
UV-VIS (MeOH), λmax/nm (log ɛ): 278.8 (3.7); MS, m/z (Ir/%):
280.11 (27) (M+); FT-IR (Neat) υmax (cm
-1): 3085 (Ar-H), 2850,
73
1757 (C=O), 1723 (CO2Ar), 1592, 1538, 1435 (C=C), 1237, 1133, 1041 (C-O); 1H-, and
13C-
NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.5. 2,4-Dimethoxybenzyl γ-ketohexanoate (5b)
Physical characteristics are given in Table 2;
UV-VIS (MeOH), λmax/nm (log ɛ): 278.6 (3.87) ;
MS, m/z (Ir/%): 280.11 (24) (M+); FT-IR (Neat) υmax (cm
-1)
3054 (Ar-H), 1754 (C=O), 1726 (CO2Ar), 1600, 1540, 1436 (C=C), 1290, 1135(C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.6. 2,5-Dimethoxybenzyl γ-ketohexanoate (6b)
Physical characteristics are given in Table 2;
UV-VIS (MeOH), λmax/ nm (log ɛ): 282.5 (3.6);
MS, m/z (Ir/%): 280.11 (18) (M+); FT-IR (Neat) υmax (cm
-1):
3092 (Ar-H), 1753 (C=O), 1722 (ArO-C=O), 1605, 1595, 1435 (C=C), 1245, 1125 (C-O); 1H-,
and 13
C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.7. 3,4-Dimethoxybenzyl γ-ketohexanoate (7b)
Physical characteristics are given in Table 2; UV-VIS
(MeOH), λmax/nm (log ɛ): 279.7 (3.8). MS, m/z (Ir/%): 280.11
(18) (M+). FT-IR (Neat) υmax (cm
-1): 3086 (Ar-H), 1755
(C=O), 1721 (CO2Ar), 1603, 1592, 1433 (C=C), 1247, 1128 (C-O); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.8. 3,5-Dimethoxybenzyl γ-ketohexanoate (8b)
Physical characteristics are given in Table 2; UV-VIS
(MeOH), λmax/nm (log ɛ): 279.9 (3.8); MS, m/z (Ir/%): 280.11
74
(22) (M+); FT-IR (Neat) υmax (cm
-1): 1751 (C=O), 1726 (CO2Ar), 1592, 1538, 1515, 1435 (C=C),
1235, 1155, 1141, 1133, 1041, 1022 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3):
(Tables 14 and 16).
3.14.9. 2-Nitrobenzyl γ-ketohexanoate (9b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 267 (4.0); MS, m/z (Ir/%): 265.12 (16) (M+); FT-IR
(Neat) υmax (cm-1
): 3092 (Ar-H), 1746 (C=O), 1723 (CO2R), 1596,
1530, 1441 (C=C, Ar-H), 1375 (NO2), 1244, 1139, 1045 (C-O); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 14 and 16).
3.14.10. 3-Nitrobenzyl γ-ketohexanoate (10b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 267.5 (4.0). MS, m/z (Ir/%): 265.12 (19) (M+); FT-
IR (Neat) υmax (cm-1
): 3086 (Ar-H), 1757 (C=O), 1721 (CO2R),
1597, 1539, 1440 (C=C), 1374 (NO2), 1249, 1137, 1044 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 14 and 16).
3.14.11. 4-Nitrobenzyl γ-ketohexanoate (11b)
Physical characteristics are given in Table 2; UV-VIS
(MeOH), λmax/nm (log ɛ): 267.6 (4.2); MS, m/z (Ir/%): 265.12
(14) (M+); FT-IR (Neat) υmax (cm
-1): 3071 (Ar-H), 1753
(C=O), 1722 (CO2Ar), 1595, 1535, 1440 (C=C), 1372 (NO2), 1248, 1136, 1045(C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.12. 2-Chlorobenzyl γ-ketohexanoate (12b)
Physical characteristics are given in Table 2;
75
UV-VIS (MeOH), λmax/nm (log ɛ): 266.5 (4.1);
MS, m/z (Ir/%): 254.71 (19) (M+); FT-IR (Neat) υmax (cm
-1): 3077 (Ar-H), 1748 (C=O), 1721
(CO2Ar), 1597, 1529, 1497, 1456 (C=C), 1251, 1237, 1134, 1094, 1047, 1015 (C-O), 723 (C-Cl);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.13. 3-Chlorobenzyl γ-ketohexanoate (13b)
Physical characteristics are given in Table 2;
UV-VIS (MeOH), λmax/nm (log ɛ): 266.8 (3.7);
MS, m/z (Ir/%): 254.71 (16) (M+); FT-IR (Neat) υmax (cm
-1):
3079 (Ar-H), 1739 (C=O), 1722 (CO2Ar), 1599, 1525, 1452 (C=C), 1248, 1133 (C-O), 727 (C-
Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.14. 4-Chlorobenzyl γ-ketohexanoate (14b)
Physical characteristics are given in Table 2;
UV-VIS (MeOH), λmax/nm (log ɛ): 266.1 (3.7);
MS, m/z (Ir/%): 254.71 (15) (M+); FT-IR (Neat) υmax (cm
-1):
3093 (Ar-H), 1754 (C=O), 1720 (CO2Ar), 1597, 1529 (C=C), 1383, 1251, 1047, 721 (C-Cl); 1H-,
and 13
C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.15. 2-Bromrobenzyl γ-ketohexanoate (15b)
Physical characteristics are given in Table 2;
MS, m/z (Ir/%): 299.11 (18) (M+); FT-IR (Neat) υmax (cm
-1): 3085
(Ar-H), 1736 (C=O), 1715 (CO2Ar), 1596, 1527(C=C), 1413, 1254,
1054, 535 (C-Br); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.16. 3-Bromrobenzyl γ-ketohexanoate (16b)
Physical characteristics are given in Table 2;
76
UV-VIS (MeOH), λmax/nm (log ɛ): 263.2 (3.8);
MS, m/z (Ir/%): 299.11 (21) (M+); FT-IR (Neat) υmax (cm
-1): 3085 (Ar-H), 1739 (C=O), 1718
(CO2Ar), 1591, 1522, 1451 (C=C), 1417, 1271, 1252, 1140, 1051 (C-O), 528 (C-Br); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 16).
3.14.17. 4-Bromrobenzyl γ-ketohexanoate (17b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 263.9 (3.9); MS, m/z (Ir/%): 299.11 (22) (M+);
FT-IR (Neat) υmax (cm-1
): 3083 (Ar-H), 1743 (C=O), 1717
(CO2Ar), 1598, 1532, 1455 (C=C), 1419, 1266, 531 (C-Br); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 14 and 16).
3.14.18. 2-Iodobenzyl γ-ketohexanoate (18b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 260.3 (3.6); MS, m/z (Ir/%): 346.09 (11) (M+);
FT-IR (Neat) υmax (cm-1
): 3046 (Ar-H), 1735 (C=O), 1718 (CO2Ar),
1592, 1524, 1456 (C=C), 1258, 1156, 488 (C-I); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3):
(Tables 14 and 16).
3.14.19. 3-Iodobenzyl γ-ketohexanoate (19b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 263.2 (3.9); MS, m/z (Ir/%): 346.09 (8) (M+);
FT-IR (Neat) υmax (cm-1
): 3042 (Ar-H), 1732 (C=O), 1719
(CO2Ar), 1591, 1529, 1467 (C=C), 1251, 1161, 1058, 492 (C-I); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 14 and 16).
77
3.14.20. 4-Iodobenzyl γ-ketohexanoate (20b)
Physical characteristics are given in Table 2; UV-VIS (MeOH),
λmax/nm (log ɛ): 263.8 (3.9); MS, m/z (Ir/%): 346.09 (9) (M+);
FT-IR (Neat) υmax (cm-1
): 3048 (Ar-H), 1733 (C=O), 1715
(CO2Ar), 1599, 1521, 1460 (C=C) 1255, 1151, 1054, 483(C-I); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 14 and 17).
3.14.21. 2-Methylbenzyl γ-ketohexanoate (21b)
Yield 74 %, 0.87 g (3.70 mmol), viscous oil; MS, m/z (Ir/%): 234.29
(28) (M+). UV-VIS (MeOH), λmax/nm (log ɛ): 272.1 (3.35); FT-IR
(Neat) υmax (cm-1
): 3084 (Ar-H), 1755 (C=O), 1719 (CO2Ar), 1606,
1554, 1424 (C=C), 1228, 1120, 1025 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3):
(Tables 14 and 17); Analysis calculated for C14H18O3 (234.29): C, 71.77; H, 7.74; Found: C,
71.73; H, 7.76.
3.14.22. 3-Methylbenzyl γ-ketohexanoate (22b)
Yield 73 %, 0.86 g (3.65 mmol), viscous oil; MS, m/z (Ir/%):
234.29 (26) (M+); UV-VIS (EtOH), λmax nm (log ε): 263.9
(3.66). FT-IR (Neat) υmax (cm-1
): 3094 (Ar-H), 1735 (CO2Ar),
1756 (C=O), 1622, 1550 1438 (C=C, Ar-H), 1255, 1136, 1028 (C-O); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 14 and 17); Analysis calculated for C14H18O3 (234.29): C,
71.77%; H, 7.74%; Found: C, 71.75%; H, 7.75%.
3.14.23. 4-Methylbenzyl γ-ketohexanoate (23b)
Yield 77 %, 0.90 g (3.85 mmol), viscous oil; MS, m/z (Ir/%):
234.29 (26) (M+); UV-VIS (EtOH) λ max nm (log ε): 266.3
78
(3.64); FT-IR (Neat) υmax (cm-1
): 3076 (Ar-H), 1731 (CO2Ar), 1757 (C=O), 1596, 1557, 1444
(C=C, Ar-H), 1256, 1136, 1015 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables
14 and 17); Analysis calculated for C14H18O3 (234.29): C, 71.77%; H, 7.74%; Found: C, 71.76%;
H, 7.74%.
3.14.24. 2-Hydroxybenzyl γ-ketohexanoate (24b)
Yield 74 %, 0.87 g (3.70 mmol), viscous oil; MS, m/z (Ir/%): 236.26
(23) (M+); UV-VIS (EtOH) λmax nm (log ε): 259.7 (3.75);
FT-IR (Neat) υmax (cm-1
): 3225-3187 (OH), 3088 (Ar-H), 1739
(CO2Ar), 1763 (C=O), 1608, 1532, 1440 (C=C, Ar-H), 1252, 1123 (C-O); 1H-, and
13C-NMR
(300 MHz, 75 MHz, CDCl3): (Tables 14 and 17); Analysis calculated for C13H16O4 (236.26): C,
66.09%; H, 6.83%; Found: C, 66.12%; H, 6.84%.
3.14.25. 3-Hydroxybenzyl γ-ketohexanoate (25b)
Yield 71%, 0.84 g (3.55 mmol), viscous oil; MS, m/z (Ir/%):
236.26 (23) (M+); UV-VIS (EtOH) λmax nm (log ε): 263.6
(3.48); FT-IR (Neat) υmax (cm-1
): 3276-3145 (OH), 3098 (Ar-
H), 1736 (CO2Ar), 1768 (C=O), 1619, 1551, 1442, (C=C, Ar-H), 1247, 1138, 1044 (C-O); 1H-,
and 13
C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 17); Analysis calculated for C13H16O4
(236.26): C, 66.09%; H, 6.83%; Found: C, 66.10%; H; 6.82%.
3.14.26. 4-Hydroxybenzyl γ-ketohexanoate (26b)
Yield 76 %, 0.90 g (3.80 mmol), viscous oil; MS, m/z (Ir/%):
236.26 (21) (M+); UV-VIS (EtOH) λmax nm (log ε): 259.4
(3.76); FT-IR (Neat) υmax (cm
-1): 3255-3120 (OH), 3095 (Ar-H),
1749 (CO2Ar), 1757 (C=O), 1617, 1546, 1443 (C=C, Ar-H), 1229, 1130, 1044 (C-O); 1H-, and
79
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 17); Analysis calculated for C13H16O4
(236.26): C, 66.09%; H, 6.83%; Found: C, 66.08%; H; 6.85%.
3.14.27. 2-Aminobenzyl γ-ketohexanoate (27b)
Yield 73%, 0.86 g (3.65 mmol), viscous oil; MS, m/z (Ir/%): 235.28
(24) (M+); UV-VIS (EtOH) λmax nm (log ε): 262.9 (3.95). FT-IR
(Neat) υmax (cm-1
): 3235 (NH2), 3089 (Ar-H), 1745 (CO2Ar), 1764
(C=O), 1603, 1537, 1492, 1453, (C=C, Ar-H), 1381 (C-N), 1252, 1230, 1135, 1041, 1002 (C-O);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 14 and 17); Analysis calculated for
C13H17NO3 (235.28): C, 66.36%; H, 7.28%; N, 5.95%; Found: C, 66.38; H, 7.27; N, 5.94%.
3.14.28. 3-Aminobenzyl γ-ketohexanoate (28b)
Yield 69%, 0.81 g (3.45 mmol), viscous oil; MS, m/z (Ir/%):
235.28 (29) (M+); UV-VIS (EtOH) λmax nm (log ε): 264.2
(3.67); FT-IR (Neat) υmax (cm-1
): 3230 (Broad, NH2), 3096
(Ar-H), 1739 (CO2Ar), 1757 (C=O), 1598, 1533, 1456, (C=C, Ar-H), 1393 (C-N), 1241, 1136,
1042 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 17); Analysis
calculated for C13H17NO3 (235.28): C, 66.36%; H, 7.28%; N, 5.95%; Found: C, 66.34; H, 7.29;
N, 5.96%.
3.14.29. 4-Aminobenzyl γ-ketohexanoate (29b)
Yield 77%, 0.91 g (3.85 mmol), viscous oil; MS, m/z (Ir/%):
235.28 (25) (M+); UV-VIS (EtOH) λmax nm (log ε): 263.6
(3.64); FT-IR (Neat) υmax (cm-1
): 3236 (Broad, intense, NH2),
3095 (Ar-H), 1738 (CO2Ar), 1767 (C=O), 1611, 1595, 1459 (C=C, Ar-H), 1387 (C-N), 1268,
1153, 1026 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 17). Analysis
80
calculated for C13H17NO3 (235.28): C, 66.36%; H, 7.28%; N, 5.95%; Found: C, 66.35; H, 7.27;
N, 5.97%.
3.14.30. 2,4-Dichlorobenzyl γ-ketohexanoate (30b)
Yield 72%, 1.04 g (3.60 mmol), viscous oil; MS, m/z (Ir/%):
289.15 (33) (M+); UV-VIS (EtOH) λmax nm (log ε): 258.5 (3.72);
FT-IR (Neat) υmax (cm-1
): 3076 (Ar-H), 1728 (CO2Ar), 1767
(C=O), 1615, 1479 (C=C), 1267, 1148, 1023 (C-O), 722 (C-Cl); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated for C13H14Cl2O3 (289.15): C, 54.00; H,
4.88; Cl, 24.52; Found: C, 54.05; H, 4.89; Cl, 24.51%.
3.14.31. 2,5-Dichlorobenzyl γ-ketohexanoate (31b)
Yield 75%, 1.08 g (3.75 mmol), viscous oil; MS, m/z (Ir/%): 289.15
(31) (M+); UV-VIS (EtOH) λmax nm (log ε): 264.2 (3.57);FT-IR
(Neat) υmax (cm-1
): 3097 (Ar-H), 1726 (CO2Ar), 1768 (C=O), 1619,
1439 (C=C), 1268, 1131, 1024 (C-O), 725 (C-Cl);1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 15 and 17); Analysis calculated for C13H14Cl2O3 (289.15): C, 54.00; H, 4.88; Cl,
24.52; Found: C, 54.09; H, 4.87; Cl, 24.53%.
3.14.32. 2,6-Dichlorobenzyl γ-ketohexanoate (32b)
Yield 76%, 1.10 g (3.80 mmol), viscous oil; MS, m/z (Ir/%):
289.15 (34) (M+). UV-VIS (EtOH) λmax nm (log ε): 264.2 (3.57);
FT-IR (Neat) υmax (cm-1
): 3099 (Ar-H), 1729 (CO2Ar), 1764
(C=O), 1622, 1428 (C=C), 1262, 1135, 1020 (C-O), 725 (C-Cl); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated for C13H14Cl2O3 (289.15): C, 54.00; H,
4.88; Cl, 24.52; Found: C, 54.10; H, 4.85; Cl, 24.51%.
81
3.14.33. 3,4-Dichlorobenzyl γ-ketohexanoate (33b)
Yield 77%, 1.11 g (3.85 mmol), viscous oil; MS, m/z (Ir/%):
289.15 (30) (M+); UV-VIS (EtOH) λmax nm (log ε): 258.4
(3.88). FT-IR (Neat) υmax (cm-1): 3087 (Ar-H), 1759 (C=O),
1728 (CO2Ar), 1619, 1447 (C=C), 1258, 1135, 1028 (C-O), 727 (C-Cl); 1H-, and 13C-NMR
(300 MHz, 75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated for C13H14Cl2O3 (289.15):
C, 54.00%; H, 4.88%; Cl, 24.52%; Found: C, 54.08%; H, 4.89%; Cl, 24.53%.
3.14.34. 3,5-Dichlorobenzyl γ-ketohexanoate (34b)
Yield 76%, 1.10 g (3.80 mmol), viscous oil; MS, m/z (Ir/%):
289.15 (29) (M+); UV-VIS (EtOH) λmax nm (log ε): 266.6
(3.79); FT-IR (Neat) υmax (cm-1
): 3066 (Ar-H), 1767 (C=O),
1725 (CO2Ar), 1618, 1438 (C=C), 1249, 1127, 1020 (C-O), 732
(C-Cl); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated
for C13H14Cl2O3 (289.15): C, 54.00; H, 4.88; Cl, 24.52; Found: C, 54.07; H, 4.87; Cl, 24.51%.
3.14.35. 2,3-Difluorobenzyl γ-ketohexanoate (35b)
Yield 71%, 0.91 g (3.55 mmol), viscous oil; MS, m/z (Ir/%):
256.25 (28) (M+). UV-VIS (EtOH) λmax nm (log ε): 264.6 (4.25);
FT-IR (Neat) υmax (cm-1
): 3076 (Ar-H), 1765 (C=O), 1729
(CO2Ar), 1608, 1483 (C=C), 1258, 1128, 1015 (C-O), 1155 (C-F); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated for C13H14F2O3 (256.25): C, 60.93; H,
5.51; F, 14.83; Found: C, 60.92; H, 5.52; F, 14.82%.
82
3.14.36. 2,4-Difluorobenzyl γ-ketohexanoate (36b)
Yield 69%, 0.88 g (3.45 mmol), viscous oil; MS, m/z (Ir/%):
256.25 (26) (M+); UV-VIS (EtOH) λmax nm (log ε): 265.3
(3.98); FT-IR (Neat) υmax (cm-1): 3094 (Ar-H), 1767 (C=O),
1731 (CO2Ar), 1597, 1471 (C=C), 1245, 1114, 1021 (C-O) 1158 (C-F); 1H-, and 13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated for C13H14F2O3 (256.25): C,
60.93; H, 5.51; F, 14.83; Found: C, 60.94; H, 5.50; F, 14.84%.
3.14.37. 2,5-Difluorobenzyl γ-ketohexanoate (37b)
Yield 72%, 0.92 g (3.60 mmol), viscous oil; MS, m/z (Ir/%): 256.25
(33) (M+); UV-VIS (EtOH) λmax nm (log ε): 265.8 (3.57); FT-IR
(Neat) υmax (cm-1
): 3092 (Ar-H), 1768 (C=O), 1728 (CO2Ar), 1594,
1489 (C=C), 1250, 1130, 1026 (C-O), 1149 (C-F); 1H-, and
13C-
NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 17); Analysis calculated for C13H14F2O3
(256.25): C, 60.93; H, 5.51; F, 14.83; Found: C, 60.95; H, 5.52; F, 14.82%.
3.14.38. 2,6-Difluorobenzyl γ-ketohexanoate (38b)
Yield 68%, 0.87 g (3.40 mmol), viscous oil; MS, m/z (Ir/%):
256.25 (34) (M+); UV-VIS (EtOH) λmax nm (log ε): 267.6 (3.95); FT-
IR (Neat) υmax (cm-1
): 3075 (Ar-H), 1766 (C=O), 1732 (CO2Ar),
1598, 1405 (C=C), 1235, 1129, 1011 (C-O), 1159 (C-F); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 15 and 17); Analysis calculated for C13H14F2O3 (256.25): C, 60.93; H, 5.51; F,
14.83; Found: C, 60.94; H, 5.53; F, 14.85%.
83
3.14.39. 2,4-Dimethylbenzyl γ-ketohexanoate (39b)
Yield 74%, 0.92 g (3.70 mmol), viscous oil; MS, m/z (Ir/%):
248.32 (27) (M+); UV-VIS (EtOH) λmax nm (log ε): 264.2
(3.56); FT-IR (Neat) υmax (cm-1
): 3094 (Ar-H), 1772 (C=O),
1731 (CO2Ar), 1609, 1437 (C=C), 1259, 1122, 1018 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C15H20O3 (248.32): C, 72.55%; H,
8.12%; Found: C, 72.54%; H, 8.13%.
3.14.40. 2,5-Dimethylbenzyl γ-ketohexanoate (40b)
Yield 72%, 0.89 g (3.60 mmol), viscous oil; MS, m/z (Ir/%): 248.32
(24) (M+); UV-VIS (EtOH) λmax nm (log ε): 268.6 (3.78); FT-IR
(Neat) υmax (cm-1
): 3074(Ar-H), 1765 (C=O), 1723 (CO2Ar), 1607,
1485 (C=C), 1246, 1138, 1013 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables
15 and 18); Analysis calculated for C15H20O3 (248.32): C, 72.55%; H, 8.12%; Found: C, 72.56%;
H, 8.11%.
3.14.41. 3,4-Dimethylbenzyl γ-ketohexanoate (41b)
Yield 77%, 0.95 g (3.85 mmol), viscous oil; MS, m/z (Ir/%):
248.32 (29) (M+); UV-VIS (EtOH) λmax nm (log ε): 267.8
(3.84);
FT-IR (Neat) υmax (cm-1
): 3089 (Ar-H), 1772 (C=O), 1724 (C=O), 1608, 1476 (C=C), 1255,
1124, 1016 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis
calculated for C15H20O3 (248.32): C, 72.55%; H, 8.12%; Found: C, 72.56%; H, 8.13%.
84
3.14.42. 3,5-Dimethylbenzyl γ-ketohexanoate (42b)
Yield 78%, 0.97 g (3.90 mmol), viscous oil; MS, m/z (Ir/%):
248.32 (32) (M+); UV-VIS (EtOH) λmax nm (log ε): 267.2
(3.76);
FT-IR (Neat) υmax (cm-1
): 3087 (Ar-H), 1773 (C=O), 1726
(CO2Ar), 1621, 1492 (C=C), 1251, 1124, 1017 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz,
CDCl3): (Tables 15 and 18); Analysis calculated for C15H20O3 (248.32): C, 72.55%; H, 8.12%;
Found: C, 72.57%; H, 8.10%.
3.14.43. 3,4-Dinitrobenzyl γ-ketohexanoate (43b)
Yield 68%, 1.05 g (3.40 mmol), pale yellow viscous oil; MS,
m/z (Ir/%): 310.26 (35) (M+); UV-VIS (EtOH) λmax nm (log ε):
271.2 (3.56); FT-IR (Neat) υmax (cm-1
): 3117 (Ar-H), 1778
(C=O), 1734 (CO2Ar), 1518, 1456 (C=C), 1368 (NO2), 1245, 1123, 1024 (C-O); 1H-, and
13C-
NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C13H14N2O7
(310.26): C, 50.33%; H, 4.55%; N, 9.03%; Found: C, 50.34%; H, 4.56%; N, 9.05%.
3.14.44. 3,5-Dinitrobenzyl γ-ketohexanoate (44b)
Yield 69%, 1.07 g (3.45 mmol), pale yellow viscous oil;
MS, m/z (Ir/%): 310.26 (34) (M+); UV-VIS (EtOH) λmax nm
(log ε): 275.1 (3.95); FT-IR (Neat) υmax (cm-1
): 3107 (Ar-H),
1771 (C=O), 1729 (CO2Ar), 1612, 1581, 1412 (C=C), 1372 (NO2), 1249, 1124, 1022 (C-O). 1H-,
and 13
C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for
C13H14N2O7 (310.26): C, 50.33%; H, 4.55%; N, 9.03%; Found: C, 50.32%; H, 4.56%; N, 9.08%.
85
3.14.45. 2,6-Diethoxybenzyl γ-ketohexanoate (45b)
Yield 67%, 1.03 g (3.35 mmol), viscous oil; MS, m/z (Ir/%): 308.37
(32) (M+); UV-VIS (EtOH) λmax nm (log ε): 274.2 (4.11);
FT-IR (Neat) υmax (cm-1
): 3123 (Ar-H), 1775 (CO-Cl), 1734 (C=O),
1615, 1494 (C=C), 1255, 1124, 1022 (C-O); 1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3):
(Tables 15 and 18); Analysis calculated for C17H24O5 (308.37): C, 66.21%; H, 7.84%; Found: C,
66.22%; H, 7.83%.
3.14.46. 3,4-Diethoxybenzyl γ-ketohexanoate (46b)
Yield 74%, 1.14 g (3.70 mmol), viscous oil; MS, m/z (Ir/%):
308.37 (31) (M+); UV-VIS (EtOH) λmax nm (log ε): 273.6
(4.27); FT-IR (Neat) υmax (cm-1
): 3323 (OH), 3074 (Ar-H),
1776 (C=O), 1731 (CO2Ar), 1608, 1472 (C=C), 1246, 1122, 1026 (C-O); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C17H24O5 (308.37): C, 66.21;
H, 7.84; Found: C, 66.20; H, 7.85%.
3.14.47. 3,5-Dihydroxybenzyl γ-ketohexanoate (47b)
Yield 75%, 0.95 g (3.75 mmol), viscous oil; MS, m/z (Ir/%):
252.26 (28) (M+); UV-VIS (EtOH) λmax nm (log ε): 275.3
(3.91); FT-IR (Neat) υmax (cm-1
): 3250 (OH), 3064 (Ar-H),
1774 (C=O), 1732 (CO2Ar), 1516, 1493 (C=C), 1268, 1136, 1027 (C-O); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C13H16O5 (252.26): C, 61.90;
H, 6.39; Found: C, 61.91; H, 6.38;%.
86
3.14.48. 2,3,4-Trimetxoxybenzyl γ-ketohexanoate (48b)
Yield 76%, 1.18 g (3.80 mmol), viscous oil; MS, m/z (Ir/%):
310.34 (31) (M+); UV-VIS (EtOH) λmax nm (log ε): 276.5.
(3.89); FT-IR (Neat) υmax (cm-1
): 3091 (Ar-H), 1772 (C=O),
1736 (CO2Ar), 1616, 1490 (C=C), 1262, 1133, 1014 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C16H22O6 (310.34): C, 61.92; H, 7.15;
Found: C, 61.91; H, 7.16%.
3.14.49. 2,4,5-Trimethoxbenzyl γ-ketohexanoate (49b)
Yield 75%, 1.16 g (3.75 mmol), viscous oil; MS, m/z (Ir/%):
310.34 (32) (M+); UV-VIS (EtOH) λmax nm (log ε): 277.3
(4.13); FT-IR (Neat) υmax (cm-1
):3088 (Ar-H), 1777 (C=O),
1730 (CO2Ar), 1606, 1482 (C=C), 1268, 1155, 1028 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C16H22O6 (310.34): C, 61.92%; H,
7.15%. Found: C, 61.93%; H, 7.14%.
3.14.50. 3,4,5-Trimethoxybenzyl γ-ketohexanoate (50b)
Yield 78%, 1.21 g (3.90 mmol), viscous oil; MS, m/z (Ir/%):
310.34 (30) (M+); UV-VIS (EtOH) λmax nm (log ε): 275.6
(4.2); FT-IR (Neat) υmax (cm-1
): 3078 (Ar-H), 1776 (C=O),
1732 (C=O), 1508, 1485 (C=C), 1252, 1157, 1023 (C-O); 1
H-, and 13
C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C16H22O6 (310.34): C, 61.92%; H,
7.15%; Found: C, 61.91%; H, 7.16%.
3.14.51. 3-Methoxy-4-nitrobenzyl γ-ketohexanoate (51b)
Yield 71%, 1.05 g (3.55 mmol), light yellow viscous oil;
87
MS, m/z (Ir/%): 295.29 (25) (M+); UV-VIS (EtOH) λmax nm (log ε): 269.8 (3.87); FT-IR (Neat)
υmax (cm-1
): 3084 (Ar-H), 1774 (C=O), 1733 (CO2Ar), 1625, 1572, 1390 (C=C), 1373 (NO2),
1252, 1131, 1027 (C-O);1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 18);
Analysis calculated for C14H17NO6 (295.29): C, 56.94%; H, 5.80%; N, 4.74%; Found: C,
56.95%; H, 5.81%; N, 4.75%.
3.14.52. 4-Methoxy-3-nitrobenzyl γ-ketohexanoate (52b)
Yield 72%, 1.06 g (3.60 mmol), light yellow viscous oil;
MS, m/z (Ir/%): 295.29 (24) (M+); UV-VIS (EtOH) λmax nm
(log ε): 270.9 (3.85); FT-IR (Neat) υmax (cm-1
): 3094 (Ar-H),
1779 (C=O), 1728 (CO2Ar), 1622, 1575, 1383 (C=C), 1371 (NO2), 1254, 1133, 1015 (C-O);
1H-, and
13C-NMR (300 MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for
C14H17NO6 (295.29): C, 56.94%; H, 5.80%; N, 4.74%; Found: C, 56.93%; H, 5.82%; N, 4.76%.
3.14.53. 2-Methoxy-5-nitrobenzyl γ-ketohexanoate (53b)
Yield 69%, 1.02 g (3.45 mmol), light yellow viscous oil;
MS, m/z (Ir/%): 295.29 (22) (M+); UV-VIS (EtOH) λmax nm (log ε):
269.4 (3.92); FT-IR (Neat) υmax (cm-1
): 3066 (Ar-H), 1782 (C=O),
1725 (CO2Ar), 1516, 1488 (C=C), 1373 (NO2), 1248, 1124, 1011 (C-O); 1H-, and
13C-NMR (300
MHz, 75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C14H17NO6 (295.29): C,
56.94%; H, 5.80%; N, 4.74%; Found: C, 56.96%; H, 5.81%; N, 4.75%.
3.14.54. 2,4,6-Trichlorobenzyl γ-ketohexanoate (54b)
Yield 67%, 1.08 g (3.35 mmol), viscous oil; MS, m/z (Ir/%):
323.60 (36) (M+); UV-VIS (EtOH) λmax nm (log ε): 268.5 (3.91);
FT-IR (Neat) υmax (cm-1
): 3084 (Ar-H), 1776 (C=O), 1728
88
(CO2Ar), 1615-1394 (C=C), 1248, 1127, 1012 (C-O), 732 (C-Cl); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C13H13Cl3O3 (323.60): C, 48.25%;
H, 4.05%; Cl, 32.87%; Found: C, 48.24%; H, 4.08%; Cl, 32.86%.
3.14.55. 2,4,5-Tribromobenzyl γ-ketohexanoate (55b)
Yield 61%, 1.39 g (3.05 mmol), viscous oil; MS, m/z (Ir/%):
456.95 (28) (M+). UV-VIS (EtOH) λmax nm (log ε): 273.7 (4.24);
FT-IR (Neat) υmax (cm-1
): 3092 (Ar-H), 1776 (C=O), 1727
(CO2Ar), 1518, 1494 (C=C), 1250, 1137, 1016 (C-O), 526 (C-Br); 1H-, and
13C-NMR (300 MHz,
75 MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C13H13Br3O3 (456.95): C, 34.17%;
H, 2.87%; Br, 52.46%; Found: C, 34.17%; H, 2.87%; Br, 52.46%.
3.14.56. 2,4,6-Trimethylbenzyl γ-ketohexanoate (56b)
Yield 64%, 0.84 g (3.20 mmol), viscous oil; MS, m/z (Ir/%):
262.34 (33) (M+); UV-VIS (EtOH) λmax nm (log ε): 268.8
(3.48); FT-IR (Neat) υmax (cm-1
): 3087 (Ar-H), 1774 (C=O),
1725 (CO2Ar), 1616-1394 (C=C), 1256, 1138, 1014 (C-O); 1H-, and
13C-NMR (300 MHz, 75
MHz, CDCl3): (Tables 15 and 18); Analysis calculated for C16H22O3 (262.34): C, 73.25%; H,
8.45%; Found: C, 73.26%; H, 8.44%.
3.14.57. Isopropyl γ-ketohexanoate (57b)
Yield, b.p. and elemental analysis of 57b have been provided in Table
19. Spectroscopic data (UV, IR, MS, 1H-, and
13C-NMR) of 57b is
given in Table 21. In table 20 yields of 57b-60b from other
89
organometallic reagents are compared.
3.14.58. Isobutyl γ-ketohexanoate (58b)
Yield, b.p. and elemental analysis of 58b have been provided in
Table 19. Spectroscopic data (UV, IR, MS, 1H-, and
13C-NMR) of
58b is given in Table 21.
3.14.59. Isopentyl γ-ketohexanoate (59b)
Yield, b.p. and elemental analysis of 58b have been provided in
table 19. Spectroscopic data (UV, IR, MS, 1H-, and
13C-NMR) of
58b is given in Table 22.
3.14.60. Benzyl γ-ketohexanoate (60)
Yield, b.p. and elemental analysis of 60b have been provided in
table 19. Spectroscopic data (UV, IR, MS, 1H-, and 13C-NMR) of
60b is given in Table 22.
90
TABLES
91
Table 1. Physical characteristics of 1a-20a
Entry Ara
Time Yield Formula Mr Physical state wi(calc.)/%
wi(found)/%
Min % C H N Cl Br I
1a 2-MeO-C6H4 165 75 C12H13ClO4 256.68 Viscous oil 56.15
56.23
5.10
4.78
- 13.81
13.94
- -
2a 3-MeO-C6H4 165 70 C12H13ClO4 256.68 Viscous oil 56.15
56.34
5.10
5.22
- 13.81
13.33
- -
3a 4-MeO-C6H4 165 74 C12H13ClO4 256.68 Viscous oil 56.15
56.33
5.10
5.23
- 13.81
13.86
- -
4a 2,3-(MeO)2-C6H3 150 79 C13H15ClO5 286.70 Viscous oil 54.46
54.37
5.27
5.31
- 12.37
12.66
- -
5a 2,4-(MeO)2-C6H3 150 79 C13H15ClO5 286.70 Viscous oil 54.46
54.64
5.27
5.11
- 12.37
12.56
- -
6a 2,5-(MeO)2-C6H3 150 75 C13H15ClO5 286.70 Viscous oil 54.46
54.55
5.27
5.13
- 12.37
12.14
- -
7a 3,4-(MeO)2-C6H3 150 72 C13H15ClO5 286.70 Viscous oil 54.46
54.61
5.27
5.16
- 12.37
12.48
- -
8a 3,5-(MeO)2-C6H3 150 74 C13H15ClO5 286.70 Viscous oil 54.46
54.59
5.27
5.16
- 12.37
12.22
- -
9a 2-NO2-C6H4 180 70 C11H10ClNO5 271.66 Viscous oil 48.63
48.86
3.71
3.65
5.16
5.31
13.05
12.84
- -
10a 3-NO2-C6H4 180 69 C11H10ClNO5 271.66 Viscous oil 48.63
48.33
3.71
3.58
5.16
5.10
13.05
12.97
- -
92
a) Aromatic substituent (Fig. 2)
11a 4-NO2-C6H4 180 67 C11H10ClNO5 271.66 Viscous oil 48.63
48.42
3.71
3.88
5.16
5.23
13.05
12.82
- -
12a 2-Cl-C6H4 210 63 C11H10Cl2O3 260.95 Viscous oil 50.60
50.76
3.86
3.65
- 27.16
27.33
- -
13a 3-Cl-C6H4 210 65 C11H10Cl2O3 260.95 Viscous oil 50.60
50.47
3.86
3.79
- 27.16
27.32
- -
14a 4-Cl-C6H4 210 66 C11H10Cl2O3 260.95 Viscous oil 50.60
50.67
3.86
3.68
- 27.16
26.98
- -
15a 2-Br-C6H4 225 68 C11H10BrClO3 305.76 Viscous oil 43.24
43.16
3.30
3.45
- 11.60
11.26
26.15
26.45
-
16a 3-Br-C6H4 225 67 C11H10BrClO3 305.76 Viscous oil 43.24
43.35
3.30
3.21
- 11.60
11.53
26.15
26.24
-
17a 4-Br-C6H4 225 72 C11H10BrClO3 305.76 Viscous oil 43.24
43.17
3.30
3.26
- 11.60
11.76
26.15
26.08
-
18a 2-I-C6H4 210 63 C11H10ClIO3 352.65 Viscous oil 37.47
37.42
2.86
2.77
- 10.06
10.32
- 36.00
35.98
19a 3-I-C6H4 210 64 C11H10ClIO3 352.65 Viscous oil 37.47
37.56
2.86
2.67
- 10.06
9.97
- 36.00
36.23
20a 4-I-C6H4 210 66 C11H10ClIO3 352.65 Viscous oil 37.47
37.41
2.86
2.98
- 10.06
9.98
- 36.00
35.76
93
Table 2. Physical characteristics of 1b-20b
Entry Ar Time Yield Formula Mr Physical state wi(calc.)/%
wi(found)/%
H % C H N Cl Br I
1b 2-MeO-C6H4 13 69 C14H18O4 250.29 Viscous oil 67.18
67.43
7.25
7.16
- - - -
2b 3-MeO-C6H4 12 73 C14H18O4 250.29 Viscous oil 67.18
67.32
7.25
7.13
- - - -
3b 4-MeO-C6H4 13 71 C14H18O4 250.29 Viscous oil 67.18
67.13
7.25
7.36
- - - -
4b 2,3-(MeO)2-
C6H3
11 74 C15H20O5 280.11 Viscous oil 64.27
64.12
7.19
7.14
- - - -
5b 2,4-(MeO)2-
C6H3
11 79 C15H20O5 280.11 Viscous oil 64.27
64.18
7.19
7.23
- - - -
6b 2,5-(MeO)2-
C6H3
13 75 C15H20O5 280.11 Viscous oil 64.27
64.23
7.19
7.11
- - - -
7b 3,4-(MeO)2-
C6H3
14 74 C15H20O5 280.11 Viscous oil 64.27
64.34
7.19
7.11
- - - -
8b 3,5-(MeO)2-
C6H3
12 71 C15H20O5 280.11 Viscous oil 64.27
64.19
7.19
7.35
- - - -
9b 2-NO2-C6H4 13 68 C13H15NO5 265.12 Viscous oil 58.86
58.95
5.70
5.56
5.28
5.32
- - -
94
10b 3-NO2-C6H4 13 66 C13H15NO5 265.12 Viscous oil 58.86
56.73
5.70
5.67
5.28
5.38
- - -
11b 4-NO2-C6H4 13 59 C13H15NO5 265.12 Viscous oil 58.86
56.95
5.70
5.66
5.28
5.45
- - -
12b 2-Cl-C6H4 12 59 C13H15ClO3 254.71 Viscous oil 61.30
61.28
5.94
5.77
- 13.92
13.99
- -
13b 3-Cl-C6H4 13 64 C13H15ClO3 254.71 Viscous oil 61.30
61.19
5.94
5.83
- 13.92
13.87
- -
14b 4-Cl-C6H4 14 64 C13H15ClO3 254.71 Viscous oil 61.30
61.55
5.94
5.45
- 13.92
13.88
- -
15b 2-Br-C6H4 12 63 C13H15BrO3 299.11 Viscous oil 52.19
52.23
5.05
5.12
- - 26.71
25.72
-
16b 3-Br-C6H4 14 59 C13H15BrO3 299.11 Viscous oil 52.19
52.33
5.05
4.87
- - 26.71
26.68
-
17b 4-Br-C6H4 14 60 C13H15BrO3 299.11 Viscous oil 52.19
52.21
5.05
5.02
- - 26.71
26.85
-
18b 2-I-C6H4 15 59 C13H15IO3 346.09 Viscous oil 45.11
45.31
4.37
4.16
- - - 36.66
36.55
19B 3-I-C6H4 16 67 C13H15IO3 346.09 Viscous oil 45.11
44.87
4.37
4.46
- - - 36.66
36.45
20b 4-I-C6H4 14 66 C13H15IO3 346.09 Viscous oil 45.11
45.24
4.37
4.15
- - - 36.66
36.67
95
Table 3. 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 1-20
Cmpd OH 3 2 1ʹʹ Ar-H R Rʹ
1 12.41, br, s 2.85, t, 6.8 Hz 2.75, t, 6.8 Hz 5.06, s 6.93-7.22 m, 4H 3.81, s
2 12.33, br, s 2.80, t, 6.8 Hz 2.73, t, 6.8 Hz 5.23, s 6.86-7.25, m, 4H 3.75, s
3 12.40, br, s 2.81, t, 6.8 Hz 2.72, t, 6.8 Hz 5.09, s 6.90-7.20, m, 4H 3.77, s
4 12.37, br, s 2.82, t, 6.8 Hz 2.73, t, 6.8 Hz 5.06, s 6.93-7.19, m, 3H 3.82, s 3.75, s
5 12.36, br, s 2.84, t, 6.8 Hz 2.73, t, 6.8 Hz 5.04, s 6.53-7.29, m, 3H 3.85, s 3.79, s
6 12.25, br, s 2.84, t, 6.8 Hz 2.73, t, 6.8 Hz 5.06, s 6.68-7.10, m, 3H 3.78, s 3.79, s
7 12.32, br, s 2.83, t, 6.8 Hz 2.73, t, 6.8 Hz 5.11, s 6.81-7.10, m, 3H 3.82, s 3.74, s
8 12.31, br, s 2.81, t, 6.8 Hz 2.73, t, 6.8 Hz, 5.14, s 6.41-6.81, m, 3H 3.75, s 3.75, s
9 12.12, br, s 2.84, t, 6.8 Hz 2.73, t, 6.8 Hz 5.18, s 7.46-8.05, m, 4H
10 12.50, br, s 2.81, t, 6.8 Hz 2.73, t, 6.8 Hz 5.25, s 7.46-8.22, m, 4H
11 12.36, br, s 2.84, t, 6.8 Hz 2.72, t, 6.8 Hz 5.19, s 7.40-8.06, m, 4H
12 12.22, br, s 2.82, t, 6.8 Hz, 2.72, t, 6.8 Hz 5.17, s 7.27-7.54, m, 4H
13 12.44, br, s 2.83, t, 6.8 Hz 2.75, t, 6.8 Hz 5.19, s 7.15-7.41, m, 4H
14 12.37, br, s 2.84, t, 6.8 Hz 2.72, t, 6.8 Hz 5.16, s 7.41-7.56, m, 4H
15 12.28, br, s 2.83, t, 6.8 Hz 2.73, t, 6.8 Hz 5.17, s 6.96-7.36, m, 4H
16 12.43, br, s 2.84, t, 6.8 Hz 2.73, t, 6.8 Hz 5.20, s 7.10-7.30, m, 4H
17 12.36, br, s 2.86, t, 6.8 Hz 2.70, t, 6.8 Hz 5.16, s 7.23-7.32, m, 4H
18 12.31, br, s 2.87, t, 6.8 Hz 2.77, t, 6.8 Hz, 5.20, s 7.17-7.38, m, 4H
19 12.39, br, s 2.82, t, 6.8 Hz 2.72, t, 6.8 Hz 5.20, s 6.99-7.41, m, 4H
20 12.27, br, s 2.79, t, 6.8 Hz 2.72, t, 6.8 Hz 5.70, s 7.32-7.46, m, 4H
96
Table 4. 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 21-40
Cmpd OH 3 2 1ʹʹ Ar-H R Rʹ
21 12.27, br, s 2.90, t, 6.8 Hz 2.78, t, 6.8 Hz 5.10, s 7.15-7.29, m, 4H 2.36, s
22 12.22, br, s 2.91, t, 6.8 Hz 2.79, t, 6.8 Hz 5.22, s 7.11-7.55, m, 4H 2.37, s
23 12.32, br, s 2.92, t, 6.8 Hz 2.75, t, 6.8 Hz 5.22, s 7.14-7.35, m, 4H 2.39, s
24 11.98, br, s 2.84, t, 6.8 Hz 2.76, t, 6.8 Hz 5.26, s 6.98-7.44, m, 4H 13.51, br, s
25 11.96, br, s 2.85, t, 6.8 Hz 2.77, t, 6.8 Hz 5.19, s 6.98-7.35,m, 4H 13.55, br, s
26 11.94, br, s 2.88, t, 6.8 Hz 2.78, t, 6.8 Hz 5.19, s 6.88-7.10, m, 4H 12.58 br, s
27 11.86, br, s 2.90, t, 6.8 Hz 2.69, t, 6.8 Hz 5.10, s 6.87-7.32, m, 4H 12.1, br, s
28 11.87, br, s 2.91, t, 6.8 Hz 2.70, t, 6.8 Hz 5.10, s 6.78-7.31, m, 4H 12.13, br, s
29 11.88, br, s 2.92, t, 6.8 Hz 2.71, t, 6.8 Hz 5.21, s 6.78-7.26, m, 4H 12.16, br, s
30 11.82, br, s 2.93, t, 6.9 Hz 2.82, t, 6.9 Hz 5.24, s 7.36-7.87, m
31 11.82, br, s 2.93, t, 6.9 Hz 2.82, t, 6.9 Hz 5.24, s 7.30-7.77, m
32 11.75, br, s 2.95, t, 6.9 Hz 2.85, t, 6.9 Hz 5.26, s 7.69-7.71, m
33 11.68, br, s 2.93, t, 6.9 Hz 2.84, t, 6.9 Hz 5.22, s 7.30-7.79, m
34 11.89, br, s 2.93, t, 6.9 Hz 2.84, t, 6.9 Hz 5.22, s 7.56-7.74, m
35 11.98, br, s 2.91, t, 6.9 Hz 2.77, t, 6.9 Hz 5.15, s 7.21-7.26, m
36 11.81, br, s 2.94, t, 6.9 Hz 2.81, t, 6.9 Hz 5.12, s 6.70-7.42, m
37 11.98, br, s 2.95, t, 6.9 Hz 2.84, t, 6.9 Hz 5.16, s 6.98-7.27, m
38 11.90, br, s 2.96, t, 6.9 Hz 2.82, t, 6.9 Hz 5.10, s 7.41-7.84, m
39 11.99, br, s 2.87, t, 6.9 Hz 2.76, 6.9 Hz 5.10, s 7.04-7.20, m 2.42, s 2.42, s
40 11.91, br, s 2.87, t, 6.9 Hz 2.74, t, 6.9 Hz 5.20, s 7.10-7.24, m 2.39, s 2.39, s
97
Table 5. 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 41-56
Cmpd OH 3 2 1ʹʹ Ar-H R Rʹ
41 11.85, br, s 2.87, t, 6.9 Hz 2.74, t, 6.9 Hz 5.23, s 6.99-7.22, m 2.38, s 2.38, s
42 11.72, br, s 2.86, t, 6.9 Hz 2.75, t, 6.9 Hz 5.24, s 7.10-7.38, m 2.40, s 2.40, s
43 11.99, br, s 2.96, t, 6.9 Hz 2.83, t, 6.9 Hz 5.25 s 8.15-8.65, m
44 11.96, br, s 2.97, t, 6.9 Hz 2.81, t, 6.9 Hz 5.21, s 8.69-8.73, m
45 11.55, br, s 2.86, t, 6.9 Hz 2.69, t, 6.9 Hz 5.12, s 6.57-7.25, m 1.38, t, 7.6 Hz,
2CH3
4.15, q, 7.6
Hz,2CH2
46 11.57, br, s 2.88, t, 6.9 Hz 2.70, t, 6.9 Hz 5.21, s 6.66-7.21, m 1.37, t, 7.6 Hz,
2CH3)
4.16, q, 7.6 Hz,
2CH2
47 11.75, br, s 2.88, t, 6.9 Hz 2.70, t, 6.9 Hz 5.21, s 6.36-6.75, m
48 11.74, br, s 2.89, t, 6.9 Hz 2.71, t, 6.9 Hz 5.27, s 6.30-6.75, m 3.87, s, 3×C H3
49 11.80, br, s 2.88, t, 6.9 Hz 2.71, t, 6.9 Hz 5.27, s 6.38-6.96, 2s 3.86, s, 3× CH3
50 11.80, br, s 2.90, t, 6.9 Hz 2.72, t, 6.9 Hz 5.21, s 6.59, s 3.86, s, 3×CH3)
51 11.89, br, s 2.87 t, 6.9 Hz 2.71 (t, 6.9 Hz 5.22, s 7.22-8.12, m 3.85, s, CH3)
52 11.96, br, s 2.88 t, 6.9 Hz 2.71 t, 6.9 Hz 5.22, s 7.22-8.18, m 3.86, s, CH3
53 11.97, br, s 2.87, t, 6.9 Hz 2.74, t, 6.9 Hz 5.26, s 7.20-8.21, m 3.84, s, CH3
54 11.96, br, s 2.89, t, 6.9 Hz 2.75, t, 6.9 Hz 5.12, s 7.71 s, 2H
55 11.99, br, s 2.85, t, 6.9 Hz 2.70, t, 6.9 Hz 5.12, s 7.90, s
56 12.02, br, s 2.85, t, 6.9 Hz 2.69, t, 6.9 Hz 5.12, s 6.97, s, 2H 2.46, s, 3×CH3)
98
Table 6. 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 1-14
Cmpd 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ Rʹ Rʹ
1 172.7, s 31.3,
t
29.5,
t
173.9, s 59.9, t 131.1 147.7 113.4 130.3 118.8 127.5 55.8, q, OMe
2 172.5, s 30.9,
t
29.0,
t
173.9, s 65.6, t 139.2 112.2 159.4 113.3 129.3 118.3 55.9, q, OMe
3 173.2, s 32.5,
t
30.0,
t
174.2, s 65.1, t 129.2 129.3 113.6 159.1 113.6 129.3 55.0, q, OMe
4 173.7, s 32.2,
t
29.3,
t
175.0, s 60.3, t 130.6 139.1 153.1 116.6 124.4 119.2 60.2, q, OMe 57.1, q, OMe
5 172.2, s 33.3,
t
31.5,
t
173.7, s 59.8,
T
123.1 153.1 98.7 162.6 108.5 128.8 55.7, q, OMe 55.2, q, OMe
6 173.1, s 32.2,
t
29.3,
t
174.2, s 60.2, t 130.5 139.1 113.1 118.5 154.5 110.5 55.9, q, OMe 55.6, q, OMe
7 172.5, s 33.2,
t
31.1,
t
174.0, s 65.5, t 130.6 110.8 149.3 149.2 112.7 120.5 55.7, q, OMe 55.5, q, OMe
8 172.6, s 32.6,
t
30.2,
t
173.4, s 66.3, t 137.5 104.3 160.9 102.3 160.9 104.3 55.3, q, 2 × OMe
9 171.2, s 33.0,
t
30.1,
t
172.7, s 61.5, t 133.9 144.6 124.7 130.4 131.7 130.3
10 173.2, s 33.7,
t
31.9,
t
174.1, s 68.4, t 130.1 121.4 147.8 123.8 130.6 124.6
11 172.2, s 36.2,
t
29.3,
t
173.5, s 68.4, t 1431 130.0 123.8 147.4 123.8 130.0
12 172.7, s 34.0,
t
32.1,
t
174.2, s 63.7, t 132.5 129.6 129.2 131.2 127.4 127.1
13 173.5, s 32.8,
t
29.3,
t
174.1, s 65.6, t 138.1 125.8 136.3 128.1 130.3 124.1
14 173.6, s 33.7,
t
32.0,
t
175.3, s 65.3, t 137.9 127.5 128.3 133.8 128.3 127.5
99
Table 7. 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 15-28
Cmpd 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ Rʹ Rʹ
15 173.0, s 32.9, t 30.9, t 174.1, s 66.6, t 140.3 120.8 131.8 128.9 128.8 127.1
16 173.1, s 33.5, t 31.5, t 174.2, s 66.6, t 138.5 128.7 122.2 130.7 129.9 126.1
17 173.3, s 32.7, t 30.2, t 175.1, s 65.5, t 136.8 128.8 131.6 121.7 131.6 128.8
18 173.1, s 32.8, t 30.2, t 176.0, s 71.8, t 142.6 95.7 138.2 129.3 127.7 126.7
19 173.6, s 35.1, t 33.5, t 175.3, s 66.8, t 139.2 135.1 94.2 137.1 129.7 127.3
20 173.2, s 34.0, t 31.1, t 175.2, s 65.1, t 137.7 128.6 137.4 93.7 137.4 128.6
21 173.4, s 30.7, t 28.9, t 175.3, s 66.5, t 141.9 133.4 128.2 128.1 124.5 129.1 16.9, q
22 173.7, s 30.8, t 29.8, t 175.8, s 67.6, t 137.7 128.9 138.2 128.1 128.4 123.8 21.6, q
23 174.3, s 30.7, t 29.4, t 175.3, s 67.3, t 136.9 128.9 130.8 138.1 130.8 128.9 20.9, q
24 170.2, s 32.5, t 29.7, t 172.6, s 65.8, t 127.6 155.4 117.2 128.7 122.9 130.6
25 170.6, s 32.4, t 29.8, t 172.7, s 65.7, t 138.8 113.5 158.7 113.8 132.9 120.1
26 170.2, s 32.5, t 29.4, t 172.8, s 66.1, t 127.9 130.1 115.8 156.8 115.8 130.1
27 173.7, s 32.1, t 29.4, t 175.2, s 63.5, t 139.6 143.5 117.0 128.6 125.3 126.4
28 173.8, s 32.2, t 29.5, t 175.3, s 66.8, t 138.6 115.4 145.5 112.8 128.1 11.8
100
Table 8. 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 29-42
Cmpd 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ Rʹ Rʹ
29 173.9, s 32.3, t 29.7, t 175.4, s 66.9, t 125.8 130.1 116.4 148.6 116.4 130.1
30 171.3, s 33.2, t 32.2, t 176.9 s 65.8, t 137.6, s 135.8, s 131.4, d 134.1,s 128.9
,d
129.7,
d
31 171.4, s 33.1, t 32.6, t 177.9, s 66.5, t 138.3, s 129.4, s 133.3, d 133.6, d 131.2
, s
128.6,
d
32 171.7, s 32.5, t 32.1, t 176.8, s 59.8, t 142.3, s 132.7, s 128.4, d 130.5, d 128.4
, d
132.7,
s
33 171.4, s 33.1, t 32.6, t 177.9, s 66.8, t 138.3, s 129.6, d 133.3, s 133.6, s 131.5
, d
128.7,
d
34 171.4, s 33.1, t 32.6, t 177.9, s 66.1, t 146.2, s 126.3, d 136.5, s 129.8, d 136.5
, s
126.3,
d
35 172.9, s 33.2, t 32.4, t 178.7, s 62.6, t 130.7, s 138.6, s 150.6, s 117.5, d 127.5
, d
125.4,
d
36 171.7, s 32.9, t 31.4, t 177.2, s 62.1, t 124.6, s 162.3, s 105.4, d 162.2, s 112.2
, d
133.6,
d
37 172.1, s 32.2, t 31.7, t 179.7, s 62.4, t 130.6, s 156.8, s 118.3, d 117.2, d 159.1
, s
116.9,
d
38 171.4, s 33.1, t 32.6, t 177.9, s 56.5, t 115.4, s 162.6, s 113.6, d 129.9, d 113.6
, d
162.6,
s
39 171.4, s 33.1, t 32.6, t 177.9, s 66.3, t 140.6, s 138.7, s 132.2, d 139.2, s 127.6
, d
128.4,
d
19.8,
q, CH3
22.8,
q, CH3
40 171.9, s 33.1, t 32.6, t 177.2, s 66.3, t 143.6, s 132.6, s 131.5, d 129.8, d 136.3
, s
129.6,
d
19.7, q,
CH3
22.8,
q, CH3
41 171.7, s 33.3, t 32.5, t 177.6, s 67.2, t 134.6, s 129.7, d 138.3, s 136.2, s 131.6
, d
125.4,
d
19.2, q,
CH3
20.3,
q, CH3
42 171.3, s 33.4, t 32.2, t 177.9, s 67.4, t 136.4, s 126.3, d 139.6, s 130.2, d 139.6
, s
126.3,
d
22.4, q,
CH3
22.4,
q, CH3
101
Table 9. 13
C-NMR (75 MHz, CDCl3, δ, DEPT, multiplicity) of 43-56
Cmpd 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ Rʹ Rʹ
43 171.9, s 32.8, t 31.6, t 179.7, s 66.3, t 149.8, s 125.6, d 150.3, s 144.9, s 126.
4, d
135.
5, d
44 171.7, s 33.6, t 32.4, t 179.4, s 65.6, t 144.2, s 130.1, d 150.4, s 118.4, d 150.
4, s
130.
1, d
45 172.1, s 32.6, t 31.4, t 175.9, s 56.6, t 119.7, s 155.5, s 105.7, d 130.1, d 105.
7, d
155.
5, s
15.7, q,
2CH3
65.7, t,
2CH2
46 172.4, s 32.9, t 31.3, t 175.8 s 67.8, t 124.6, s 115.5, d 150.3, s 151.2, s 113.
7, d
122.
3, d
15.5, q,
2CH3
65.8, t,
2CH2
47 172.2, s 33.3, t 31.5, t 175.9, s 67.7, t 139.2, s 103.1, d 157.9, s 101.7, d 157.
9, s
103.
1, d
48 172.6,s 33.3, t 31.1 t 175.9, s 63.7, t 121.2, s 150.5, s 141.5, s 154.2, s 105.
7, d
122.
3, d
57.5
3×CH3
49 172.8, s 33.2, t 31.7, t 176.3, s 63.6, t 121.3, s 152.5, s 96.9, d 150.4 (s 143.
0, s
112.
3, d
57.3, s,
3×CH3
50 172.8, s 33.2, t 31.7, t 176.3 s 63.6, t 131.3, s 105.2, d 154.5, s 137.5, s 154.
5, s
105.
2, d
57.3, q,
2CH3
61.3, q,
CH3
51 171.8, s 33.5, t 31.5, t 177.6, s 67.3, t 143.9, s 113.5, d 155.4, s 140.3, s 126.
7, d
121.
3, d
55.6, q,
CH3
52 171.6, s 33.8, t 31.1, t 177.7, s 66.7, t 135.4, s 125.6, d 142.1, s 151.4, s 113.
7, d
136.
5, d
55.6, q,
CH3
53 171.3, s 33.4, t 31.7, t 177.6, s 66.7, t 129.3, s 163.2, s 113.4, d 125.1, d 141.
1, s
125.
6, d
56.9, q,
CH3
54 172.1,
s
33.2, t 31.8, t 178.7, s 59.3, t 140.2, s 136.3, s 129.1, d 135.9, s 129.
1, d
136.
3, s
55 173.2,
s
33.7, t 31.2, t 178.7, s 64.3, t 140.7, 124.6, s 136.8, d 127.9, s 123.
9, s
136.
8, d
56 171.2, s 33.9, t 31.2, t 176.5, s 63.9, t 133.7, s 135.2, s 130.1, d 136.9, s 130.
1, d
135.
2, s
19.9 q,
2CH3
22., q,
CH3
102
Table 10. 1
H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 1a-28a
Cmpd 3 2 1ʹʹ Ar-H R Rʹ
1a 2.74, t, 6.5 Hz 2.60, t, 6.5 Hz 5.14, s 6.96-7.80, m, 4H 3.89, s
2a 2.74, t, 6.5 Hz 2.60, t, 6.5 Hz 5.14, s 6.96-7.80, m, 4H 3.89, s
3a 2.76, t, 6.5 Hz 2.61, t, 6.5 Hz 5.18, s 6.97-7.25, m, 4H 3.82, s
4a 2.79, t, 6.5 Hz 2.64, t, 6.5 Hz 5.23, s 6.96-7.31, m, 3H 3.87, s 3.87, s
5a 2.78, t, 6.5 Hz 2.66, t, 6.5 Hz 5.23, s 6.73-7.18, m, 3H 3.82, s 3.82, s
6a 2.74, t, 6.5 Hz. 2.60, t, 6.5 Hz 5.14, s 6.96-7.80, m, 3H 3.89, s, 2×OMe
7a 2.93, t, 6.5 Hz 2.79, t, 6.5 Hz 5.19, s 6.66-7.40, m, 3H 3.84, s, 2 × OMe
8a 2.87, t, 6.5 Hz 2.67, t, 6.5 Hz 5.16, s 6.92-6.53, m, 3H 3.83, s, OMe 3.84, s, OMe
9a 2.98, t, 6.5 Hz 2.81, t, 6.5 Hz 5.14, s 7.54-7.92, m, 4H
10a 2.99, t, 6.5 Hz 2.83, t, 6.5 Hz 5.21, s 7.45-7.99, m, 4H
11a 2.98, t, 6.5 Hz 2.78, t, 6.5 Hz 5.19, s 7.57-8.05, m, 4H
12a 2.85, t, 6.5 Hz, 2.67, t, 6.5 Hz 5.11, s 7.22-7.65, m, 4H
13a 2.87, t, 6.5 Hz 2.68, t, 6.5 Hz 5.19, s 7.31-7.59, m, 4H
14a 2.88, t, 6.5 Hz 2.72, t, 6.5 Hz 5.21, s 7.28-7.39, m, 4H
15a 2.83, t, 6.5 Hz 2.75, t, 6.5 Hz 5.12, s 7.23-7.55, m, 4H
16a 2.84, t, 6.5 Hz 2.73, t, 6.5 Hz 5.18, s 7.25-7.54, m, 4H
17a 2.82, t, 6.5 Hz 2.73, t, 6.5 Hz 5.22, s 7.21-7.86, m, 4H
18a 2.85, t, 6.5 Hz 2.76, t, 6.5 Hz 5.20, s 7.11-7.81, m, 4H
19a 2.88, t, 6.5 Hz 2.77, t, 6.5 Hz 5.25, s 7.16-7.72, m, 4H
20a 2.84, t, 6.5 Hz 2.73, t, 6.5 Hz 5.18, s 7.25-7.54, m, 4H
21a 2.92, t, 6.5 Hz 2.77, t, 6.5 Hz 5.11, s 7.22-7.27, m, 4H 2.35, s
22a 2.92, t, 6.5 Hz 2.76, t, 6.5 Hz 5.21, s 7.13-7.52, m, 4H 2.36, s
23a 2.96, t, 6.5 Hz 2.81, t, 6.5 Hz 5.21, s 7.15-7.21, m, 4H 2.37, s
24a 2.87, t, 6.5 Hz 2.74, t, 6.5 Hz 5.24, s 6.78-7.32, m, 4H 13.41, br, s
25a 2.92, t, 6.5Hz 2.75, t, 6.5 Hz 5.22, s 6.93-7.36,m, 4H 13.24, br, s
26a 2.93, t, 6.5 Hz 2.77, t, 6.5 Hz 5.23, s 6.88-7.15, m, 4H 12.78 br, s
27a 2.90, t, 6.5Hz 2.69, t, 6.5 Hz 5.10, s 6.87-7.32, m, 4H 12.32, br, s
28a 2.91, t, 6.5 Hz 2.70, t, 6.5 Hz 5.12, s 6.82-7.31, m, 4H 12.33, br, s
103
Table 11. 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 29a-56a
Cmpd 3 2 1ʹʹ Ar-H R Rʹ
29a 2.92, t, 6.5 Hz 2.71, t, 6.5 Hz 5.18, s 6.76-7.27, m, 4H 12.31, br, s
30a 2.91, t, 6.8 Hz 2.67, t, 6.8 Hz 5.06, s 7.18-7.87, m, 3H
31a 2.90, t, 6.8 Hz 2.71, t, 6.8 Hz 5.05, s 7.32-7.74, m, 3H
32a 2.92, t, 6.8 Hz 2.68, t, 6.8 Hz 5.07, s 7.46-7.66, m, 3H
33a 2.93, t, 6.8 Hz 2.69, t, 6.8 Hz 5.18, s 7.25-7.77, m, 3H
34a 2.91, t, 6.8 Hz 2.68, t, 6.8 Hz 5.22, s 7.41-7.79, m, 3H
35a 2.92, t, 6.8 Hz 2.69, t, 6.8 Hz 5.06, s 7.05-7.22, m, 3H
36a 2.93, t, 6.8 Hz 2.68, t, 6.8 Hz 5.07, s 6.58-7.46, m, 3H
37a 2.91, t, 6.8 Hz 2.70, t, 6.8 Hz 5.07, s 6.76-7.24, m, 3H
38a 2.92, t, 6.8 Hz 2.71, t, 6.8 Hz 5.11, s 7.22-7.83, m, 3H
39a 2.90, t, 6.8 Hz 2.68, t, 6.8 Hz 5.04, s 6.88-7.22, m, 3H 2.38, s, 2×Me
40a 2.92, t, 6.8 Hz 2.69, t, 6.8 Hz 5.05, s 6.98-7.19, m, 3H 2.39, s, 2×Me
41a 2.91, t, 6.8 Hz 2.68, t, 6.8 Hz 5.22, s 6.86-7.16 m, 3H 2.37, s, 2×Me
42a 2.90, t, 6.8 Hz 2.65, t, 6.8 Hz 5.21, s 7.12-7.34, m, 3H 2.38, s, 2×Me
43a 2.93, t, 6.8 Hz 2.66, t, 6.8 Hz 5.23, s 7.97-8.58, m, 3H
44b 2.92, t, 6.8 Hz 2.67, t, 6.8 Hz 5.23, s 8.55-8.72, m, 3H
45a 2.88, t, 6.8 Hz 2.66, t, 6.8 Hz 5.06, s 6.42-7.24, m, 3H 1.26, t; 4.25, q, 7.6 Hz
46a 2.89, t, 6.8 Hz 2.68, t, 6.8 Hz 5.19, s 6.62-7.09, m, 3H 1.25, t; 4.28, q, 7.6 Hz
47a 2.88, t, 6.8 Hz 2.69, t, 6.8 Hz 5.22, s 6.27-6.75, m, 3H 11.5 br, s
48a 2.87, t, 6.8 Hz 2.67, t, 6.8 Hz 5.26, s 6.39-6.84, m, 2H 3.98, s, 3×OMe
49a 2.88, t, 6.8 Hz 2.69, t, 6.8 Hz 5.26, s 6.44-6.95,2s, 2H 3.94, s, 3×OMe
50a 2.87, t, 6.8 Hz 2.71, t, 6.8 Hz 5.22, s 6.66, s, 2H 3.95, s, 3×OMe
51a 2.91, t, 6.8 Hz 2.71, t, 6.8 Hz 5.21, s 7.22-8.15, m, 3H 3.91, s, OMe
52a 2.89, t, 6.8 Hz 2.69, t, 6.8 Hz 5.19, s 7.24-8.23, m, 3H 3.97, s, OMe
53a 2.91, t, 6.8 Hz 2.68, t, 6.8 Hz 5.26, s 7.25-8.18, m, 3H 3.97, s, OMe
54a 2.92, t, 6.8 Hz 2.67, t, 6.8 Hz 5.03, s 7.77, s, 2H
55a 2.91, t, 6.8 Hz 2.66, t, 6.8 Hz 5.05, s 7.33-7.98, m, 2H
56a 2.93, t, 6.8 Hz 2.69, t, 6.8 Hz 5.12, s 6.92, s, 2H 2.47, s, OMe
104
Table 12. 13
C-NMR (75 MHz, CDCl3, δ) of 1a-28a
Cmpd 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ R Rʹ
1a 175.6 36.6 31.5 169.9 67.8 121.2 159.1 113.8 128.1 120.1 128.9 56.6, OMe
2a 175.3 36.2 30.9 169.1 67.5 137.6 112.5 115.6 112.2 128.3 118.4 56.7
3a 176.5 37.6 30.1 168.9 67.8 127.2 127.3 112.5 157.5 112.4 126.4 55.5
4a 177.4 36.7 30.5 169.9 67.7 127.2 156.5 143.8 112.3 120.7 120.1 56.1 58.6,OMe
5a 176.7 36.3 29.4 169.2 67.2 115.8 158.6 99.8 159.6 105.9 128.2 56.3, 2×OMe
6a 179.7 36.1 29.6 169.9 64.8 121.1 159.2 113.3 128.8 128.8 120.1 56.6, 2× OMe
7a 176.6 36.3 29.5 167.4 68.4 123.5 113.3 149.1 147.8 111.7 120.7 55.2 (2 × OMe)
8a 173.3 36.1 29.2 168.5 68.9 136.7 104.6 160.7 98.2 160.7 104.6 57.4 (2 × OMe)
9a 172.3 35.5 30.2 169.7 64.7 135.3 148.3 126.2 129.5 131.1 113.7
10a 173.6 36.7 29.8 167.8 66.7 141.2 123.6 147.2 121.9 128.9 132.3
11a 173.2 35.8 29.3 169.5 66.9 141.6 127.1 123.2 145.7 123.2 127.1
12a 174.3 35.6 29.7 169.9 66.7 137.8 129.8 128.1 128.3 126.2 127.2
13a 174.4 35.5 29.7 168.5 64.4 137.6 125.4 133.0 126.2 128.8 123.7
14a 174.5 35.7 29.6 168.9 65.9 133.7 129.2 128.5 132.7 128.5 129.2
15a 174.4 35.5 29.3 168.8 63.9 136.6 125.2 128.0 128.3 126.2 130.2
16a 173.5 36.6 29.8 167.6 66.8 141.8 130.3 121.7 128.9 128.1 124.5
17a 173.6 36.5 29.4 167.8 66.2 136.3 128.7 130.6 121.4 130.6 128.7
18a 173.3 36.6 29.1 167.7 66.9 139.3 94.5 138.5 128.6 126.7 127.5
19a 173.5 36.2 29.3 167.4 66.5 139.4 138.5 94.6 135.8 129.6 126.7
20a 173.5 36.6 29.8 167.6 66.8 141.8 130.3 121.7 128.9 128.1 124.5
21a 175.2 37.5 28.9 168.9 66.3 140.8 132.3 122.5 122.3 124.2 129.4 20.6
22a 174.2 37.4 28.3 168.9 66.4 135.3 128.2 137.8 128.2 126.9 125.4 22.5
23a 174.9 37.1 28.2 168.8 66.1 136.4 127.6 128.5 136.4 128.5 127.6 22.4
24a 174.8 37.5 28.1 168.7 63.2 127.8 154.3 115.2 127.8 122.7 131.3
25a 174.7 38.1 28.5 168.8 66.3 136.4 113.2 158.3 116.1 131.4 120.2
26a 175.3 37.4 28.5 168.6 66.2 127.8 130.2 115.8 156.5 115.8 130.2
27a 174.9 38.2 28.4 168.7 63.5 142.4 115.6 127.3 125.2 126.3 138.8
28a 174.7 37.9 28.8 168.8 65.9 136.5 115.3 145.4 114.6 128.5 118.4
105
Table 13. 13
C-NMR (75 MHz, CDCl3, δ) of 29a-56a
Cmpd 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ R
29a 175.1 37.6 28.2 168.3 66.1 125.6 128.5 114.4 146.6 114.4 128.5
30a 176.3 38.5 28.4 168.2 62.8 138.2 132.3 131.4 133.2 126.3 128.5
31a 175.9 38.7 28.8 168.7 62.9 138.8 127.6 129.3 128.5 131.6 127.8
32a 175.8 38.4 28.6 169.4 57.5 142.5 134.5 128.3 130.6 28.3 134.5
33a 175.7 38.4 28.8 169.2 66.2 138.3 129.4 133.7 133.7 131.6 128.4
34a 175.6 38.6 28.7 169.6 66.3 145.0 126.5 136.7 129.4 136.7 126.5
35a 174.7 37.9 28.3 170.2 62.3 130.4 138.8 148.3 115.4 125.6 123.6
36a 174.3 37.5 28.6 170.4 62.5 122.5 162.4 105.8 162.7 113.4 132.6
37a 173.9 37.6 28.9 170.3 61.8 130.8 156.4 116.7 115.6 159.5 114.7
38a 174.5 38.3 28.1 170.5 54.9 115.7 160.5 112.4 129.7 112.4 160.5
39a 175.6 38.0 28.4 169.9 65.4 138.6 136.7 132.1 136.7 125.6 125.9 20.6, 22.4
40a 174.7 37.8 28.2 170.4 65.8 141.2 130.1 129.0 126.7 134.5 127.8 19.3, 22.8
41a 174.0 38.4 28.3 171.2 66.9 132.3 127.9 136.7 134.5 129.4 123.1 19.4, 20.5
42a 175.2 38.6 28.1 171.3 67.2 134.5 125.2 137.5 128.9 137.5 125.2 22.6, 2C
43a 176.2 39.3 29.8 171.4 66.8 147.8 123.4 149.0 142.3 124.1 133.4
44a 176.3 39.4 29.6 171.5 64.7 142.2 128.7 148.9 116.7 148.9 128.7
45a 175.8 38.6 28.5 171.7 55.8 117.8 153.2 103.4 127.6 103.4 153.2 65.4, 15.9 (4C)
46a 174.9 38.3 29.4 171.6 66.8 122.3 112.4 145.8 146.7 111.8 119.4 65.5, 15.8 (4C)
47a 175.2 38.4 29.3 170.7 67.1 137.8 106.8 157.4 104.6 157.4 106.8
48a 175.5 39.2 29.5 171.3 62.5 119.8 147.5 140.4 153.6 105.7 119.8 61.5, 2×OMe
49a 174.4 38.8 29.7 172.9 63.1 119.6 149.8 96.9 148.5 141.3 112.6 57.2, 2×OMe
50a 175.1 38.9 29.1 171.2 67.5 129.2 108.4 154.6 137.9 154.6 108.4 61.2, 57.3, 3×OMe
51a 174.7 38.5 29.6 171.4 65.9 143.4 113.8 153.2 136.5 124.7 118.9 55.3, OMe
52a 175.7 37.6 28.9 171.3 65.7 133.2 123.8 139.6 149.5 112.4 133.7 55.4, OMe
53a 174.6 37.6 28.4 172.8 61.8 127.4 157.5 112.7 123.6 140.7 125.8 57.4, OMe
54a 174.3 39.2 29.4 171.6 57.8 138.4 134.9 127.5 134.9 127.5 134.9
55a 175.8 38.7 28.5 171.9 63.7 136.2 122.5 136.7 125.8 124.6 135.4
56a 175.2 37.9 28.6 171.4 63.5 135.8 132.6 127.4 132.6 127.4 132.6 20.3, 22.6 (3OMe)
106
Table 14. 1
H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 1b-27b
Cmpd 6 5 3 2 1ʹʹ Ar-H R Rʹʹ
1b 1.05, t, 7.4 Hz 2.55, q, 7.4 Hz 2.82, t, 6.8 Hz 2.72, t, 6.8 Hz 5.22, s 6.81-7.26, m, 4H 3.86, s
2b 1.05, t, 7.4 Hz 2.57, q, 7.4 Hz 2.83, t, 6.8 Hz 2.72, t, 6.8 Hz 5.21, s 6.96-7.32, m, 4H 3.82, s
3b 1.04, t, 7.4 Hz 2.56, q, 7.4 Hz 2.82, t, 6.8 Hz 2.72, t, 6.8 Hz 5.21, s 6.94-7.19, m, 4H 3.76, s
4b 1.02, t, 7.4 Hz 2.61, q, 7.4 Hz 2.85, t, 6.8 Hz 2.72, t, 6.8 Hz 5.13, s 6.67-6.99, m, 3H 3.79, s 3.82, s
5b 1.05, t, 7.4 Hz 2.62, q,7.4 Hz 2.85, t, 6.8 Hz 2.79, t, 6.8 Hz 5.21, s 6.63-7.41, m, 3H 3.78, s 3.85, s
6b 1.04, t, 7.4 Hz 2.49, q, 7.4 Hz 2.86, t, 6.8 Hz 2.73, t, 6.8 Hz 5.21, s 6.82-7.33, m, 3H 3.82, s, 2 × OMe
7b 1.03, t, 7.4 Hz 2.48, q, 7.4 Hz 2.85, t, 6.8 Hz 2.75, t, 6.8 Hz 5.17, s 6.43-7.21, m, 3H 3.81, s, 2 × OMe
8b 1.03, t,7.4 Hz 2.44, q, 7.4 Hz 2.81, t, 6.8 Hz 2.71, t, 6.8 Hz 5.19, s 6.45-6.99, m, 3H 3.84, s, 2 × OMe
9b 1.06, t, 7.4 Hz 2.57, q, 7.4 Hz 2.85, t, 6.8 Hz 2.72, t, 6.8 Hz 5.19, s 7.62-8.26, m, 4H
10b 1.06, t, 7.4 Hz 2.57, q, 7.4 Hz 2.80, t, 6.8 Hz 2.72, t, 6.8 Hz 5.19, s 7.57-8.24, m, 4H
11b 1.03, t, 7.4 Hz 2.57, q, 7.4 Hz 2.82, t, 6.8 Hz 2.72, t, 6.8 Hz 5.18, s 7.59-8.20, m, 4H
12b 1.04, t, 7.4 Hz 2.59, q, 7.4 Hz 2.82, t, 6.8 Hz 2.72, t, 6.8 Hz 5.10, s 7.28-7.65, m, 4H
13b 1.03, t, 3H, Hz 2.42, q, 7.4 Hz 2.81, t, 6.8 Hz 2.72, t, 6.8 Hz 5.19, s 7.33-7.59, m, 4H
14b 1.03, t, 7.4 Hz 2.42, q, 7.4 Hz 2.83, t, 6.8 Hz 2.73, t, 6.8 Hz 5.19, s 7.38-7.45, m, 4H
15b 1.03, t, 7.4 Hz 2.42, q, 7.4 Hz 2.82, t, 6.8 Hz 2.73, t, 6.8 Hz 5.10, s 7.24-7.51, m, 4H
16b 1.03, t, 7.4 Hz 2.43, q, 7.4 Hz 2.83, t, 6.8 Hz 2.75, t, 6.8 Hz 5.20,s 7.29-7.55, m, 4H
17b 1.03, t, 7.4 Hz 2.44, q, 7.4 Hz 2.85, t, 6.8 Hz 2.76, t, 6.8 Hz 5.21, s 7.22-7.87, m, 4H
18b 1.04, t, 7.4 Hz 2.41, q, 7.4 Hz 2.79, t, 6.8 Hz 2.66, t, 6.8 Hz 5.10, s 7.11-7.83, m, 4H
19b 1.03, t, 7.4 Hz 2.40, q, 7.4 Hz 2.77, t, 6.8 Hz 2.64, t, 6.8 Hz 5.18, s 7.15-7.84, m, 4H
20b 1.03, t, 7.4 Hz 2.38, q, 7.4 Hz 2.76, t, 6.8 Hz 2.65, t, 6.8 Hz 5.19, s 7.15-7.65, m, 4H
21b 1.04, t, 7.4 Hz 2.37, q, 7.4 Hz 2.85, t, 6.8 Hz 2.66, t, 6.8 Hz 5.16, s 7.16-7.42, m, 4H 2.49, s
22b 1.05, t, 7.4 Hz 2.41, q, 7.4 Hz 2.86, t, 6.8 Hz 2.67, t, 6.8 Hz 5.22, s 7.15-7.54, m, 4H 2.44, s
23b 1.05, t, 7.4 Hz 2.42, q, 7.4 Hz 2.88, t, 6.8 Hz 2.69, t, 6.8 Hz 5.21, s 7.13-7.45, m, 4H 2.45, s
24b 1.05, t, 7.4 Hz 2.43, q, 7.4 Hz 2.87, t, 6.8 Hz 2.66, t, 6.8 Hz 5.23, s 6.82-7.25, m, 4H 11.2 br, s
25b 1.04, t, 7.4 Hz 2.45, q, 7.4 Hz 2.89, t, 6.8 Hz 2.67, t, 6.8 Hz 5.18, s 6.79-7.28, m, 4H 11.5 br, s
26b 1.05, t, 7.4 Hz 2.51, q, 7.4 Hz 2.91, t, 6.8Hz 2.69, t, 6.8 Hz 5.18, s 6.72-7.02, m, 4H 11.3 br, s
27b 1.04, t, 7.4 Hz 2.49, q, 7.4 Hz 2.88, t, 6.8Hz 2.68, t, 6.8 Hz 5.05, s 6.68-7.18, m, 4H 11.6 br, s
107
Table 15. 1H-NMR (300 MHz, CDCl3, δ, multiplicity, J in Hz) of 28b-56b
Cmpd 6 5 3 2 1ʹʹ Ar-H R Rʹʹ
28b 1.05, t, 7.4 Hz 2.48, q, 7.4 Hz 2.89, t, 6.8 Hz 2.70, t, 6.8 Hz 5.22, s 6.65-7.23, m, 4H 11.8 br, s
29b 1.04, t, 7.4 Hz 2.44, q, 7.4 Hz 2.88, t, 6.8 Hz 2.69, t, 6.8 Hz 5.19, s 6.64-7.22, m, 4H 11.7 br, s
30b 1.05, t, 7.4 Hz 2.46, q, 7.4 Hz 2.91, t, 6.8 Hz 2.67, t, 6.8 Hz 5.06, s 7.18-7.87, m, 3H
31b 1.05, t, 7.4 Hz 2.48, q, 7.4 Hz 2.90, t, 6.8 Hz 2.71, t, 6.8 Hz 5.05, s 7.32-7.74, m, 3H
32b 1.03, t, 7.4 Hz 2.46, q, 7.4 Hz 2.92, t, 6.8 Hz 2.68, t, 6.8 Hz 5.07, s 7.46-7.66, m, 3H
33b 1.04, t, 7.4 Hz 2.50, q, 7.4 Hz 2.93, t, 6.8 Hz 2.69, t, 6.8 Hz 5.18, s 7.25-7.77, m, 3H
34b 1.05, t, 7.4 Hz 2.50, q, 7.4 Hz 2.91, t, 6.8 Hz 2.68, t, 6.8 Hz 5.22, s 7.41-7.79, m, 3H
35b 1.04, t, 7.4 Hz 2.49, q, 7.4 Hz 2.92, t, 6.8 Hz 2.69, t, 6.8 Hz 5.06, s 7.05-7.22, m, 3H
36b 1.05, t, 7.4 Hz 2.51, q, 7.4 Hz 2.93, t, 6.8 Hz 2.68, t, 6.8 Hz 5.07, s 6.58-7.46, m, 3H
37b 1.04, t, 7.4 Hz 2.51, q, 7.4 Hz 2.91, t, 6.8 Hz 2.70, t, 6.8 Hz 5.07, s 6.76-7.24, m, 3H
38b 1.04, t, 7.4 Hz 2.49, q, 7.4 Hz 2.92, t, 6.8 Hz 2.71, t, 6.8 Hz 5.11, s 7.22-7.83, m, 3H
39b 1.03, t, 7.4 Hz 2.42, q, 7.4 Hz 2.90, t, 6.8 Hz 2.68, t, 6.8 Hz 5.04, s 6.88-7.22, m, 3H 2.38, s, 2×Me
40b 1.03, t, 7.4 Hz 2.43, q, 7.4 Hz 2.92, t, 6.8 Hz 2.69, t, 6.8 Hz 5.05, s 6.98-7.19, m, 3H 2.39, s, 2×Me
41b 1.04, t, 7.4 Hz 2.42, q, 7.4 Hz 2.91, t, 6.8 Hz 2.68, t, 6.8 Hz 5.22, s 6.86-7.16 m, 3H 2.37, s, 2×Me
42b 1.05, t, 7.4, Hz 2.44, q, 7.4 Hz 2.90, t, 6.8 Hz 2.65, t, 6.8 Hz 5.21, s 7.12-7.34, m, 3H 2.38, s, 2×Me
43b 1.05, t, 7.4 Hz 2.45, q, 7.4 Hz 2.93, t, 6.8 Hz 2.66, t, 6.8 Hz 5.23, s 7.97-8.58, m, 3H
44b 1.04, t, 7.4 Hz 2.44, q, 7.4 Hz 2.92, t, 6.8 Hz 2.67, t, 6.8 Hz 5.23, s 8.55-8.72, m, 3H
45b 1.04, t, 7.4 Hz 2.43, q, 7.4 Hz 2.88, t, 6.8 Hz 2.66, t, 6.8 Hz 5.06, s 6.42-7.24, m, 3H 1.26, t; 4.25, q, 7.6 Hz
46b 1.03, t, 7.4 Hz 2.42, q, 7.4 Hz 2.89, t, 6.8 Hz 2.68, t, 6.8 Hz 5.19, s 6.62-7.09, m, 3H 1.25, t; 4.28, q, 7.6 Hz
47b 1.02, t, 7.4 Hz 2.42, q, 7.4 Hz 2.88, t, 6.8 Hz 2.69, t, 6.8 Hz 5.22, s 6.27-6.75, m, 3H 11.5 br, s
48b 1.04, t, 7.4 Hz 2.43, q, 7.4 Hz 2.87, t, 6.8 Hz 2.67, t, 6.8 Hz 5.26, s 6.39-6.84, m, 2H 3.98, s, 3×OMe
49b 1.05, t, 7.4 Hz 2.42, q, 7.4 Hz 2.88, t, 6.8 Hz 2.69, t, 6.8 Hz 5.26, s 6.44-6.95,2s, 2H 3.94, s, 3×OMe
50b 1.04, t, 7.4 Hz 2.43, q, 7.4 Hz 2.87, t, 6.8 Hz 2.71, t, 6.8 Hz 5.22, s 6.66, s, 2H 3.95, s, 3×OMe
51b 1.05, t, 7.4 Hz 2.41, q, 7.4 Hz 2.91, t, 6.8 Hz 2.71, t, 6.8 Hz 5.21, s 7.22-8.15, m, 3H 3.91, s, OMe
52b 1.04, t, 7.4 Hz 2.42, q, 7.4 Hz 2.89, t, 6.8 Hz 2.69, t, 6.8 Hz 5.19, s 7.24-8.23, m, 3H 3.97, s, OMe
53b 1.04, t, 7.4 Hz 2.43, q, 7.4 Hz 2.91, t, 6.8 Hz 2.68, t, 6.8 Hz 5.26, s 7.25-8.18, m, 3H 3.97, s, OMe
54b 1.03, t, 7.4 Hz 2.41, q, 7.4 Hz 2.92, t, 6.8 Hz 2.67, t, 6.8 Hz 5.03, s 7.77, s, 2H
55b 1.04, t, 7.4 Hz 2.43, q, 7.4 Hz 2.91, t, 6.8 Hz 2.66, t, 6.8 Hz 5.05, s 7.33-7.98, m, 2H
56b 1.05, t, 7.4 Hz 2.42, q, 7.4 Hz 2.93, t, 6.8 Hz 2.69, t, 6.8 Hz 5.12, s 6.92, s, 2H 2.47, s, OMe
108
Table 16. 13
C-NMR (75 MHz, CDCl3, δ) of 1b-19b
Cmpd 6 5 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ R Rʹ
1b 7.7 36.1 212.1 34.2 28.3 172.2 62.8 124.7 155.6 129.3 128.9 123.7 127.5 56.3, OMe
2b 7.7 36.1 212.1 31.3 29.3 172.2 65.4 138.8 112.2 159.4 113.3 129.3 118.3 54.9, OMe
3b 7.7 34.2 212.1 33.4 27.8 172.2 66.2 129.2 129.3 113.6 159.1 113.6 129.3 55.4, OMe
4b 7.7 34.9 213.1 32.4 27.3 174.2 62.0 127.6 138.9 147.2 115.5 124.2 119.1 55.6, OMe 59.7, OMe
5b 7.7 36.1 214.1 33.2 29.3 171.2 62.8 116.1 158.3 100.4 162.6 108.5 128.8 55.4, OMe 56.5, OMe
6b 7.7 35.3 214.7 32.6 29.6 171.4 63.4 128.7 148.5 124.6 115.8 155.5 114.8 56.3, 2 × OMe
7b 7.7 36.1 214.4 35.8 31.2 171.8 66.3 124.7 147.3 148.7 146.3 111.4 121.2 55.7, 2 × OMe
8b 7.7 36.4 215.4 32.7 27.2 171.1 66.7 137.2 105.1 158.4 98.7 158.4 105.1 55.6, s, 2 × OMe
9b 7.7 36.7 213.2 32.6 29.1 171.2 65.1 134.3 147.4 124.7 129.2 129.9 134.3
10b 7.7 36.2 213.8 36.1 29.3 171.4 65.6 143.2 123.3 147.8 123.8 130.6 132.4
11b 7.7 36.6 214.2 31.4 27.8 171.6 66.3 143.4 129.9 123.7 147.4 123.7 129.9
12b 7.7 36.1 213.2 30.6 28.5 174.2 62.2 138.4 129.6 129.2 131.2 127.4 127.1
13b 7.7 36.2 212.1 36.1 29.3 172.0 65.7 138.6 125.8 133.5 128.1 130.1 124.1
14b 7.7 35.7 213.0 32.3 28.7 171.7 66.5 133.9 128.8 128.6 133.8 128.6 128.8
15b 7.7 37.1 214.2 32.2 27.7 173.2 66.3 139.7 123.7 128.6 128.7 127.5 131.2
16b 7.7 37.2 214.4 32.3 27.8 173.4 66.3 143.6 131.7 123.5 130.3 129.1 125.8
17b 7.7 37.4 214.7 32.7 27.3 173.8 66.5 134.6 139.7 132.3 121.6 132.3 139.7
18b 7.7 35.4 208.5 31.7 29.2 169.2 67.6 142.7 92.5 138.2 129.3 127.7 126.8
19b 7.7 35.6 208.1 31.3 29.4 169.7 65.1 142.2 136.1 94.2 137.1 129.7 127.3
109
Table 17. 13
C-NMR (75 MHz, CDCl3, δ) of 20b-38b
Cmpd 6 5 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ R Rʹ
20b 7.7 35.8 208.9 31.7 29.0 169.3 66.1 134.2 129.6 137.9 92.3 137.9 129.6
21b 7.6 36.2 209.1 32.3 29.4 170.2 66.3 144.2 135.8 128.4 128.7 126.2 129.4 19.9
22b 7.8 36.4 209.1 32.2 29.4 170.3 67.1 137.1 128.4 136.8 129.3 127.2 125.5 22.6
23b 7.6 36.3 208.6 31.6 29.3 171.2 66.9 135.8 126.5 128.8 138.6 128.8 126.5 22.2
24b 7.7 37.1 209.2 31.4 29.1 171.4 62.2 129.3 155.8 117.1 128.3 125.4 131.2
25b 7.8 36.9 208.8 31.3 29.2 171.5 66.2 138.4 111.9 156.6 113.5 129.7 118.8
26b 7.8 36.4 208.7 31.5 29.5 171.6 66.7 129.5 130.4 117.6 154.5 117.6 130.4
27b 7.7 36.7 208.5 31.2 29.6 171.4 63.6 141.3 143.7 115.8 127.2 123.4 124.8
28b 7.8 36.5 208.4 31.7 29.1 172.2 66.8 136.2 115.2 127.4 112.1 146.9 113.8
29b 7.6 36.2 209.3 32.3 29.4 172.3 66.7 125.2 127.4 116.2 145.6 116.2 127.4
30b 7.8 36.3 209.4 32.3 29.1 171.8 62.9 137.5 131.2 129.3 133.6 126.8 128.6
31b 7.7 36.1 209.1 32.4 29.5 172.2 61.9 138.5 127.4 129.6 128.3 131.7 128.9
32b 7.7 36.3 209.1 32.4 29.0 171.8 57.9 139.8 134.3 128.5 126.8 128.5 134.3
33b 7.8 36.4 208.6 32.1 29.2 172.1 66.3 137.2 129.4 133.5 133.6 131.6 128.4
34b 7.8 36.1 208.2 32.4 29.4 172.3 65.9 145.8 126.4 136.8 127.9 136.8 126.4
35b 7.8 36.2 209.3 32.6 29.5 172.4 62.3 130.2 136.3 150.2 117.5 127.4 125.5
36b 7.8 36.7 208.8 31.9 29.1 172.1 62.1 122.4 159.8 105.4 158.4 112.3 129.6
37b 7.8 36.3 209.1 31.2 29.2 172.6 61.9 127.5 153.2 116.4 114.2 156.3 114.8
38b 7.7 36.4 208.9 33.3 29.4 172.2 55.2 113.4 162.4 112.6 129.7 112.6 162.4
110
Table 18. 13
C-NMR (75 MHz, CDCl3, δ) of 39b-56b
Cmpd 6 5 4 3 2 1 1ʹʹ 1ʹ 2ʹ 3ʹ 4ʹ 5ʹ 6ʹ R
39b 7.8 36.5 208.4 33.2 29.1 172.3 66.2 140.2 138.1 132.5 137.6 127.2 127.8 20.5, 22.6
40b 7.7 37.1 209.4 32.8 30.1 172.4 66.3 141.5 132.2 131.6 128.5 138.4 127.8 19.8, 22.4
41b 7.8 36.9 208.9 33.3 30.2 172.2 66.9 134.7 129.4 138.0 136.2 131.2 124.5 19.3, 20.4
42b 7.7 37.1 209.2 32.9 29.8 171.9 67.3 136.7 127.2 139.5 128.9 139.5 127.2 22.6 2×Me
43b 7.8 36.7 209.3 32.5 29.1 172.2 65.8 149.5 123.7 151.6 145.3 125.8 134.9
44b 7.8 36.5 208.8 32.2 29.7 171.8 64.8 144.2 130.2 148.5 116.4 148.5 130.2
45b 7.7 36.1 209.5 33.1 29.2 171.2 55.7 117.2 155.6 106.5 127.6 106.5 155.6 15.7, 65.4
46b 7.8 37.3 209.4 33.0 29.4 172.2 67.1 124.5 112.6 149.8 151.2 113.5 122.4 15.6, 65.5
47b 7.8 36.9 209.3 33.2 29.5 171.7 67.5 137.4 106.5 157.8 104.3 157.8 106.5
48b 7.8 36.8 209.6 32.9 29.3 172.4 62.9 119.6 148.5 143.6 153.2 106.3 123.7 62.2, 62.6, 57.2
49b 7.7 36.4 208.9 32.7 29.2 172.3 62.8 119.7 152.2 98.4 151.3 141.2 112.6 57.3 3×OMe
50b 7.8 37.2 209.1 32.1 29.4 172.2 67.6 132.6 108.3 154.7 139.6 154.7 108.3 62.5, 57.4 (2C)
51b 7.7 36.5 208.6 32.6 29.2 171.9 67.2 145.2 113.6 155.3 141.6 126.2 121.4
52b 7.8 36.5 208.7 32.3 29.5 172.1 65.8 135.6 125.8 142.3 153.2 115.4 136.7 55.2
53b 7.7 36.1 208.5 32.9 29.1 172.5 62.2 129.5 163.5 112.4 126.5 142.3 126.7 56.8
54b 7.8 36.2 208.6 32.8 29.2 172.6 58.4 140.7 136.6 129.8 137.9 129.8 136.6
55b 7.8 36.3 208.4 32.4 29.1 172.4 64.4 141.2 124.5 138.6 128.3 126.8 137.4
56b 7.4 37.1 208.7 33.4 29.4 172.3 63.7 135.2 135.8 129.4 138.5 129.4 135.8 20.3, 22.7
111
Table 19. Yield, mps/bps and Elemental Analysis of 57-60 and 57a-60a
Cmpd
Yield
(%)
mp.
(°C)
bp. /18mm
(°C)
Elemental Analysis (Found)
C H
57 76 64-65 ………. 52.49 (52.52) 7.55 (7.56)
58 77 69-71 ………. 55.16 (55.10) 8.10 (8.11)
59 76 75-76 ………. 57.43 (57.45) 8.57 (8.58)
60 76 115-116
(Lit.117-119)
………. 63.45 (63.47) 5.81 (5.75)
57a 78 … 94-95 ………. ……….
58a 78 … 101-103 ………. ……….
59a 72 … 108-109 ………. ……….
60a 71 … 110-112 ………. ……….
112
Table 20. Yield and bps of 57b-60b for comparison
Cmpd
Yield
(%)
bp. /18mm
(°C)
Diethyl cadmium Gilman reagent Grignard reagent
57b 77 29 22 106-107
58b 74 28 21 112-113
59b 72 27 18 118-119
60b 71 23 18 116-117
113
Table 21. Spectroscopic data of 57-60, 57a-60a and 57b-60b
Cmpd
IR
(cm-1
)
1H-NMR
(δ)
13C-NMR (DEPT)
(δ)
HR-EI-MS (m/z)
Calcd.
Found
57 3417 (OH)
1728 (CO2H)
1755 (CO2R)
2.55 (t, 6.7)
2.72 (t, 6.7)
4.45 (septet, 7.5)
1.1 (d, 7.5)
173.3 (s), 28.2 (t)
36.6 (t), 180 (s)
68.3 (d) 21.2 (q)
160.17
C7H12O4
160.15
58 3438 (OH)
1725 (CO2H)
1759 (CO2R
2.55 (t, 6.7), 2.72 (t, 6.7)
4.01 (d, 7.5)
1.18 (septet, 7.5)
1.1 (d, 7.5)
173.3 (s), 28.2 (t)
36.6 (t),180 (s)
68.3 (t), 26.7 (d)
21.2 (q)
174.19
C8H14O4
174.18
59 3396 (OH)
1722 (CO2H)
1765 (CO2R)
2.55 (t, 6.7), 2.72 (t, 6.7)
4.45 (d, 7.5), 1.48 (m)
1.77 (m), 1.1 (d, 7.5)
173.3 (s), 28.2 (t)
36.6 (t), 180 (s)
68.3 (t), 36.7 (t)
23.6 (d), 21.2 (q)
188.22
C9H16O4
188.24
60 3324 (OH)
3014 (Ar-H)
1748 (CO2R)
1708 (CO)
2.57 (t, 6.7), 2.69 (t, 6.7)
5.2 (s), 7.2-7.3 (Ph)
171.7 (s), 28.3 (t)
35.5 (t), 203.2 (s)
79.1 (t), 128-137
(1C, s, 5C, d)
208.21
C11H12O4
208.19
57a 1810 (COCl)
1755 (CO2R)
741 (C-Cl)
2.53 (t, 6.7), 2.73 (t, 6.7)
4.5 (septet, 7.5)
1.12 (d, 7.5)
171.4 (s), 28.4 (t)
37.5 (t), 172.6 (s)
66.2 (d), 20.1 (q)
178.61
C7H11ClO3
178.62
58a 1802 (COCl)
1740 (CO2R)
734 (C-Cl)
2.56 (t, 6.7), 2.70 (t, 6.7)
4.05 (d, 7.5), 1.47 (m)
1.16 (d, 7.5)
172.2 (s), 27.0 (t)
37.8 (t), 205.2 (s)
64.5 (t), 31.7 (d)
22.1 (q)
192.64
C8H13ClO3
192.65
59a 1807 (COCl)
1739 (CO2R)
739 (C-Cl)
2.58 (t, 6.7), 2.74 (t, 6.7)
4.1 (t, 7.5), 1.6 (dt, 7.5)
1.5 (m), 1.1 (d, 7.5)
171.1 (s), 27.5 (t)
36.9 (t), 172.3 (s)
59.9 (t), 37.2 (t)
25.5 (d), 22.2 (q)
206.67
C11H20O3
206.66
60a 3094 (Ar-H)
1787 (COCl)
1748 (CO2R)
734 (C-Cl)
2.57 (t, 6.7), 2.69 (t, 6.7),
5.2 (s), 7.2-7.3 (Ph)
171.7 (s), 28.3 (t)
35.5 (t), 176.7 (s)
79.1(t), 128-137
(1C, s. 5C, d)
226.66
C11H11ClO3
226.67
57b 1745 (CO2R)
1729 (CO)
1210 (C-O)
2.57 (t, 6.7), 2.71 (t, 6.7)
2.49 (t, 7.3), 1.08 (t, 7.3)
4.52 (septet,7.5)
1.15 (d, 5)
171.2 (s), 27.9 (t)
35.6 (t), 204.5 (s)
34.7 (t), 7.9 (q)
63.7 (d), 22.6 (q)
172.22
C9H16O3
172.21
58b 1740 (CO2R)
1722 (C=O)
1220 (C-O)
2.56 (t, 6.7), 2.70 (t, 6.7)
2.47 (t, 7.3), 1.07 (t, 7.3)
4.05 (d, 7.5), 1.47(m)
1.16 (d, 7.5)
172.3 (s), 27.0 (t)
37.8 (t), 205.2 (s)
35.2 (t), 8.3 (q)
64.5 (t), 31.7 (d)
186.23
C10H18O3
186.24
114
Table 22. Spectroscopic data of 59b-60b
Cmpd IR (cm-1
) 1H-NMR (δ)
13C-NMR (DEPT)
(δ)
HR-EI-MS (m/z)
Calcd. Found
59b 1739 (CO2R)
1717 (C=O)
1225 (C-O)
2.58 (t, 6.7), 2.74 (t, 6.7)
2.51 (q, 7.3), 1.09 (t, 7.3)
4.1 (t, 7.5), 1.6 (dt, 7.5)
1.5 (septet, 7.5)
1.1 (d, 7.5)
173.2 (s), 27.5 (t)
36.9 (t), 202.3 (s)
35.9 (t), 7.7 (q)
59.9 (t), 37.2 (t)
25.5 (d), 22.2 (q)
200.27
C11H20O3
200. 26
60b 1736 (CO2R)
1718 (C=O)
1230 (C-O)
1.05 (t, J = 7.3 Hz, 3 H)
2.48 (q, J = 7.3 Hz, 2 H)
2.65 (t, J = 6.7 Hz, 2 H)
2.74 (t, J = 6.7 Hz, 2 H)
5.15 (s, 2 H)
7.33-7.35 (m, 5 H)
171.7 (s), 28.3 (t)
35.5 (t), 208.2 (s)
36.1 (t), 7.9 (q)
66.1 (t)
128-137
(1C, s, 5C, d)
220.26
C13H16O3
220.24
115
Table 23. Inhibition zones of monoesters 1-29 against fungi and bacteria
Organism
/compound
Antifungal activity
Zone of inhibition (mm)
Antibacterial activity
Zone of inhibition (mm)
C.
gloeosporioides
A.
brassicicola
C.
capsici
K.
pneumonia
E. coli Staph.
Aureus
1 11.72 12.43 13.47 13.14 12.10 13.74
2 9.96 11.24 10.19 11.11 10.71 10.54
3 13.24 15.55 13.22 13.66 15.82 13.11
4 9.66 8.64 9.45 11.22 10. 55 10.56
5 8.98 9.43 8.45 9.81 10.17 10.66
6 10.50 9.24 6.86 9.29 7.83 8.77
7 8.66 8.89 6.74 7.77 8.37 9.66
8 8.44 9.33 6.72 10.75 9.71 9.77
9 - - - - - -
10 - - - - - -
11 - - - - - -
12 14.33 16.34 17.37 12.35 13.53 14.36
13 12.35 14.38 13.39 11.37 9.39 10.38
14 14.33 15.36 16.36 13.33 12.38 15.36
15 13.27 14.31 16.28 12.27 11.44 13.28
16 12.39 11.35 12.36 11.65 13.32 13.33
17 21.88 22.88 19.28 9.32 11.31 8.43
18 22.15 22.11 23.11 16.19 17.18 16.23
19 16.45 18.50 16.15 14.43 15.29 16.25
20 22.21 23.13 23.12 22.12 22.13 20.12
21 12.25 12.34 11.22 11.34 12.31 11.45
22 12.71 11.23 10.23 9.23 8.65 10.33
23 11.36 12.24 10.35 9.53 11.32 10.34
24 12.68 12.64 12.09 12.66 12.26 12.76
25 12.72 12.17 12.47 12.11 12.70 12.73
26 12.66 12.14 12.36 12.56 12.67 12.64
27 12.48 12.54 12.58 12.33 12.53 12.59
28 12.64 12.63 12.56 12.36 12.61 12.64
29 12.24 12.54 12.48 12.56 12.54 12.49
Chloramph
enicol
26.67 25.11 26.15 - - -
Ketoconazo
le
- - - 25.25 24.13 23.56
116
Table 24. MICs of monoesters 1-29 against fungi and bacteria
Organism
/compound
Antifungal activity
MIC mg/L=µg/Ml
Antibacterial activity
MIC mg/L=µg/mL
C.
gloeosporioides
A.
brassicicola
C. capsici K.
pneumonia
E. coli Staph. Aureus
1 4.7 0 4.21 4.71 4.73 4.26 4.75
2 5.2 9 5.31 5.61 5.51 5.76 5.41
3 5.61 4.49 4.51 4.7 1 3.31 3.61
4 4.89 7.58 6.89 6.81 6.41 5.81
5 5.58 6.19 7.68 7.59 7.14 6.68
6 4.81 6.39 6.78 6.89 6.37 7.78
7 4.78 6.18 6.87 7.77 7.38 6.63
8 6.68 6.29 6.71 6.61 7.29 7.72
9 - - - - - -
10 - - - - - -
11 - - - - - -
12 2.31 2.41 2.71 2.51 2.54 2.65
13 2.51 2.81 2.91 2.71 2.9 1 2.86
14 2. 31 2.61 2.61 2. 31 2.80 2.64
15 2.71 2.14 2.86 2.71 2.43 2.80
16 2.91 2.51 2.65 2.81 2.26 2.36
17 2.92 2.88 2.87 2.29 2.12 2.48
18 2.45 2. 50 2.55 2.21 2.91 2.41
19 2.95 2.97 2.94 2.96 2.88 2.78
20 2.12 2.13 2.12 2.22 2.32 2.22
21 3.25 3.40 3.71 3.40 3.11 4.51
22 3.30 3.21 3.41 3.29 3.08 3.31
23 3.63 3.31 3.51 3.56 3.29 3.46
24 6.86 6.41 6.91 6.62 6.21 6.71
25 7.28 7.11 7.41 7.10 7.01 7.32
26 5.64 5.11 6.31 6.53 6.78 6.48
27 4.88 5.41 5.81 5.71 5.32 5.68
28 6.41 6.31 6.51 6.36 6.12 6.51
29 4.91 5.41 4.81 5.61 5.21 4.90
Chloramp
henicol
1.22 1.12 1.12 - - -
Ketoconaz
ole
- - - 1.15 1.32 1.22
117
FIGURES
118
Fig. 1. General structures for various ketoesters
119
Fig. 2. Preparation of monoesters (1-60), acid chlorides (1a-60a) and γ-ketoesters (1b-60b)
Ar Compound Ar Compound
2-(OMe)C6H4 1, 1a, 1b 2,5-(Cl2)C6H3 31, 31a, 31b
3-(OMe)C6H4 2, 2a, 2b 2,6-(Cl2)C6H3 32, 32a, 32b
4-(OMe)C6H4 3, 3a, 3b 3,4(Cl2)C6H3 33, 33a, 33b
2,3-(OMe)2C6H3 4,4a,4b 3,5-(Cl2)C6H3 34, 34a, 34b
2,4-(OMe)2C6H3 5,5a,5b 2,3-(F2)C6H3 35, 35a, 35b
2,5-(OMe)2C6H3 6, 6a, 6b 2,4-(F2)C6H3 36, 36a, 36b
3,4-(OMe)2C6H3 7, 7a, 7b 2,5-(F2)C6H3 37, 37a, 37b
3,5-(OMe)2C6H3 8, 8a, 8b 2,6-(F2)C6H3 38, 38a, 38b
120
2-NO2-C6H4 9, 9a, 9b 2,4-(Me2)C6H3 39, 39a, 39b
3-NO2-C6H4 10, 10a, 10b 2,5-(Me2)C6H3 40, 40a, 40b
4-NO2-C6H4 11, 11a, 11b 3,4-(Me2)C6H3 41, 41a, 41b
2-Cl-C6H4 12, 12a, 12b 3,5-(Me2)C6H3 42, 42a, 42b
3-Cl-C6H4 13, 13a, 13b 3,4-(NO2)2C6H3 43, 43a, 43b
4-Cl-C6H4 14, 14a, 14b 3,5-(NO2)2C6H3 44, 44a, 44b
2-Br-C6H4 15, 15a, 15b 2,6-(EtO)2C6H3 45, 45a, 45b
3-Br-C6H4 16, 16a, 16b 3,4-(EtO)2C6H3 46, 46a, 46b
4-Br-C6H4 17, 17a, 17b 3,5-(HO)2C6H3 47, 47a, 47b
2-I-C6H4 18, 18a, 18b 2,3,4-(MeO)3C6H2 48, 48a, 48b
3-I-C6H4 19, 19a 19b 2,4,5-(MeO)3C6H2 49, 49a, 49b
4-I-C6H4 20, 20a, 20b 3,4,5-(MeO)3C6H2 50, 50a, 50b
2-Me-C6H4 21, 21a, 21b 3-MeO-4-NO2-C6H3 51, 51a, 51b
3-Me-C6H4 22, 22a 22b 4-MeO-3-NO2-C6H3 52, 52a, 52b
4-Me-C6H4 23, 23a, 23b 2-MeO-5-NO2-C6H3 53, 53a, 53b
2-OH-C6H4 24, 24a, 24b 2,4,6-(Cl)3C6H2 54, 54a, 54b
3-OH-C6H4 25, 25a, 25b 2,4,5-(Br)3C6H2 55, 55a, 55b
4-OH-C6H4 26, 26a, 26b 2,4,6-(Me3)C6H2 56, 56a, 56b
2-NH2-C6H4 27, 27a, 27b (CH3)2CH 57, 57a, 57b
3-NH2-C6H4 28, 28a, 28b (CH3)2CH-CH2 58, 58a, 58b
4-NH2-C6H4 29, 29a, 29b (CH3)2CH- CH2-CH2 59, 59a, 59b
2,4-(Cl2)C6H3 30, 30a, 30b C6H5 60, 60a, 60b
121
Fig. 3. Atom numbering in compounds for assignment of spectral data
122
Fig. 4. Tetrahedral intermediate from reaction of RCdCl with CH3COCl
123
Fig. 5. Proposed mechanism for ketone formation from acid chlorides and diethyl cadmium
124
Fig. 6.
1H (
13C) NMR and 2DNMR: (i) COSY-45
0 and HOHAHA Bold-bond (ii) HMBC
(iii) NOESY (iv) HMQC for compound 1.
125
Fig. 7. Presentation of 2D NMR interactions in 30
126
1H (
13C) NMR and 2DNMR: (i) COSY-45
0 and HOHAHA Bold-bond (ii) HMBC
(iii) NOESY (iv) HMQC
Fig. 8. Presentation of 2D NMR interactions in 1b
127
Fig. 9. Presentation of 2D NMR in 30b
128
Fig. 10. Fragmentation pattern of compound 1
129
BIBLIOGRAPHY
130
REFERENCES
Agami, C., Dechoux, L. and Hebbe, S. A novel stereocontrolled synthesis of enantiopure bicyclic
lactams. Tetrahedron Lett., 44, 5311 (2003).
Andrews, J. M. Determination of minimum inhibitory concentrations. J. Antimicrob.
Chemotherap., 48, Suppl. S1, 5 (2011).
Antimicrobial susceptibility testing EUCAST .(2012). disk diffusion method, Version, 2 and 2.1.
Arends, I. W. C. E., and Sheldon R. A. (2004). Modern oxidation of alcohols using
environmentally benign oxidants. In J. E. Bäckvall (Ed.), Modern oxidation methods (pp.
83-118). Weinheim, Germany: Wiley-VCH.
Ballini, R., Barboni, L., Bosica, G. and Fiorini, D. One-pot synthesis of γ-diketones, γ-Ketoesters,
and conjugated cyclopentenones from nitroalkanes. Synthesis, 18, 2725 (2002).
Ballini, R., Bosica, G., and Gigli, F. α-Nitrocycloaikanones as a new source for the one-pot
synthesis of functionalized 1,4-diketones, γ-oxoaldehydes, γ-ketoesters, and methyl ω-
oxoalkanoates. Tetrahedron, 54, 7573 (1998).
Ballini, R. and Petrini, M. Recent synthetic developments in the nitro to carbonyl conversion
(Nef reaction). Tetrahedron, 60, 1017 (2004).
Bandgar, B. P., Hashmi, A. M. and Pandit, S. S. Facile and selective transesterification of β-
Ketoesters using NaIO4, KIO4 and anhydrous CaCl2 as inexpensive catalysts under neutral
conditions. J. Chin. Chem. Soc., 52, 1101 (2005).
Barrero, A. F., Rosales, A., Cuerva, J. M., Gansauer, A. and J. E. Oltra. Titanocene-catalysed,
selective reduction of ketones in aqueous media. A safe, mild, inexpensive procedure for
the synthesis of secondary alcohols via radical chemistry. Tetrahedron Lett., 44, 1079
(2003).
131
Baruah, B., Boruah, A, Prajapati, D, Sandhu, J, S. Cadmium promoted allylation of acid
chlorides: Synthesis of β,γ-unsaturated ketones. Tetrahedron Lett., 37, 9087 (1996).
Basak, A., Cooper, S., Roberge, A.G., Banik, U.K., Tien, M.C. and Seidah, N.G. Inhibition of
proprotein convertases-1,-7 and furin by diterpenes of Andrographis paniculata and their
succinoyl esters. Biochem. J., 107, 338 (1999).
Benincori, T., Rizzo, S., Pilati, T., Ponti, A., Sada, M., Pagliarini, E., Ratti, S., Giuseppe, C., de
Ferraf, L and Sannicolo, F. Process-scale preparation of enantiomerically pure γ-lactones
by asymmetric hydrogenation of γ-ketoesters and comparative tests of the sensory
properties of some antipodes. Tetrahedron: Asymmetry, 15, 2289 (2004).
Cason, J. Branched-chain fatty acids. IV. A further study of the preparation of ketones and
Ketoesters by means of orgaocadmium reagents. J. Am. Chem. Soc., 68, 2078 (1946).
Chaudhuri, S. K., Saha, M., Saha, A. and Bhar, S. Systematic investigations on the reduction of
4-aryl-4-oxoesters to 1-aryl-1,4-butanediols with methanolic sodium borohydride. Beilstein
J. Org. Chem., 6, 748 (2010).
Chen, R. and Zhang, Y. Cleavage of Se-Se bond by Sm/cat. CoCl2 system. A novel method for
the preparation of selenoesters. Synth. Commun., 30, 133 (2000).
Clancy, C. J., and Ngyugen, M. H. Correlation between in vitro susceptibility determined by
Etest and response to therapy with amphotericin B: results from a multi-centre prospective
study of candidemia. Antimicrob. Agents and Chemother., 43, 1289 (1999).
Clinical Laboratory Standards Institute. (2006). Performance standards for antimicrobial disk
susceptibility tests; Approved standard-9th
ed. CLSI document M2-A9. 26:1. Clinical
Laboratory Standards Institute, Wayne, PA.
132
Csende, F. Some alternative synthetic routes to γ- and δ-oxo acid derivatives. Acta Chim. Slov.,
49, 663 (2002).
Csende, F and Stajer, G. 4- and 5-Oxocarboxylic acids as versatile synthons for the preparation of
heterocycles. Heterocycles, 53, 1379 (2000).
Doern, G. V. Detection of Fastidious Bacteria. Clinical Infectious Diseases, 30,166 (2000).
Enders, D., Kownatka, D., Hundertmark, T., Prokopenko, O. F. and Runsink, J. Asymmetric
Michael additions via 2,2-dimethyl-1,3-dioxan-5-one samp-hydrazone. diastereo- and
enantioselective synthesis of protected 3-substituted 4,6-dihydroxy-5-oxoesters. Synthesis,
649 (1997).
Ennis, D. S., Ince, J., Rahman, S and Shipman, M. Observations on the ring opening reactions of
2-methyleneaziridines with acid chlorides and alkyl chloroformates. J. Chem. Soc., Perkin
Trans. I, 2047 (2000).
EUCAST DEFINITIVE DOCUMENT E.Def 3.1. (2000). Determination of minimum inhibitory
concentrations (MICs) of antibacterial agents by agar dilution.
Forzato, C., Gandolfi, R., Molinari, F., Nitti, P., Pitacco, G. and Valentin, E. Microbial
bioreductions of γ- and δ-ketoacids and their esters. Tetrahedron: Asymmetry, 12, 1039
(2001).
Fujimaki, T. Processability and properties of aliphatic polyesters, ‘Bionolle’, synthesized by
polycondensation reaction. Polym. Degrad. Stab., 59, 209 (1998).
Geng, F. and Maleczka Jr., R. E. Synthesis of aryl and alkyl acylsilanes using trimethyl
(tributylstannyl)silane. Tetrahedron Lett., 40, 3113 (1999).
133
Giardina, A., Marcantoni, E., Mecozzi, T. and Petrini, M. Claisen-Johnson orthoester
rearrangement of γ-hydroxy α,β-unsaturated ketones and nitriles. Eur. J. Org. Chem., 713
(2001).
Grey, R. A. A palladium catalyzed synthesis of ketones from acid chlorides and organozinc
compounds. J. Org. Chem., 49, 2288 (1983).
Haddach, M. and McCarthy, J. R. A new method for the synthesis of ketones: The palladium-
catalyzed cross-coupling of acid chlorides with arylboronic acids. Tetrahedron Lett., 40,
3109 (1999).
Heiss, C., Laivenieks, M., Zeikus, J. G. and Phillips, R. S. The stereospecificity of secondary
alcohol dehydrogenase from Thermoanaerobacter ethanolicus is partially determined by
active site water. J. Am.Chem.Soc., 123, 345 (2001).
Hekking, K. F., Lefort, L., de Vries, A. H., van Delft, F. L., Schoemaker, H. E., de Vries, J. G.
and Rutjes, F. P. Synthesis of versatile building blocks through asymmetric hydrogenation
of functionalized itaconic acid mono-esters. Adv. Synth. Catal., 350, 85 (2008).
Hilgenkamp, R. and Zercher, C. K. Tandem chain extension-homoenolate formation: the
formation of α-methylated-γ-Ketoesters. Organic Lett., 3, 3037 (2001).
Hog, S., Wellendorph, P., Nielsen, B., Frydenvang, K., Dahl, I. F., Brauner-Osborne, H., Brehm,
L., Frølund, B., and Clausen, R. P. (Novel High-Affinity and Selective Biaromatic 4-
Substituted γ-Hydroxybutyric Acid (GHB): Analogues as GHB Ligands: Design, Synthesis,
and Binding Studies. J. Med. Chem., 51, 8088 (2008).
Huang, D., Yan, M., Zhao, W. J. and Shen, Q. Efficient synthesis of γ-Ketoesters from enamines
and EDA. Synth. Commun., 35, 745 (2005).
134
Inoue, K., Shimizu, Y., Shibata, I. and Baba, A. Indium (III) chloride-catalyzed coupling reaction
of acid chlorides and allylic tins. Synlett., 11, 1659 (2001).
Izquierdo, J., Rodriguez, S. and Gonzalez, F. V. Regioselective ring opening and isomerization
reactions of 3,4-epoxyesters catalyzed by boron trifluoride. Organic Lett., 13, 3856 (2011).
Itoh, N., Matsuda, M., Mabuchi, M., Dairi, T. and Wang, J. Chiral alcohol production by NADH-
dependent phenylacetaldehyde reductase coupled with in situ regeneration of NADH. Eur.
J. Biochem., 269, 2394 (2002).
Jiang, Y. P., Guo, X. K. and Chen, Y. O-Succinyl derivative of i-carrageenan fragments:
Synthesis and characterization. Carbohydr. Polym., 68, 457 (2007).
Kamal, A., Sandbhor, M. and Shaik, A. A. Application of a one-pot lipase resolution strategy for
the synthesis of chiral γ- and δ-lactones. Tetrahedron: Asymmetry, 14, 1575 (2003).
Kashima, C., Shirahata, Y. and Tsukamoto, Y. Preparation of β-substituted γ-Ketoesters by the
Grignard reaction on n-acylpyrazoles. Heterocycles, 54, 309 (2001).
King, A. G., Meinwald, J., Eisner. T. and Blankespoor, C. L. Synthesis of 9-Propyl-l0-
azacyclododecan-12-olide. Tetrahedron Lett., 37, 2141 (1996).
Kinne-Saffran, E. and Kinne, R. K.Vitalism and synthesis of urea. From Friedrich Wöhler to
Hans A. Krebs. Am. J. Nephrol., 19, 290 (1999) and references 1 and 2 cited therein.
Kizaki, N., Yasohara, Y., Hasegawa, J., Wada, M., Kataoka, M. and Shimizu, S. Synthesis of
optically pure ethyl (S)-4-chloro-3-hydroxybutanoate by Escherichia coli transformant cells
coexpressing the carbonyl reductase and glucose dehydrogenase genes. Appl. Microbiol.
Biotechnol., 55, 590 (2001).
135
Kobayashi, S. and Iwamoto, S. Catalytic Friedel-Crafts acylation of benzene, chlorobenzene and
fluorobenzene using a novel catalyst system, hafnium triflate and trifluoromethanesulfonic
acid. Tetrahedron Lett., 39, 4697 (1998).
Khan, S, Singhal, S, Mathur, T., Upadhyay, D. J, Rattan, A. Antifungal susceptibility testing
method for resource constrained laboratories. Ind. J. Med. Microbiol., 24, 171 (2006).
Kwon, D. W., Kim, Y. H. and Lee. K. Highly regioselective cleavages and iodinations of cyclic
ethers utilizing SmI2. J. Org. Chem., 67, 9488 (2002).
Lee, W. S., Park, K. H. and Yoon, Y.-J. N,N-dimethyamination of acid chlorides with DMF.
Synth. Commun., 30, 4241 (2000).
Liu, Y. and Zhang, Y. Reductive cleavage of Se-Se bond by Sm/cat. CrCl3 system. A novel
method for the preparation of selenoesters. Synth. Commun., 29, 4043 (1999).
Lozano-Chiu M., Ghannoum, M. A. and Rex J. H. Detection of resistance to amphotericin B
among C. neoformans clinical isoaltes: performance of three different media using E-test
and the NCCLS M27-A methodologies. J. Clin. Microbiol., 36, 2817 (1998).
Luman, N. R., Kim. T. and Grinstaff, M. W. Dendritic polymers composed of glycerol and
succinic acid: Synthetic methodologies and medical applications. Pure Appl. Chem., 76,
1375 (2004).
Maeda, H., Yamagata. Y., Abe, K., Hasegawa, F., Machida, M., Ishioka, R., Gomi, K. and
Nakajima, T. Purification and characterization of a biodegradable plastic-degrading enzyme
from Aspergillus oryzae. Appl. Microbiol. Biotechnol., 67, 778 (2005).
Maeda, Y., Nakayama, A., Kawasaki, N., Hayashi, K., Aiba, S. and Yamamoto, N. Ring-opening
copolymerization of succinic anhydride with ethylene oxide initiated by magnesium
diethoxide. Polymer, 38, 4719 (1997).
136
Marchal, F., Nardello-Rataj, V., Chailloux, N., Aubry, J. M. and Tiddy, G. J. Lyotropic liquid
crystal behaviour of azelate and succinate monoester surfactants based on fragrance
alcohols. J. Colloid Interface Sci., 321, 177 (2008).
Matsumura, Y., Endo, T., Chiba, M., Fukawa, H., and Terao, Y. Facile synthesis of optically
active γ-lactones via lipase-catalyzed reaction of 4-substituted 4-hydroxybutyramides.
Chem. Pharm. Bull., 48, 304 (2000).
Matsunami, M., Sakai, N., Morimoto, T., Maekawa, Ikuzo Nishiguchi, H. Magnesium-Promoted
One-Pot Double C-Acylation and Cycloaddition of Anthracene and Double C-Acylation of
Benzyl Acrylates. Synlett., 5, 769 (2007).
Meshram, H. M., Reddy, G. S., Reddy, M. M., Yadav, J. S. Zinc promoted facile method for the
acylation of ylides at α-carbon. Tetrahedron Lett., 39, 4107 (1998).
Nakamura, K., Yamanaka, R., Matsuda, T. and Harada, T. Recent developments in asymmetric
reduction of ketones with biocatalysts. Tetrahedron: Asymmetry, 14, 2659 (2003).
Nanduri, V. B., Hanson, R. L., Goswami, A., Wasylyk, J. M., LaPorte, T. L., Katipally, K.,
Chung, H.-J. and Patel, R. N. Enzyme Microb. Technol., 28, 632 (2001).
Nardello, V., Chailloux, N., Joly, G. and Aubry, J. M. Preparation, amphiphilic properties and
lyotropic phase behaviour of new surfactants based on sodium monoalkyl a,-dicarboxylates.
Colloids and Surfaces A: Physicochem. Eng. Aspects, 288, 86 (2006).
Osawa, T., Mienoa, E, Harada, T. and Takayasu, O. Study of the parameters controlling the
enantio-differentiating ability of asymmetrically modified solid catalysts for the
hydrogenation of γ-ketoesters. J. Mol. Catal. A: Chem., 200, 315 (2003).
137
Ostermeier, M., Brunner, B., Korff, C. and Helmchen, G. Highly enantioselective Rhodium-
catalyzed hydrogenation of 2-(2-methoxy-2-oxoethyl) acrylic acid-a convenient access of
enantiomerically pure isoprenoid building blocks. Eur. J. Org. Chem., 3453 (2003).
Pfaller M. A., Messer S. A., Karlsson Å. and Bolmström, A. Evaluation of E-test method for
determining fluconazole susceptibilities of 402 clinical yeast isolates by using different
agar media. J. Clin. Microbiol., 36, 2586 (1998).
Pohmakotr, M., Panichakul, D., Tuchinda, P. and Reutrakul, V. gem-difluoromethylation of γ-
and γ-ketoesters: preparation of gem-difluorinated α-hydroxyesters and γ-butyrolactones.
Tetrahedron, 63, 9429 (2007).
Poliakoff, M., Fitzpatrick, J. M., Farren, T. R. and Anastas, P. T. Green chemistry: science and
politics of change. Science, 297, 807 (2002).
Ragavan, R. V., Vijayakumar, V., Rajesh, K., Reddy, B. P., Karthikeyan, S. and Kumari, N. S.
Simple, fast and efficient synthesis of β-keto esters from the esters of heteroaryl
compounds, its antimicrobial study and cytotoxicity towards various cancer cell lines.
Bioorg. Med. Chem. Lett., 22, 4193 (2012).
Romo, D. and Meyers, A. I. Chiral non-racemic bicyclic lactams. Vehicles for the construction of
natural and unnatural products containing quaternary carbon centers. Tetrahedron, 47, 9503
(1991).
Ronsheim, M. D., Hilgenkamp, R. K. and Zercher, C. K. Formation of γ-ketoesters from β-
ketoesters: methyl 5,5-dimethyl-4-oxo-hexanoate. Organic Syntheses, 79, 146 (2002).
Sen, A and Batra, A. Evaluation of antimicrobial activity of different solvent extracts of
medicinal plant: Melia azedarach L. Int. J. Curr. Pharm. Res., 4, 67 (2012).
138
Singh, P., Bundiwale, R. and Dwivedi, L. K. In-vitro study of antifungal activity of various
commercially available Itra (volatile plant oil) against the keratinophilic fungi isolated from
soilInternational. J. Pharm. and Bio. Sc., 2, 178 (2011).
Singh, R. P., Leitch, J. M., Twamley, B and Shreeve, J. M. Diketo compounds with
(trifluoromethyl) trimethylsilane: Double nucleophilic trifluoromethylation reactions. J.
Org. Chem., 66, 1436 (2001).
Sirinivasan, S. and Manisankar, P. Foramide as an ammonia synthon in amination of acid
chlorides. Synth. Commun., 40, 3538 (2010).
Sonpatki, V. M., Herbert, M. R., Sandvoss, L. M and Seed, A. J. Troublesome alkoxythiophenes.
A highly efficient synthesis via cyclization of γ-ketoesters. J. Org. Chem., 66, 7283 (2001).
Starodubtseva, E. V., Turova, O. V., Vinogradov, M. G., Gorshkova, L. S., Ferapontov, V. A.
and Struchkova, M. I. A convenient route to chiral γ-lactones via asymmetric
hydrogenation of γ-ketoesters using the RuCl3-BINAP-HCl catalytic system. Tetrahedron,
64, 11713 (2008) .
Todorov, D., Alexieva, V., Karanov. E., Velichkov, D. and Velikov, V. Effect of certain
dicarboxylic acid monoesters on growth, chlorophyll content, chlorophyllase and
peroxidase activities, and gas-exchange of young maize plants. J. Plant Growth Regul., 11,
233 (1992).
Tojo, G. and Fernández, M. (2006). Oxidation of alcohols to aldehyde and ketones. New York,
NY, USA: Springer.
Turova, O. V., Starodubtseva, E. V., Vinogradov, M. G. and Ferapontov, V. A. Kinetic study of
asymmetric hydrogenation of methyl levulinate using the (COD)Ru(2-methylallyl)2-
BINAP-HCl catalytic system. J. Mol. Catal. A: Chem., 311, 61 (2009).
139
Von Rudloff, E. Synthesis of some hexanediols. Can. J. Chem., 36, 486 (1958).
Vraka, P. S., Drouza, C., Rikkou, M. P., Odysseos, A. D. and Keramidas, A. D. Synthesis and
study of the cancer cell growth inhibitory properties of α-, γ-tocopheryl and γ-tocotrienyl 2-
phenylselenyl succinates. Bioorg. Med. Chem., 14, 2684 (2006).
Yeung, K.-S., Farkas, M. E., Qiu, Z. and Yang, Z. Friedel-Crafts acylation of indoles in acidic
imidazolium chloroaluminate ionic liquid at room temperature. Tetrahedron Lett., 43, 5793
(2002).
Wan, W., Hou, J., Jiang, H., Wang Y., Zhu, S., Deng, H., Hao, J. Concise synthesis of γ-
fluoroalkylated ketoesters. A building block for the synthesis of six-, seven-, and eight-
membered fluoroalkyl substituted 1,2-diaza-3-one heterocycles. Tetrahedron, 65, 4212
(2009).
Wang, W., Xu, B. and Hammond, G. B. Efficient synthesis of γ-ketoesters through neighbouring
carbonyl group-assisted regioselective hydration of 3-alkynoates. J. Org. Chem., 74, 1640
(2009).
Wanger, A., Mills, K., Nelson, P. W., and Rex, J. H. Comparison of E-test and NCCLS broth
macrodilution method for antifungal susceptibility testing: enhanced ability to detect
amphotericin B resistant isolates. Antimicrob. Agents Chemother., 39, 2520 (1995).
Williams, D. B. G., Blann, K., Caddy, J. and Holzapfel, C. W. Aryl γ-ketoesters as precursors for
γ- butyrolactone dimers in Samarium (II) Iodide mediated reactions. Synth. Commun., 32,
3755 (2002).
Williams, D. B. G., Blann, K and Holzapfel, C.W. ARYL γ-ketoesters as precursors for γ-
butyrolactones in Samarium(ii) iodide-Mediated reactions. Synth. Commun., 31, 203
(2001).
140
Yamamoto, H., Kimoto, N., Matsuyama, A. and Kabayashi, Y. Purification and properties of a
carbonyl reductase useful for production of ethyl (S)-4-chloro-3-hydroxybutanoate from
Kluyveromyces lactis. Biosci. Biotechnol. Biochem., 66, 1775 (2002a).
Yamamoto, H., Matsuyama, A. and Kabayashi, Y. Synthesis of ethyl (R)-4-chloro-3-
hydroxybutanoate with recombinant Escherichia coli cells expressing (S)-specific
secondary alcohol dehydrogenase. Biosci. Biotechnol. Biochem., 66, 481 (2002b).
Yan, M., Zhao, W.-J., Huang, D. and Ji, S.-J. Unusual reaction of aryldiazoacetates with
enamines: highly effective synthesis of γ-ketoesters. Tetrahedron Lett., 45, 6365 (2004).
Zhang, B., Ren, J., Liu, X., Guo, Y., Guo, Y., Lu, G. and Wang, Y. Novel sulfonated
carbonaceous materials from p-toluenesulfonic acid/glucose as a high-performance solid-
acid catalyst. Catal. Commun., 11, 629 (2010).
Zhao, W.-J., Yan, M., Huanga, D. and Jia, S.-J. New reaction of enamines with aryldiazoacetates
catalyzed by transition metal complexes. Tetrahedron, 61, 5585 (2005).
141
PART-II
PHYTOCHEMICAL STUDIES
OF
BIOACTIVE COMPOUNDS
FROM
CORIANDRUM SATIVUM LINN.
UMBELLIFERAE
142
CHAPTER-1
INTRODUCTION
143
1. INTRODUCTION
1.1. General Introduction
Importance of the plants like, fig, olive, date palm, pomegranates, onion, garlic, lentils, zinger,
colocynth and basil has been referred in “AL-QURAN and Hadith” (Surah No. 16, Verse No. 68,
69; Marwat et al., 2009; Janick, 2007).
Almost all medicines in use have directly or indirectly origin from plants (Marwat et al., 2009).
Hence plants can be considered as the major source of medicines and drugs (Kainsa et al., 2012;
Lu et al., 2012; Shoeb, 2006; Li et al., 2003; Nirmala et al., 2011). In this connection some of the
drugs/medicines origin from plants with uses are listed in Table 1. The importance of Natural
Products can be highlighted from the fact that most of the anticancer drugs have plants origin and
still the work is going on to explore such type of drugs (Marwat et al., 2009; Newman and Cragg,
2007; Ali et al., 2008).
It has therefore, become mandatory to explore the plants for their phytochemicals constituents
and evaluate their bioactivity. Luckily, Indopak subcontinent is very rich in medicinal plants and
a number of medicinal plants families like the Berberidaceae, the Euphorbiaceae, the
Caesalpiniaceae, the Solanaccac etc are in abundance (Chen et al., 2002; Juan et al., 2008;
Maghraby and Hassan, 2005). However, upto now only 10% plants has been explored and there
is a need to extract, isolate and identify bio-active constituents of the plants. The prevailing
situation prompterd us to undertake phytochemical study on the Coriandrum sativum Linn, a
species of family the Umbelliferae.
144
Photo: Coriandrum sativum Linn, with shoots, leaves and inflorescence
145
1.2. The Umbelliferae
The Umbelliferae family comprises of 455 genera and 3600-3751 species and is distributed all
over the world (Pimenov and Leonov, 1993; Menglan, 2005; Tenni et al., 1998; Suguna et al.,
1996). A major number of plants of the family are native of hilly and plain regions of Indo-Pak
subcontinent (Kljuykov and Ukrainskaja, 2010). Pakistan is a habitat of approximately 56 genera
and 167 species of the Umbelliferae (Perveen and Qaiser, 2006).
Coriandrum sativum grow in hilly and plain parts of Pakistan and is widely used in folk
medicines (Perveen and Qaiser, 2006; Pimenov and Leonov, 2004; Khan and Khatoon, 2008;
Khan et al., 2011). Coriandrum sativum is a rich source of spices and is termed as plant of
economical significance ( Koppula and Choi, 2011). Plants of the Umbelliferae have diversity in
chemical constituents (Sriti et al., 2010; Radulovic et al., 2012; Siripornvisal et al., 2011; Singh
et al., 2012; James and Dubery, 2009; Olle and Bender, 2010; Pimenov and Leonov 2004; Amin
and Mousa, 2007; Vetter, 2004). Food, perfumery and medicine industries make use of these
Plants (Olle and Bender, 2010; Pimenov and Leonov, 2004; Gui-Sheng et al., 2012).
The Umbelliferae family is enrich with essential oils having antioxidant, antibacterial, antifungal
and insecticidal properties, and are also used against mosquito slaying (Kilama, 2009; Nickavar
and Abolhasani, 2009; Orhan et al., 2012; Singh et al., 2012).
The genus Coriandrum of the Umbelliferae has two species: Coriandrum tordylium Fenzl (Hedge
and Lamond, 1972; Mouterde, 1986) and Coriandrum sativum Linn.
Coriandrum sativum Linn is an annual green herb with an approximate height of 250-1450 cm. It
is cultivated all over the world almost in all seasons. Stem of the plant is erect, glabrous with
several side branches at the basal node and root is taproot. Leaves are alternate and each branch
ends with an inflorescence called umbel.
146
The botanical taxonomy of Coriandrum sativum Linn is given below
Kingdom Eukaryota
Division Spermatophyta
Subdivision Angiosperm
Class Dicotyledon
Sub class Rosidae
Order Umbellales
Family Umbelliferae
Genus Coriander
Species Coriandrum sativum Linn
Coriandrum sativum has been subject of an active research of a large number of researchers
(Pandey et al., 2011; Mouterde, 1986; Hedge and Lamond, 1972; Burdock and Carabin, 2009;
Burt, 2004; Wangensteen et al., 2004; Cantore et al., 2004; Ramadan et al., 2003; Barrtta et al.,
1998; Sriti et al., 2011, 2012; Msaada, 2007; Sreelatha et al., 2009; Emamghoreishi et al., 2005)
From the seeds of coriandrum sativum glucosinolates and sinapine have been isolated (Matthäus
and Angelini, 2005, Chen and Viljoen, 2010; Bakkali et al., 2008; Wangensteen et al., 2004;
Zhou et al., 2011).
Unfortunately, all of the research that has been carried out up to now on C. sativum was limited
to the essential oils (Bhuiyan et al., 2009; Wangensteen et al., 2004; Cantore et al., 2004;
Ramadan et al., 2003; Burt, 2004). But no proper attention has been concentrated to isolate other
natural products from the species (Ramadan and Morsel, 2003).
These properties prompted us to explore Coriandum sativum Linn for some more bioactive
compounds and study their biological activity against bacteria and fungi.
Present investigation on C. sativum Linn, led us to quite encouraging results and several new
oleane type pentacyclic triterpenoids have been isolated and characterized with the help of
modern spectroscopic techniques.
147
CHAPTER-2
RESULTS AND DISCUSSION
148
2. RESULTS AND DISCUSSION
2.1. Essential Oil
After hydrodistillation of C. sativum seeds the obtained EO was subjected to gas chromatography
which displayed seventeen peaks. The peaks were identified by running the parallel authentic
samples and determining retention time as well as Rf values. In addition, functional groups
present in the essential oil were identified by recording IR spectrum. Alcoholic, aldehydic, and
ester groups were identified (Fig. 1). The results revealed that the essential oil is a rich source of
β-Linalool (79.86%) as displayed in Table 2.
149
2.2. Isolates
2.2.1. 1-Oxo-11β, 21β-dihydroxyoleane (1)
The whole plant methanolic extract was suspended in water and re-extracted, with various
organic solvents (Experimental section 3.6.1). Ethyl acetate soluble portion was subjected to
column chromatography on silica gel, elution was carried out with mixture of petroleum
ether/ethyl acetate to yield eight (1-8) fractions. The active fractions 3-4 containing more than
two components were subjected to separation on the same silica gel column and eluted with
petroleum ether/acetone (7/3), to get semi-pure triterpenes. Further purification was carried out
on preparative HPLC and eluted with MeOH-H2O (80/20) to get compounds (1) (31.3 mg), (tR =
7.9 min) (2), (tR = 8.1 min) (25.5 mg), (tR = 8.4 min) (3) (31.7 mg), (tR = 8.7 min) (4) (15.8 mg)
and (tR = 9.3 min) (5) (37.6 mg).
Powdered fresh shade dried seeds of C. sativum L. were extracted with methanol using the
procedure as described in experimental section (3.6.5). Ethyl acetate soluble fraction was
150
subjected to purification on preparative HPLC, using MeCN/ H2O, gradient scheme (A = H2O;
B = MeCN/H2O 88/ 12; 5 min A, linear gradient to B in 20 min, 5 min B, linear gradient back to
A in 2 min at 2 mL/min flow rate), as a mobile phase, to afford pure compounds (6) (131.3 mg),
(7) (125.3 mg), (8) (130.1. mg), (9) (151.5 mg), (10) (127.4 mg) (11) (137.6 mg), and 12 (155.3
mg), and 13 (152.5 mg), respectively. The pure compounds were subjected to spectroscopic
study for structure elucidation. After spectral analysis, compounds 6-13 were identified (Tables
11,13 ).
Compound 1, obtained as solid needles, m.p. 255-258 ºC; [α]25
D + 5.43° and displayed an [M]+ ion
peak at m/z= 458 in HR-EIMS for [C30H50O3]+
. EIMS gave peaks at m/z= 430 [M-28-CO]+, 440
[M-18- H2O]+ and m/z= 412 [M-36-2H2O]
+. In IR spectrum bands were at 1689 cm
-1 (keto) and
3404, 3532 (OH) cm-1
. Its UV spectrum displayed an absorption band at 216 nm (1.56) for an
isolated cyclic ketone (Gershenzon and Dudareva, 2007). Its 1H-NMR (Table 3) displayed eight
singlets three protons each at δ 0.97, 1.07, 1.13, 1.16, 1.17, 1.55,1.66, 1.38 and were due to eight
methyl groups in the basic skeleton of the molecule. Out of these four were gem-methyl that
resonated at 1.66, 1.07 (Me-23,Me-24) at C-4, 1.38, 0.97 (Me-29, Me-30) at C-20 were identified
by HMBC (Fig. 2). In the same spectrum there were nine methylene groups appeared as a
complex multiplicity. Peaks appeared at δ 2.22 ddd (J=13, 5.2, 3.5 Hz), 1.97 dd (J=13, 5.2 Hz)
were assigned to CH2-2 & CH2-3. Similarly other peaks integrated for two protons were at δ 1.83
d (J= 11.5 Hz), 2.17 dd (J= 14, 6.5 Hz) for CH2-6 and CH2-7 and peaks at δ 2.44 ddd (J=13.5,
13.5, 3.0 Hz), 1.46 ddd (J=13.5, 13.5, 3.1 Hz), 2.53 ddd (J= 13.5, 13.5, 3.0 Hz), 1.56 ddd
(J=13.5, 13.5, 3.0 Hz) were assigned to α β methylene protons of C-15,16 (Table 3). In addition
there was another set of methylene protons resonated at δ 1.88 ddd (J= 14.1, 4.5, 12.2 Hz, CH2-
12), δ 1.71 ddd (J=14.5, 11.5, 4.0 Hz, H-19α), δ 1.17 dd (J=14.5, 4.0 Hz, H-19β), δ 2.91 ddd
151
(J=13.5, 13.5, 2.5 Hz, H-22α), δ 1.91 dd (J=13.5, 13.5 Hz, H-22β) (Table 3). 1H-NMR spectrum
of compound 1 revealed six methine protons. Out of these two were in the middle region of NMR
(δ 3.29 ddd (J=14, 6.5, 4.2 Hz), δ 3.46 ddd (J= 13.5, 13.5, 3.0 Hz) for hydroxy methine moieties
at C-11 and C-21 by NOE irradiation. Remaining four methine protons were identified by peaks
at δ 1.83 d (J=11.5 Hz), 1.64 dd (J=14, 6.5 Hz), 2.01 dd (J=12.2, 4.5 Hz), 1.78 ddd (J=12.5, 12.5,
3.5 Hz). 13
C-NMR of compound 1 displayed 30 peaks for thirty carbons (Table 4). In 13
C-NMR
spectrum peak appeared at δ 214.7 due to carbonyl group and its Position was located with the
help of HMBC experiments (Fig. 2).
Various protons bearing fragments were identified with the help of COSY-45º and HOHAHA
experiments (Fig. 2). These fragments were connected with each other with the help of HMBC
technique (Fig. 2).
The BB and DEPT 13
C-NMR spectrum of 1 showed 30 carbon signals (Table 4), 8Me, 9CH2,
6CH and 7C. The relative stereochemistry of OH groups at C-11 and C-21 in 1 was deduced by
NOESY spectrum (Fig. 3). In this spectrum interactions were observed among α-oriented H-8, H-
13, H-18, Me-23 and Me-27. In the light of these experimental results it was concluded thad
compound 1 has basic skeleton of triterpene as reported earlier (Sule et al., 2011; Abreu et al.,
2011). Hence, structure for 1 was confirmed as 1-oxo-11β, 21β-dihydroxy-oleane.
152
2.2.2. 1-Oxo-11β-hydroxy-21β-O-acetyloleane (2)
Compound 2 was acetyl derivative of 1 as in HR-EIMS molecular ion peak was at m/z= 500.7515
for C32H52O4. 1H-NMR spectrum of 2 was very close to 1 except presence of an extra peak at δ
2.29 for three protons. Presence of acetyl moiety in 2 was proved by 13
C-NMR spectrum. In this
spectrum in addition to other peaks there were two more peaks present at δ 176.2 and δ 22.3 was
assigned to acetyl group. Position of the acetyl group was located at C-21 with the help of HMBC
and NOE experiments (Fig. 2, 3). The DEPT 13
C-NMR showed 32 carbon signals, 9Me, 9CH2,
6CH and 8C. Hence the proposed structure of 2 was 1-Oxo-11β-hydroxy-21β-O-acetyloleane.
153
2.2.3. 1-Oxo-11β-hydroxy-21β-O-angeloyloleane (3)
Compound 3 was obtained as white solid, crystalline, m.p. 258-260 ºC; [α]25
D + 5.43°. In UV
specrum displayed λmax at 308 (4.28) and 214 (4.26), 267 (3.7) nm indicated presence of α,β-
unsaturated ester as a chromophore.
Compound 3 showed molecular ion [M+] peak m/z=540.8143 in HR-EIMS corresponding to
C35H56O4. Therefore, it was proposed an angeloyl derivative of 1. 1H-,
13C-NMR spectra of 3 was
similar to 1 but there were peaks for angelate moiety: H-3 (δ 6.13, 1H, qq, J=6.6 Hz), CH3-4 (δ
2.01, 3H, dq, J=6.5, 2.5 Hz), and CH3-5 at δ 1.93 [3H, dqm, J= 6.5, 2.2 Hz]; δ 168.3 (C-1), 128.0
(C-2), 137.3 (C-3), 15.9 (C-4), and δ 20.6 (C-5). Therefore, 3 was considered as angeloyl
derivative of 1. Position of angelate was inferred at C-21 by HMBC and NOE interaction
between H-21 and an angeloyl proton H-3. The DEPT 13
C-NMR spectrum of 3 showed 35 carbon
signals, 10Me, 9CH2, 7CH and 9C. On the basis of these results structure of 3 was concluded as
1-oxo-11β-hydroxy-21β-O-angeloyloleane.
154
2.2.4. 1-Oxo-11β-O-angeloyl-21β-O-acetyloleane (4)
Compound 4, colorless, amorphous, m.p. 267-268 ºC; [α]25
D + 6.43°. UV spectrum showed
compound is uv active by displaying λmax at 347 (4.55), 284 (4.56), 253 (4.22) 234 (2.7) nm
typical for angelic moiety. IR spectrum showed absence of OH groups in the compound. There
were peaks at νmax 1723, 1706 cm-1
for ester carbonyl groups.
Molecular formula C37H58O5 of compound 4 was established with the help of HR-EIMS;
displaying molecular ion peak at m/z= 582. In EIMS fragmentation peak appeared at m/z = 522
[M+-60- AcOH] indicated presence of an acetate. Other peak at m/z= 482 was due to loss of
angelic acid from the parent molecule. Therefore, it was considered as diester of acetic and
angelic acid of 1
NMR (1H- and
13C-) spectra of 4 was almost same as 3 except presence of an extra acetyl moiety.
It was also proved by DEPT 13
C-NMR spectrum which showed 37 carbon signals 11Me, 9CH2,
155
7CH and 10C. Position of the acetate moiety was deduced at C-21 by HMBC and NOE
interaction. Thus structure of 4 was concluded as 1-oxo-11β-O-acetyl-21β-O-angeloyloleane.
2.2.5. 1-Oxo-11β, 21β-O-dibenzoyloleane (5)
Fractions 6-8 were combined and chromatographed over silica gel column. Active fraction was
applied to a reversed-phase preparative HPLC afforded a pure compound 5 (tR = 9.3 min)
displayed in Scheme 1(Experimental).
It was white solid, m.p. 264-268 ºC, optically active displayed [α]25
D + 5.43° in polarimeter.
Presence of chromophore was revealed by displaying λmax peaks at 349 (4.55), 286 (4.56), 254
(4.22), 247 (1.7) nm in UV. Presence of aromatic moiety was indicated by IR spectrum. Peak at
νmax 3133 (Ar-H stretching) and peaks at 806, 791, 760 cm-1
suggested monosubstituted benzene
ring. Presence of the ester carbonyl was proved by peaks at 1745, 1725 cm-1
.
156
Molecular composition C44H58O5 of 5 was proposed by HR positive ion FAB-MS in which it
indicated an [M]+ ion peak at m/z= 667. EIMS, fragmentation pattern revealed presence of two
benzoic acid species by displaying peaks at m/z = 544 [M-122-benzoic acid]+ and 422 [M-2
×122- 2 ×benzoic acid]+. The
1H,
13C-NMR spectra of 5 was close to 1 except presence of
(double) peaks in aromatic region at δ 8.04 (2H, d, J=7.2 Hz), 7.41 (2H, t, J=7.2 Hz), 7.53 (1H,
dt, J=7.2, 2.5 Hz) δ 164.6 [2 × CO s]), 2 × 5CH (δ 129.7 d, 130.0 d, 130.0 d, 128.4 d, 128.4 d), 2
× C (133.7). Therefore, it was suggested as diester of benzoic acid of 1.
Positions of the ester moieties were deduced by HMBC interactions. The H-11 (δ 4.29) displayed
interaction with carbonyl carbon of ester (δ 164.6) similarly H-21(δ 4.46) displayed interaction
with other carbonyl (δ 164.4) in HMBC spectrum (Fig. 2). Therefore, ester moieties were
suggested at C-11 and C-21, respectively.
On this basis, compound 5 was declared as 1-oxo-11β, 21β-O-dibenzoyloleane. The DEPT 13
C-
NMR spectrum of 5 showed 44 carbon signals 8Me, 9CH2, 16CH and 11C. On this basis,
compound 5 was declared as 1-oxo-11β, 21β-O-dibenzoyloleane. According to our knowledge,
since compounds 1-5 have not been reported earlier from plant kingdom and hence can be
declared as new entities.
157
2.2.6. 28-β-D-Glucopyranosyl, 2α, 3α, 19α, 24-tetrahydroxy-12-ene-oleaenoate (6)
Compound 6 was obtained as an amorphous powder and its positive ion FAB-MS indicated an
[M + Na]+ ion peak at m/z= 689 and molecular formula of 6 was found to be C36H58O11.
The 1H-NMR spectrum of 6 was close to triterpenenoid arjunglucoside I isolated from
Terminalia tropophylla (Cao et al., 2010). On the basis of COSY-45° and HOHAHA (Fig . 5);
and other 2D-NMR (1H,
13C) data suggested that compounds 6-13 were saponins of olea-12-en-
28-oic acid β-D-glucopyranose. Compounds 6-13 has same basic skeleton which is triterpene
oleanes (Cao et al., 2010). They are different from each other on the basis of position and
stereochemistry of OH groups. Therefore structure elucidation of 6 will be discussed in detail.
Six singlets were observed in 1H-NMR for three protons each at δ 1.66, 1.09, 1.17, 1.54, 1.14,
0.98 and were due to six methyl in the basic skeleton of the molecule. Out of these two were
gem-methyl that resonated at δ 1.14, 0.98 (Me-29,Me-30) at C-20 were identified by HMBC (Fig.
4). The methyl group numbered 27 present at quaternary allylic carbon (C-14) displayed signals
at δ 1.54 in 1H-NMR spectrum. Two CH2 were oxidized into alcohol and carboxylic acid. In the
158
same spectrum there were peaks in the middle region of the NMR resonated as α β proton on the
same carbon (δ 4.13 d, J=11.5 Hz and δ 3.85 d, 11.5 Hz) were assigned to hydroxyl methylene
present at C-4. There were other eight methylene groups appeared as a complex. Peaks at δ 2.01
(ddd, 12.5, 3.5, 3.5) and 1.41 (dd, 12.5, 3.5) were due to H-C1α), H-C1β. 1HNMR revealed that
C-2,3,5,9,12, 18 and 19 as methine carbons (Table 11).
The DEPT 13
C-NMR spectrum of 6 showed 36 carbon signals, comprising of one ester carbonyl
carbon (δ= 177.3), one trisubstituted double bond system (δ= 144.4, 123.8), three oxygenated
methine carbons (δ= 81.1, 74.2, 66.3), one oxygenated methylene carbon (δ= 65.2), and one
glucopyranosyl group (δ= 95.9, 74.4, 79.3, 71.2, 79.2, 62.3). These NMR signals were confirmed
using 2D NMR techniques (HMQC, HMBC) in 6. Position of the ester group was determined by
NOE and HMBC interactions (Fig. 4). Relative stereochemistry of various stereogenic centers
was confirmed by recording ROESY spectrum (Fig. 5).
In the ROESY spectrum of 6, key NOEs were observed between H-2 and H3-25, and H-5 and H3-
23. In this compound H-2β showed interaction with H-3, therefore OH group at C-3 was placed
at α-position. There was also interaction between H-19 with H-2β and H-3β. Results of these
experiments concluded that OH groups at C-2, C-3 and C-19 were at α-position. In the light of
these spectral evidences the structure of 6 was therefore concluded to be 2α, 3α, 19α, 24-
tetrahydroxyolea-12-en-28-oic acid β-D-glucopyranosyl ester.
Compounds 7-10 were found to be stereoisomers of 6. In FAB-MS, IR and NMR data was very
close to 6. But there was a little difference in the stereochemistry of OH groups attached at C-2,
C-3, C-19 which was evident in NMR (1H,
13C) and ROESY interactions observed in these
spectra.
159
2.2.7. 28-β-D-Glucopyranosyl, 2β, 3α, 19α, 24-tetrahydroxy-12-ene-oleaenoate (7)
There was no interaction between H-2 and H-3 while H-19 displayed interaction with H-3;
therefore OH at C-2 concluded at β-position. Structure of 7 was therefore suggested as 28-β-D-
glucopyranosyl 2β,3α,19α,24-tetrahydroxy-12-ene-oleaenoate.
On the basis of spectroscopic and mass measurement data 8 was assigned a structure of 28-β-D-
glucopyranosyl 2α,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (8). Similarly, structures 28-β-D-
glucopyranosyl 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate and 28-β-D-glucopyranosyl 2β,3β,
19β,24-tetrahydroxy-12-ene-oleaenoate were given to 9 and 10, respectively.
160
2.2.8. 28-β-D-Glucopyranosyl 2α, 3β, 19α, 24-tetrahydroxy-12-ene-oleaenoate (8)
161
2.2.9. 28-β-D-Glucopyranosyl 2β, 3β, 19α, 24-tetrahydroxy-12-ene-oleaenoate (9)
162
2.2.10. 28-β-D-Glucopyranosyl 2β, 3β, 19β, 24-tetrahydroxy-12-ene-oleaenoate (10)
163
2.2.11. 28-β-D-Glucopyranosyl 2α-O-acetyl, 3α, 19α, 24-trihydroxy-12-eneoleaenoate (11)
Compounds 11-13 were acetyl derivatives of 6. Compounds were obtained as an amorphous
powder and their positive ion FAB-MS indicated an [M + Na]+ ion peak at m/z= 731. The
molecular formula of 11 was found to be C38H60O12 by using HR positive ion FAB-MS. In EIMS
peak at m/z 671 was due to loss of acetic acid from parent molecule.
In 1H-NMR presence of a peak at 2.23 (s) was attributed to acetyl moiety in the molecule. The
DEPT 13
C-NMR spectrum of 11 showed two additional carbons (38 carbons) signals which were
similar to 6 except absence of one methine attached with OH group due to replacement by acetyl
group. Position of acetyl group was located by 1H-NMR as well as
13C-NMR by displaying H-2
and C-2 peaks in low field region of NMR as compared to 6 as shown in NMR data (Tables 11,
12 and 13). Therefore acetyl was suggested at C-2 in 11.
The same assignment was also confirmed with the help of HMBC and NOE interactions between
H-2 and acetyl carbon as well as H-2 with acetyl methyl group. On the basis of these spectral
164
evidences the structure of 12 was determined as 28- β-D-glucopyranosyl 2α-O-acetyl-3α,19α,24-
trihydroxyo-12-ene-olenoate.
165
2.2.12. 28-β-D-Glucopyranosyl 3α-O-acetyl, 2α, 19α, 24-triahydroxy-12-eneoleaenoate (12)
166
2.2.13. 28-β-D-Glucopyranosyl 19α O-acetyl, 2α, 3α, 24-trihydroxy-12-eneoleaenoate (13)
167
2.3. Biological Activity
2.3.1. Antibacterial and antifungal activity
Essential oil and seed hexane fraction (SHF), seed ethyl acetate fraction (SEF), seed butanol
fraction (SBF) and seed water fraction (SWF) displayed activity against fungi and bacteria. Zones
of inhibition of essential oil (EO) and various crude extracts against fungi and bacteria are
presented in the form of histograms 1 and 2, respectively, which were in the order of T. rubrum>
C. albicans = M. audouini> C. neoformans> T. mentagrophytes> E. floccosum.
The MIC values of EO and fractions against C. albicans and C. neoformans displayed highest
activity. The results have been shown in histograms 3 and 4.
The antibacterial and antifungal activity of compounds 1-5 against the employed bacteria and
fungi was qualitatively and quantitatively assessed by measuring the inhibition zones (Tables 5
and 6), minimum inhibition concentration (MIC) (Tables 7 and 8), minimum bactericidal
concentration (MBC) (Table 9), and minimum fungicidal concentration (MFC) (Table
10).Compounds 1-5 did not show noticeable activity against tested microorganisms as compared
to control that was in accordance with the literature (Caldwell et al., 2000; Hichri et al., 2003;
Sun et al., 2006).
2.3.2. Anticancer Activity
Literature revealed that saponins anti-cancer agents (Li et al., 2009; Mbaze et al., 2007; Chen et
al., 2002). Therefore, it was decided to investigate anticancer activity of isolates 6-13 against HL-
60, SMMC-7721, A-549, MCF-7 and SW-480 cancer cell lines. Results in this connection are
displayed in Table 24. The results revealed that compounds 6-13 were significantly active against
HL-60 and displayed IC50= 2.14, 2.19, 2.17, 3.16, 2.57, 2.87, 2.84 and 3.96 µM, respectively,
whereas the standard (cisplatin) showed IC50 1.04 µM. Activity was found dependent over the
168
stereochemistry of OH group. Compounds 6 displayed maximum activity (IC50= 2.14) in which
all the three OH groups were α-oriented (Mbaze et al., 2007; Chen et al., 2002
169
CHAPTER-3
EXPERIMENTAL
170
3. EXPERIMENTAL
3.1. General Experimental Procedure
All chemicals & pure essential oil were purchased from Sigma St. Louis, USA. Bio-chemicals,
strains and culture media were obtained from, Darmstadt, Germany and Sigma St. Louis, USA.
Uncorrected melting points were determined by a Gallenkamp (U.K) melting point apparatus.
Optical rotation was measured in CHCl3 using digital polarimeter supplied by OSK OGAWA
Seiki Co. Ltd, Tokyo, Japan. The UV spectra were taken in absolute MeOH using IRMECO
UV/VIS Model U-2020 spectrophotometer, Germany. The IR spectra were recorded over
TENSOR 27 FT-IR spectrophotometer supplied by Bruker, Switzerland. The 1H-NMR and
13C-
NMR, spectra were recorded in CDCl3 on a Bruker Biospin, AMX 300 MHz FT NMR (300 MHz
for 1H, 75 MHz for
13C) spectrometer.
1H and
13C-NMR chemical shifts were referenced to
residual CHCl3 (δH = 7.26) and the central peak of the CDCl3 (δC = 77.0), respectively. EI-MS
were acquired on a double-focusing Finnigan MAT 112 at 70 eV. HR-EIMS measurements were
made on JEOL HX 110 spectrometer. Analysis of Essential Oil was carried out on GCMS-
QP2010, Shimadzu, Japan. Column chromatography was carried out with Sephadex LH-20,
Chromatorex ODS chromatography and silica gel (PF254). HPLC (Perkin Elmer, USA), equipped
with RP-18 column was used and UV detector by employing solvent gradient technique. TLC
was performed on HPTLC plates, E. Merck, Germany. The compounds were visualized, by
spraying with 10% sulfuric acid followed by heating. The final separation of the crude triterpene
fractions was performed through HPLC (Perkin Elmer). All chemicals used in the present study
were of analytical reagent quality.
171
3.2. Microorganisms
3.2.1. Fungi and bacteria
The fungi used in this study were Candida albicans ATCC 10231, Cryptococcus neoformans
TIMM 0362, Microsporum audouinii ATCC 10008, Trichophyton rubrum BCRC 32805,
Trichophyton mentagrophytes BCRC 32066, Epidermophyton Floccosum BCRC 30531,
Microsporum canis BCRC 30541 and Aspergillus niger F2723.
Bacteria employed for determination of activity were Escherichia coli MTCC-8739, Proteus
mirabilis ATCC 14153, Pseudomonas aeruginosa MTCC-2435, Micrococcus luteus MTCC-106,
Entero coli, Bacillus cereus ATCC 14603, Staphylococcus aureus MTCC-2940 and Klebsiella
pneumoniae ATCC 700603. Tested microbes were obtained from the Korea Food and Drug
Administration (KFDA), Daegu, Republic of Korea. Cultures of each fungal strain were maintained
on Luria-Bertani (LB) agar medium at 4 ºC. The bacteria were maintained and tested on trypticase
soya agar (TSA) and the yeast on Sabouraud-dextrose agar (SDA). Miconazole and Imipenem
(Sigma-Aldrich Co., St. Louis, MO, USA) were used as control.
3.2.2. Cancer cells
Human tumor cell lines HL-60, SMMC-7721, A-549, MCF-7 and SW-480 and DDP (cisplatin)
were purchased from Sigma, St. Louis, MO, USA (Sigma), maintained in RPMI-1640 medium
supplemented with 10% foetal bovine serum, 100 IU/mL penicillin (Sigma) and 100 μg/mL
streptomycin (Sigma). Experiments were performed in 96-well plates in triplicate.
3.3. Collection of Plant Material
C. sativum Linn was grown in the botanical garden, Rakh Bibi Campus Gomal University, Dera
Ismail Khan, KPK, Pakistan. The plants were identified by Professor Hamidullah Khan, Head of
Pharmacognosy Department, Faculty of Pharmacy Gomal University Dera Ismail Khan. A
172
specimen number CS 25 was retained in the herbarium. The seeds, the leaves and the whole parts
of the plant were collected at appropriate time and investigated for its essential oil, bioactive
constituents and bioactivity.
3.4. Hydrodistillation of Essential Oil from Seeds
The healthy Coriander seeds (1050 g) were placed in a locally made stainless steel sieve and
washed with distilled water to remove the dust and without letting them dry, subjected to
hydrodistillation for 10 continuous hours using Clavenger-type apparatus. The obtained EO was
dried by addition of anhydrous sodium sulphate (0.5 g) to get light yellow oil 3.5 g (yield=
0.33%).
3.5. GC Analysis of Essential Oil of C. sativum
Analysis of Essential Oil was carried out on GCMS using the following parameters; Column
oven temp: 40 °C; Capillary column length 30 m × 0.25 mm; Injection temp: 240 °C; Injection
mode: Split; Flow control mode: Linear velocity; Pressure: 68.9 KPa; Total Flow: 72.9 mL/min;
Column Flow: 1.27 mL/min; Linear Velocity: 40.7 cm/sec; Purge Flow: 8.0 mL/min; Split Ratio:
50.0;High Pressure Injection Pressure: 150.0 KPa; Oven temp rate: 40 °C to 90 °C, 2 °C/min and
from 90 °C t0 200 °C, 3 °C/min.
3.6. Extraction
The whole dried plant material (roots, stems, leaves and seeds) of C. sativum L. was powdered
using grinding machine. The grinded material (5000 g) was extracted with MeOH (7.5 L× 3) at
room temperature. Methanolic solution was filtered using whatman #1 filter paper and
concentrated at reduced temperature and pressure to get dark brown extract 500 g 10 % yield on
the basis of dry plant weight which was considered as 100%.
173
3.6.1. Isolation of compounds
The methanol extract (480 g) was suspended in water (1000 mL) and re-extracted with n-hexane
(3 × 300 mL) chloroform (3 × 250 mL), ethyl acetate (3 × 250 mL) and n-butanol (3 × 50 mL).
Each fraction was dried over anhydrous sodium sulphate and evaporated to dryness to yield n-
hexane fraction (122.4 g, 25.5%), chloroform fraction (134.3 g, 27.98%), ethyl acetate fraction
(124.3 g, 25.89%), n-butanol fraction (72.3 g, 15.06%) and aqueous fraction (25.4 g, 5.29%).
Biological activity against used microbes was evaluated and the result showed that ethyl acetate
fraction was most active among the tested fractions results are shown in histograms 1-4.
Therefore, the ethyl acetate soluble portion was further proceeded to isolate biologically active
constituents as indicated in scheme 1.
The ethyl acetate soluble fraction (20 g) was subjected to chromatograph on silica gel column
(192 × 5.4 cm). It was eluted with petroleum ether/ethyl acetate mixture (6/4, 25000 mL) with
flow rate of 2 mL/min, to yield twenty (1-20) fractions each 250 mL and evaporated to dryness in
vacuo. Fractions 3–5 (1.4g), containing triterpenoids constituents were combined, owing to their
TLC similarities, and subsequently purified by semipreparative HPLC using 15%
water:acetonitrile as eluent, yielding 1 (7 mg) and an inseparable mixture of 2 (6 mg) and 3 (5
mg). Fractions 11-13 (1.2 g) after combination was subjected to rechromatography on same
column of silica gel. The column was eluted using increasing concentrations of ethyl acetate in
petroleum ether to end up with nine (1.1-1.9) pooled fractions.
Fractions 1.4 & 1.5 were combined together (1.3 g) based on TLC behaviour and was
chromatographed over a silica gel column. The column was eluted using chloroform, 5%
methanol in chloroform and 10% methanol in chloroform, successively. The 5% methanol in
174
chloroform elution resulted in three (1.4.1–1.4.3) fractions. Repeated column chromatography of
these fractions resulted in the isolation of compound 4 (23 mg) and 5 ( 15 mg).
Fractions 6-8 (1.7 g) were combined and chromatographed over silica gel column using
chloroform as eluent and the polarity was increased by methanol. Ten (6.1-6.10) fractions were
collected. Fraction 6.1.4-6.1.7 (350 mg) was applied to a reversed-phase preparative HPLC on a
LiChrosorb RP-18 column (7 μm , 2 × 30 cm i.d, Merck), eluted with MeOH-H2O (80/20) at the
rate of 10 mL/min. (tR = 7.5 min), to afford pure compounds (1) (31.3 mg), (tR = 7.9 min) (2), (tR
= 8.1 min) (25.5 mg), (tR = 8.4 min) (3) (31.7 mg), (tR = 8.7 min) (4) (15.8 mg) and (tR = 9.3 min)
(5) (37.6 mg), respectively displayed in Scheme 1.
175
Scheme 1. Extraction of compounds 1-5
176
Scheme 2. Extraction of compounds 6-13 and solvent fractionation of MeOH extract
177
3.6.2. Crude seed extract, solvent fractionation and isolation of 6-13
The air dried and pulverized seeds of C. sativum (5000 g), were macerated at room temperature
(25 °C) in methanol (30 L) for 24 hours and extracted three times. The combined methanolic
extracts were concentrated to dryness (( 400 g). The concentrated brownish methanolic extract
(350 g) was dissolved in distilled water (1 L). It was first defatted with n-hexane (3 × 250 mL,
SHF, 77.28 g) followed by ethyl acetate (3 × 250 mL, SEF, 91.04 g), n-butanol (3 × 50 mL,
SBF, 90.56 g) and water fraction (SWF, 114.48 g) as displayed in Scheme 2. These fractions
were subjected to biological (antibacterial and antifungal) activities (Histograms 1-4).
The ethyl acetate extract (91.04 g) was found to be active against the fungal strains C. albicans C.
neoformans, M. audouinii, T. rubrum, T. mentagrophytes, E. Floccosum, M. canis and A niger.
Bacteria employed for determination of activity were E. coli, P. mirabilis, P. aeruginosa, M.
luteus, E. coli, B. cereus, S. aureus and K. pneumoniae so it was subjected to vacuum liquid
chromatography (VLC) (hexane: chloroform and chloroform: methanol) on silica gel (900 g, 60
PF254 Merck) followed by column chromatography on silica gel (70±230 mesh size). The column
was eluted with a chloroform and methanol mixture with increasing amounts of methanol to
afford twenty (1-20) fractions 250 mL each. Fraction 4 eluted with CHCl3: MeOH (90:10)
afforded compound 1 (49.8 mg), Fraction 6 after elution with CHCl3: MeOH (85:15) yielded
compound 2 (30.1 mg) while on elution with CHCl3: MeOH (80:20) gave compound 3 (79.6 mg).
Fractions 9-14 were combined together (2.38 g) using solvent system Pet. Ether:CHCl3: MeOH
(5:60:25) based on TLC behavior and was subjected to purification on preparative HPLC Perkin
Elmer RP-18 column (250 × 2.5 cm), using MeCN/ H2O, gradient scheme (A = H2O; B =
MeCN/H2O 88/ 12; 5 min A, linear gradient to B in 20 min, 5 min B, linear gradient back to A in
2 min at 2 mL/min flow rate), as a mobile phase, to afford pure compounds with tR 5.6 min. (6,
178
131.3 mg), with tR 6.8 min. (7, 125.3 mg), with tR 7.2 min. (8, 130.1. mg), with tR 7.9 min. (9,
151.5 mg), with tR 8.7 min. (10, 127.4 mg), with tR 9.6 min. (11,137.6 mg), and with tR 10.6 min.
(12, 155.3 mg), and with tR 11.3 min. (13,152.5 mg), respectively. The pure compounds were
subjected to spectroscopic study for structure elucidation. After spectral analysis, compounds 6-
13 displayed were identified (Scheme 2).
3.7. Physical and Spectroscopic Data of Isolates
3.7.1. 1-Oxo-11β,21β-dihydroxyoleane (1)
White solid needles, crystals, m.p. 255-258 ºC; [α]25
D + 5.43 (c 1.4, CHCl3); UV (MeOH) λmax
(log ) 216 (1.56) nm; IR (dry) νmax 3532, 3404, 2940, 2870, 1620, 1450, 1250, 760 cm-1
; 1
H-,
13C-NMR (300 MHz, 75 MHz, C5D5N) Tables 3 and 4; EI-MS: m/z= 458 (M
+, 3, C30H50O3),
440 (12, M+-H2O), 430 (27, M
+-CO), 422 (15, M
+-2H2O), 291 (10, C19H31O2
+), 263 (11,
C18H31O+), 249 (23, C16H25O2
+), 207 (31, C14H23O
+), (100, ), 189 (43, C14H21
+), 135 (42,
C9H11O+), 109 (34, C7H9O
+), 95 (44, C7H11
+); HR-EI-MS: m/z=458.7162, calcd. for C30H50O3;
458.7158 observed.
3.7.2. 1-Oxo-11β-hydroxy-21β-O-acetyloleane (2)
White solid, crystals, m.p. 291-293 ºC; [α]25
D + 4.43 (c 1.4, CHCl3); UV (MeOH) λmax (log)
247 (1.7) nm; IR (dry) νmax 3436, 2965, 2879, 1728, 1712, 1458, 1266, 779 cm-1
; 1
H-, 13
C-NMR
(300 MHz, 75 MHz, C5D5N) Tables 3 and 4; EI-MS: m/z= 500 (M
+, 3, C32H52O4), 482 (15,
M+-H2O), 472 (21, M
+-CO), 440 (15, M
+-MeCO2H), 291 (10,), 263 (11, C18H31O
+), 249 (23,
C16H25O2+), 207 (31, C14H23O
+), (100, C5H8O2
+), 189 (43, C14H21
+), 135 (42, C9H11O
+), 109
(34, C7H9O+), 95 (44, C7H11
+), 43 (46); HR-EI-MS: m/z= 500.7529, calcd. for C32H52O4;
500.7515 observed.
179
3.7.3. 1-Oxo-11β-hydroxy-21β-O-angeloyloleane (3)
White solid, crystalline, m.p. 258-260 ºC; [α]25
D + 5.43 (c 1.4, CHCl3); UV (MeOH) λmax (log )
308 (4.28) and 214 (4.26), 267 (3.7) nm; IR (dry) νmax 3348 (OH), 2947, 2877, , 1723 (C=C-
CO2), 1707 (CO), 1599, 1534 (C=C), 1451, 1256, 767 cm-1
; 1
H-, 13
C-NMR (300 MHz, 75 MHz,
C5D5N) Tables 3 and 4; EI-MS: m/z = 540 (M+, 3, C35H56O4), 518 (12, M
+-H2O), 512 (27, M
+-
CO), 440 (15, M+-C5H8O2), 291 (10, C19H31O2
+), 263 (11, C18H31O
+), 249 (23, C16H25O2
+), 207
(31, C14H23O+), (100, C5H8O2
+), 189 (43, C14H21
+), 135 (42, C9H11O
+), 109 (34, C7H9O
+), 95
(44, C7H11+), 83 (45), 82 (34); HR-EI-MS: m/z= 540.8167, calcd. for C35H56O4; 540.8143
observed.
3.7.4. 1-Oxo-11β-O-angeloyl-21β-O-acetyloleane (4)
White solid, amorphous, m.p. 267-268 ºC; [α]25
D + 6.43 (c 1.4, CHCl3); UV (MeOH) λmax (log )
347 (4.55), 284 (4.56), 253 (4.22) 234 (2.7) nm; IR (dry) νmax 2955, 2885, 1738, 1690, 1635,
1593, 1465, 1260, 926, 807, 764 cm-1
; 1H-,
13C-NMR (300 MHz, 75 MHz, C5D5N) Tables 3 and
4; EI-MS: m/z = 582 (M+, 3, C37H58O5), 564 (12, M
+-H2O), 554 (27, M
+-CO), 522 (15, M
+-
MeCO2H), 464 (15, M+-C5H8O2), 291 (10, C19H31O2
+), 263 (11, C18H31O
+), 249 (23,
C16H25O2+), 207 (31, C14H23O
+), (100, C5H8O2
+), 189 (43, C14H21
+), 135 (42, C9H11O
+), 109 (34,
C7H9O+), 95 (44, C7H11
+), 83 (45), 82 (56), 43 (78); HR-EI-MS: m/z= 582.8334, calcd. for
C37H58O5; 582.8343, observed.
3.7.5. 1-Oxo-11β,21β-O-dibenzoyloleane (5)
White solid, crystals, m.p. 264-268 ºC; [α]25
D + 5.43 (c 1.4, CHCl3); UV (MeOH) λmax (log )
349 (4.55), 286 (4.56), 254 (4.22), 247 (1.7) nm; IR (dry) νmax 3133, 2940, 2870, 1745, 1620,
1527, 1450, 1250, 923, 806, 791, 760 cm-1
; 1
H-, 13
C-NMR (300 MHz, 75 MHz, C5D5N) Tables
3 and 4; EI-MS: m/z= 666 (M
+, 3, C44H54O5), 440 (12, M
+-H2O), 430 (27, M
+-CO), 422 (15,
180
M+-2H2O), 291 (10, C19H31O2
+), 263 (11, C18H31O
+), 249 (23, C16H25O2
+), 207 (31, C14H23O
+),
(100, ), 189 (43, C14H21+), 135 (42, C9H11O
+), 105 (34, C7H5O
+), 109 (34, C7H9O
+), 95 (44,
C7H11+), 77 (23, C6H5
+), 65 (23, C5H5
+); HR-EI-MS: m/z= 666.9283, calcd. for C44H54O5;
666.9273 observed.
3.7.6. 28-β-D-Glucopyranosyl 2α,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (6).
Amorphous powder, m.p. 248-250 °C; [α] + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3453,
3452, 3303 (OH), 3021, 2918, 2859, 1748 (CO), 1727 (CO2), 1653, 1641 (C=C), , 1531, 1471,
1434, 1383, 1217, 1021, 923, 847; 1H-,
13C-NMR (300 MHz, 75 MHz, C5D5N) Tables 11 and
13; Positive ion FAB-MS m/z= 689 [M + Na]+; HR positive ion FAB-MS m/z= 689.3877
(Calcd. for C36H58O11: 689.3877).
3.7.7. 28-β-D-Glucopyranosyl 2β,3α,19α,24-tetrahydroxy-12-ene-oleaenoate (7)
Amorphous powder, m.p. 250-252 °C; [α] + 1.9º (c = 1.5, C5H5N); IR νmax (dry) cm
-1: 3445,
3431, 3316 (OH), 3024, 2914, 2853, 1747, 1723, 1646, 1531, 1476 (C=C), 1438, 1356, 1221,
1025, 929, 845; 1H-,
13C-NMR (300 MHz, 75 MHz, C5D5N) Tables 11 and 13; Positive ion
FAB-MS m/z= 689 [M + Na]+; HR positive ion FAB-MS m/z= 689.3877 (Calcd. for C36H58O11:
689.3877).
3.7.8. 28-β-D-Glucopyranosyl 2α,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (8)
Amorphous powder, m.p. 249-252 °C; [α]D 25 + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3466,
3462, 3311 (OH), 3021, 2918, 2859, 1744, 1721, 1649, 1538, 1477 (C=C), 1434, 1355, 1216,
1022, 924, 849; 1H-, 13
C-NMR (C5D5N, 300 MHz, 75 MHz) Tables 11 and 13; Positive ion
FAB-MS m/z= 689 [M + Na]+; HR positive ion FAB-MS m/z= 689.3877 (Calcd. for C36H58O11:
689.3877).
181
3.7.9. 28-β-D-Glucopyranosyl 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (9)
Amorphous powder, m.p. 248-250 °C; [α] + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3460,
3443, 3333, (OH), 1738, 1724, 1531 (C=C), 1219, 1044, 923, 846; 1H-,
13C-NMR (C5D5N, 300
MHz, 75 MHz) Tables 11 and 13; Positive ion FAB-MS m/z= 689 [M + Na]+; HR positive ion
FAB-MS m/z= 689.3877 (Calcd. for C36H58O11: 689.3877).
3.7.10. 28-β-D-Glucopyranosyl 2β,3β,19α,24-tetrahydroxy-12-ene-oleaenoate (10)
Amorphous powder, m.p. 247-250 °C; [α] + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3466,
3399, 3277, (OH), 1748, 1727, 1591 (C=C), 1219, 1025, 923, 845; 1H-,
13C-NMR (C5D5N, 300
MHz, 75 MHz) Tables 12 and 13; Positive ion FAB-MS m/z= 689 [M + Na]+; HR positive ion
FAB-MS m/z= 689.3877 (Calcd. for C36H58O11: 689.3877).
3.7.11. 28-β-D-Glucopyranosyl 2α-O-acetyl, 3α, 19α, 24-tetrahydroxy-12-ene-oleaenoate (11)
Amorphous powder, m.p. 253-255 °C; [α] + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3455,
3305 (OH), 1744, 1715( CO), 1585, (C=C), 1217, 1021, 923, 847; 1H-,
13C-NMR (C5D5N, 300
MHz, 75 MHz) Tables 12 and 13; Positive ion FAB-MS m/z= 731 [M + Na]+; HR positive ion
FAB-MS m/z= 731.3877 (Calcd. for C38H60O12: 731.3877).
3.7.12. 28-β-D-Glucopyranosyl 3α-O-acetyl, 2α, 19α, 24-tetrahydroxy-12-ene-oleaenoate (12)
Amorphous powder, m.p. 254-257 °C; [α] + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3471,
3321 (OH), 1746, 1735, 1587 (C=C), 1217, 1021, 923, 847; 1H-,
13C-NMR (C5D5N, 300 MHz,
75 MHz) Tables 12 and 13; Positive ion FAB-MS m/z= 731 [M + Na]+; HR positive ion FAB-
MS m/z= 731.3877 (Calcd. for C38H60O12: 731.3877).
182
3.7.13. 28-β-D-Glucopyranosyl 19α O-acetyl,2α,3α,24-tetrahydroxy-12-ene-oleaenoate (13)
Amorphous powder, m.p. 253-256 °C; [α] + 2.1º (c = 1.5, C5H5N); IR νmax (dry) cm-1
: 3453,
3303 (OH), 1755, 1724, 1598 (C=C), 1223, 1026, 928, 844; 1
H-, 13
C-NMR (C5D5N, 300 MHz, 75
MHz) Tables 12 and 13; Positive ion FAB-MS m/z=731 [M + Na]+; HR positive ion FAB-MS
m/z= 731.3877 (Calcd. for C38H60O12: 731.3877).
3.8. Biological Activities
3.8.1. Antifungal and antibacterial activity
Antifungal/antibacterial activities of pure compounds essential, seed hexane fraction (SHF) seed
ethyl acetate fraction (SEF), seed butanol fraction (SBF)) and seed water fraction (SWF) were
determined according to a standard protocol (Chandrasekaran and Venkatesalu, 2004). For
antibacterial activity solutions of extracts (200µg/disc) were laid on top of the inoculated agar
plates and incubated for 36 hours at 28° C for fungi and 24 hours at 37 °C for bacteria. The
standard drugs Miconazole and Imipenem 30 µg/disc was used as a positive control. Zones of
inhibition for essential oil and extracts were measured in millimeters. Each assay in this
experiment was replicated three times.
Mninimum inhibitory concentrations (MICs) of essential oils and crude extracts (SHF, SEF, SBF
and SWF) were measured by following standard protocols (EUCAST Definitive Document 2000,
2012). Stock solutions of essential oil, seed hexane fraction (SHF) seed ethyl acetate fraction
(SEF), seed butanol fraction (SBF)) and seed water fraction (SWF) having concentrations of
10000 mg/L were prepared in DMSO (2 mL). From the stock solutions concentration ranges of
512-0.125 mg/L were prepared in 25 mL containers by serial dilution technique. Molten agar
183
(≈19 mL; total volume in each container was 20 mL) was then added to each container and the
mixture were thoroughly mixed and poured into pre-labeled 9 cm sterile petri dishes and let dry.
The inoculum was prepared by emulsifying overnight colonies (4-5 morphologically similar)
from a potato dextrose agar (Oxoid) at 28 °C for fungal strains and a Mueller-Hinton agar (Oxid,
Hamshire, UK) at 37 ºC for bacterial strain. A 0.5 McFarland was used as a standard to get a
suspension having a density equivalent to 108 CFU/mL. The plates were inoculated within 30
min of standardizing the inoculum. The inoculum 1µL (104 CFU/spot) was transferred to each
plate employing replicator pins 2.5 mm in diameter. The plates were incubated for antifungal
activity at 28 °C and for antibacterial at 37 °C in air for 18 h and the MICs values were
determined by noticing the minimum concentration of essential oil and fractions that on plates
had inhibited the fungal/bacterial growth approximately more than 90%.
Antimicrobial activity of 1-5 was procured by following standard method. Briefly, LB medium
20 mL was poured in petri plates and after solidification standard inoculum (100 µL)
bacteria/fungi concentration 107 CFU/mL suspension was poured and dried for 5 min. Filter
paper discs (50 µg/disc, 6 mm diameter) were impregnated with 1-5 solution obtained in 5%
DMSO that was used as negative control, and standard drugs (Miconazole, and Imipenem (10
µg/disc) as a positive control) were incubated at 37 ºC for 24 h and zone of inhibition was
measured.
The MIC of compounds 1-5 was determined by following standard twofold serial dilution method
(Chandrasekaran and Venkatesalu, 2004). Solution of tested compounds (in 5% DMSO) were
prepared, and incorporated into LB broth medium to get 500 µg/mL and serially diluted to
achieve 62.5, 31.25, 15.62, 7.81, 3.95 and 1.97 µg/mL. A suspension (10 µL) of each tested
organism (107 CFU/mL) was transferred to each tube (compound containing tubes and control
184
tubes), were incubated at 37 ºC for 24 h and the lowest concentration was determined and
expressed as µg/mL. Concentration that inhibit complete growth of bacteria/fungi was identified,
and 50 µL solution of each culture broth was transferred onto the agar plates, incubated at 37 ºC
for 24 h and complete absence of growth on the agar surface was defined as MBC and MFC.
3.8.2. Cytotoxicity
All tumor cells were cultured in RPMI-1640 or DMEM medium (Hyclone, Logan, UT),
supplemented with 10% fetal bovine serum (Hyclone) at 37 ºC in a humidified atmosphere with
5% CO2. Cell viability was assessed by conducting colorimetric measurements of the amount of
insoluble formazan formed in living cells based on the reduction of 3-(4, 5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, MO) (Hu et al., 2005; Monks et al.,
1991). Briefly, 100 mL of adherent cells was seeded into each well of a 96-well cell culture plate
and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just
before drug addition, both with an initial density of 1 × 105 cells/ mL in 100 mL of medium. Each
tumor cell line was exposed to test various plant extracts at various concentrations in triplicate for
48 h, with cisplatin (Sigma) as positive controls. After the incubation, MTT (100 mg) was added
to each well, and the incubation continued for 4 h at 37 ºC. The cells were lysed with 100 mL of
20% SDS/50% DMF after removal of 100 mL of medium. The optical density of the lysate was
measured at 595 nm in a 96-well microtiter plate reader (Bio-Rad 680). The IC50 value of each
fraction was calculated by Reed and Muench’s method. Cytotoxicity of the pure isolated
compounds was also evaluated by adaption of above procedure (Table 14).
3.9. Statistical analysis
The collected data was analyzed, the IC50 values were determined, and their 95% confidence
intervals (CI 95%) were obtained through nonlinear regression using Finney software.
185
TABLES
186
Table 1. Natural product as anticancer drugs
S.No Name of Drug Source Major use Ref.
1 Allicin Allium sativum
Anticancer and antioxidant Kainsa et al., 2012
2 Chelidonine Chelidonium
majus
Anticancer Kainsa et al., 2012
3 Glycyrrhetic
acid
Glycyrrhiza
glabra
Anticancer Kainsa et al., 2012
4 Vinblastine Catharanthus roseus
Antineoplastic Kainsa et al., 2012
5 Vincristine Catharanthus
roseus
Antineoplastic Kainsa et al., 2012
6 Taxol Taxus
baccata Taxus
brevifolia
Nutt
Anticancer Kainsa et al., 2012
7 Cannabinoids Cannabis sativa
Lung-adenocarcinoma Kainsa et al., 2012
8 Salvicine Salvia
prionitis
Malignant tumors Kainsa et al., 2012
9 Berberine Rhizoma
coptidis
Anticancer, epilepsy, diarrhea, antiinflammatory,
antibacterial, antidiabetes, antiulcer, expansion of blood vessels, inhibition of platelet aggregation, hepatoprotective
Lu et al., 2012
10 Evodiamine Evodia
rutaecarpa
Antianxiety, antiobese, antinociceptive, antiinflammatory,
antiallergic,and anticancer
Lu et al., 2012
11 Matrine Sophora
flavescens Ait.
Antibacterial, antiviral, antiinflammatory, antiasthmatic,
antiobesity, anticancer, diuretic, choleretic, hepatoprotective, nephroprotective, and cardioprotective
Lu et al., 2012
12 Piperine Piper nigrum
and
Piper longum
Antioxidant, antiinflammatory, antidiarrheal,
anticonvulsant, antimutagenic, hypolipidemic, promoting
bile secretion, and Antitumor
Lu et al., 2012
13 Sanguinarine Sanguinaria canadensis L.
and
Chelidonium majus L.
Anticancer, antibacterial, antifungal, antischistosomal, antiplatelet, and anti-inflammatory
Lu et al., 2012
14 Tetrandrine Stephania
tetrandra
Anticancer, immunomodulating, antihepatofibrogenetic,
antiinflammatory, antiarrhythmic, antiportal hypertension,
and neuroprotective activities [
Lu et al., 2012
14 Paclitaxel
(Taxol)
Taxus
brevifolia
Ovarian cancer, advanced breast cancer Shoeb, 2006
15 Topotecan Semisynthetic derivative of
Camptothecin
obtained from Camptotheca
acuminate
Ovarian, lung and colo-rectal cancers Shoeb, 2006
16 3-Oxo-
19α,23,24-trihydroxyurs-
12-en-28-oic
acid
Symplocos
chinensis
Anticancer Li et al., 2003
17 Podophyllotoxin Podophyllum species
Podophyllum
peltatum L.
Anticancr
18 Betulinic acid Betula alba Anticancer Nirmala et al., 2011
187
188
189
190
191
Table 2. Quantitative analysis of EO of C. sativum Linn
ID# Name R.Time Area Conc.(%)
2 α-Pinene 8.674 354491 4.28
3 Camphene 9.342 1851 0.02
5 β-Pinene 10.531 31276 0.38
10 o-Cymene 12.726 30140 0.36
11 D-Limonene 12.919 7552 0.09
17 γ-Terpinene 14.320 20498 0.25
19 α-methyl-α[4-methyl-3-pentyl]
oxiranemethanol
15.779 13699 0.17
20 β-Linalool 16.575 6617739 79.86
23 Alcanfor 18.311 3966 0.05
25 1-Terpinen-4-ol 19.418 5217 0.06
27 p-Menth-1-en-8-ol 19.914 27330 0.33
28 n-Decaldehyde 20.130 13209 0,16
30 cis-Geraniol 20.925 2563 0.03
35 α-Citral 21.598 4050 0,05
44 Nerol acetate 23.284 9358 0.11
45 Geraniol acetate 23.620 1142423 13.79
52 α-Limonene diepoxide 25.233 1465 0.02
192
Table 3.1H-NMR (C5D5N, 300 MHz) of compounds 1-5 isolated from C. sativum L. Seeds
C# 1 2 3 4 5
2 2.22 ddd (13, 5.2,
3.5)
1.88 ddd (13, 5.2,
3.5)
1.87 ddd (13, 5.2, 3.5) 1.86 ddd (13, 5.2, 3.5) 1.87 ddd (13, 5.2, 3.5)
3 1.97 dd (13, 5.2) 2.24 dd (5, 12) 2.25 dd (4.5, 12) 2.24 dd (4.5, 12) 4.35 dd (4.5, 12)
5 1.83 d (11.5) 1.72 d (11.5) 1.74 d (11.5) 1.73 d (11.5) 1.76 d (11.5)
6 2.17 dd (14, 6.5) 2.19 dd (6.5, 14) 2.17 dd (6.5, 14) 2.18 dd (6.5, 14) 2.17 dd (6.5, 14)
7α 2.89 ddd (16.5, 12.5,
6.5)
2.87 ddd (16.5,
12.5, 6.5)
2.87 ddd (16.5, 12.5,
6.5)
2.84 ddd (16.5, 12.5,
6.5)
2.83 ddd (16.5, 12.5,
6.5)
7β 2.74 dd (16.5, 5.0) 2.71 dd (16.5, 5.0) 2.69 dd (16.5, 5.0) 2.68 dd (16.5, 5.0) 2.69 dd (16.5, 5.0)
9 1.64 dd (14, 6.5) 1.65 dd (14, 6.5) 1.66 dd (14, 6.5) 1.62 dd (14, 6.5) 1.63 dd (14, 6.5)
11 3.29 ddd (14, 6.5,
4.2)
4.23 ddd (3.0, 13.5,
13.5)
4.47 ddd (3.0, 13.5,
13.5)
4.29 ddd (3.0, 13.5,
13.5)
4.29 ddd (3.0, 13.5,
13.5)
12 1.88 ddd (14.1, 4.5,
12.2)
5.79 ddd (14.1, 4.5,
12.2)
5.77 ddd (14.1, 4.5,
12.2)
5.77 ddd (14.1, 4.5,
12.2)
5.78 ddd (14.1, 4.5,
12.2)
13 2.01 dd (12.2, 4.5) 2.02 dd (12.2, 4.5) 2.05 dd (12.2, 4.5) 2.06 dd (12.2, 4.5) 2.07 dd (12.2, 4.5)
15α 2.44 ddd (13.5, 13.5,
3.0)
2.43 ddd (13.5,
13.5, 3.0)
2.44 ddd (13.5, 13.5,
3.0)
2.45 ddd (13.5, 13.5,
3.0)
2.44 ddd (13.5, 13.5,
3.0)
15β 1.46 ddd (13.5, 13.5,
3.1)
1.47 ddd (13.5,
13.5, 3.1)
1.46 ddd (13.5, 13.5,
3.1)
1.45 ddd (13.5, 13.5,
3.1)
1.46 ddd (13.5, 13.5,
3.1)
16α 2.53 ddd (13.5, 13.5,
3.0)
2.55 ddd (13.5,
13.5, 3.0)
2.52 ddd (13.5, 13.5,
3.0)
2.51 ddd (13.5, 13.5,
3.0)
2.54 ddd (13.5, 13.5,
3.0)
16β 1.56 ddd (13.5, 13.5,
3.0)
2.57 ddd (13.5,
13.5, 3.0)
1.56 ddd (13.5, 13.5,
3.0)
1.55 ddd (13.5, 13.5,
3.0)
1.56 ddd (13.5, 13.5,
3.0)
18 1.78 ddd (12.5, 12.5,
3.5)
1.77 ddd (12.5,
12.5, 3.5)
1.78 ddd (12.5, 12.5,
3.5)
1.79 ddd (12.5, 12.5,
3.5)
1.78 ddd (12.5, 12.5,
3.5)
19α 1.71 ddd (14.5, 11.5,
4.0)
1.70 ddd (14.5,
11.5, 4.0)
1.71 ddd (14.5, 11.5,
4.0)
1.72 ddd (14.5, 11.5,
4.0)
1.73 ddd (14.5, 11.5,
4.0)
19β 1.17 dd (14.5, 4.0) 1.16 dd (14.5, 4.0) 1.19 dd (14.5, 4.0) 1.18 dd (14.5, 4.0) 1.17 dd (14.5, 4.0)
21 3.46 ddd (13.5, 13.5,
3.0)
4.46 ddd (13.5,
13.5, 3.0)
4.57 ddd (13.5, 13.5,
3.0)
4.29 ddd (13.5, 13.5,
3.0)
4.46 ddd (13.5, 13.5,
3.0)
22α 2.91 ddd (13.5, 13.5,
2.5)
2.90 ddd (13.5,
13.5, 2.5)
2.93 ddd (13.5, 13.5,
2.5)
2.92 ddd (13.5, 13.5,
2.5)
2.97 ddd (13.5, 13.5,
2.5)
22β 1.91 dd (13.5, 13.5) 1.92 dd (13.5, 13.5) 1.95 dd (13.5, 13.5) 2.89 dd (13.5, 13.5) 1.90 dd (13.5, 13.5)
23 1.66 s 1.67 s 1.65 s 1.66 s 1.65 s
24 1.07 s 1.08 s 1.09 s 1.09 s 1.10 s
25 1.13 s 1.12 s 1.09 s 1.08 s 1.14 s
26 1.16 s 1.17 s 1.18 s 1.15 s 1.19 s
27 1.55 s 1.56 s 1.58 s 1.61 s 1.60 s
28 1.17 s 1.15 s 1.14 s 1.18 s 1.17 s
29 1.38 s 1.37 s 1.36 s 1.39 s 1.37 s
30 0.97 s 0.98 s 0.97s 0.96 s 0.99 s
1H-NMR (300 MHz, C5D5N) data of acid residues in 2-5
Ac Ang Bz
1 2.29 s
2 8.04, 1H, d, J=7.2 Hz
3 6.13, 1H, qq, J=6.6 Hz 7.41, 1H, t, J=7.2 Hz
4 2.01, 3H, dq, J=6.5, 2.5 Hz 7.53, 1H, dt, J=7.2, 2.5 Hz
5 1.93, 3H, dqm, J= 6.5, 2.2 Hz 7.41, 1H, t, J=7.2 Hz
6 8.04, 1H, d, J=7.2 Hz
193
Table 4.13
C-NMR (DEPT, C5D5N, 75 MHz) of compounds 1-5 isolated from C. sativum L. Seeds
C# 1 2 3 4 5
1 214.7 s
214.5 s 214.2 s 214.8 s 214.9 s
2 68.2 t 67.9 t 68.4 t 68.3 t 68.5 t
3 47.9 t 47.8 t 47.7 t 47.6 t 47.5 t
4 45.7 s 45.5 s 45.8 s 45.9 s 46.1 s
5 56.7 d 56.6 d 56.9 d 56.6 d 56.7 d
6 19.5 t 19.6 t 19.4 t 19.3 t 19.8 t
7 35.5 t 35.4 t 35.5 t 35.5 t 35.6 t
8 40.4 s 40.3 s 40.3 s 40.2 s 40.3 s
9 50.6 d 50.6 d 50.6 d 50.6 d 50.6 d
10 38.8 s 38.8 s 38.7 s 38.8 s 38.9 s
11 71.4 d 77.4 d 78.1 d 77.9 d 77.8 d
12 43.7 t 44.6 t 44.6 t 44.5 t 44.6 t 13 51.3 d 54.4 d 54.8 d 54.7 d 54.5 d
14 42.1 s 42.4 s 42.3 s 42.7 s 42.6 s
15 29.1 t 29.0 t 29.2 t 29.3 t 29.1 t
16 27.9 t 28.0 t 28.4 t 27.9 t 28.3 t
17 46.5 s 46.6 s 46.7 s 46.4 s 46.5 s
18 44.6 d 44.8 d 44.5 d 44.6 d 44.9 d
19 27.1 t 27.3 t 27.8 t 27.6 t 27.5 t
20 35.7 s 35.5 s 35.4 s 35.5 s 35.5 s
21 72.8 d 78.8 d 78.8 d 81.8 d 81.8 d
22 42.9 t 43.0 t 43.5 t 43.6 t 44.1 t
23 24.1 q 24.2 s 24.0 s 24.1 s 24.2 s
24 23.5 q 23.7 s 23.8 s 23.8 s 23.5 s
25 17.5 q 17.4 s 17.6 s 17.5 s 17.4 s
26 17.4 q 17.3 s 17.3 s 17.1 s 17.4 s
27 24.9 q 24.7 s 24.8 s 24.8 s 24.9 s
28 25.1 q 25.5 s 25.6 s 25.7 s 25.5 s
29 28.8 q 28.7 s 28.6 s 28.8 s 28.9 s
30 24.6 q 24.8 s 24.9 s 24.6 s 24.8 s 13
C-NMR (75 MHz, C5D5N) data of acid residues in 2-5
Ac Ang Bz
1 176.2 168.3 164.6 s
2 22.3 128.0 129.7 d
3 137.3 130.0 d
4 15.9 128.4 d
5 20.6 133.7 d
6 128.4 d
7 130.0 d
194
Table 5. Inhibition zones of 1-5 isolated from C. sativum against bacteria
Zone of inhibition (mm) of 1-5
Comp/Organism 1 2 3 4 5 Std*
E. coli 7.1±1.2 22±2 17±2 8±2 8±2 28±1.2
S. aureus 3.6±1.2 23±2 16±2 8±2 18±2 31±1.2
P. mirabilis 2.4±1.2 22±2 19±2 21±2 10±2 29±1.2
P. aeruginosa 2.2±1.2 29±2 21±2 29±2 19±2 33±1.2
B. cereus 2.2±1.2 23±2 22±2 8±2 8±2 27±1.2
K. pneumonia 0 0 17±2 8±2 8±2 29±1.2
M. luteus 0 0 8±2 8±2 17±2 37±1.2
Entero Coli 0 0 0 0 0 34±1.2
* Imipenem was used as standard
195
Table 6. Inhibition zones of 1-5 isolated from C. sativum against fungi
* Miconazole was used as standard
Zone of inhibition (mm) of 1-5
Comp/Organism 1 2 3 4 5 Std*
T. rubrum 9.1±2 7±2 3±2 2±2 1±2 29±2
C. albicans 7.6±2 5±2 3±2 2±2 2±2 31±2
M. audouinii 5.4±2 6±2 2±2 2±2 1±2 24±2
C. neoformans 6.2±2 6±2 2±2 3±2 1±2 26±2
T. mentagrophytes 9.±2 5±2 3±2 2±2 1±2 29±2
E. floccosum 6.3±2 6±2 3±2 1±2 2±2 27±2
M. canis 7.6±2 3±2 3±2 3±2 1±2 28±2
A. niger 2.3±2 0 3±2 3±2 1±2 28±2
196
Table 7. MICs of 1-5 isolated from C. sativum against bacterial strains
MIC (µg/mL) of compounds 1-5 against Bacterial strains
Compd E. coli P.
mirabilis
P.
aeruginosa
M.
luteus
Entero
Coli
K.
pneumonia
B.
cereus
S.
aureus
1 4±0.5 8±1.5 8±1.5 4±0.5 3±0.5 4±0.5 4±0.5 4±0.5
2 4±0.5 8±1.5 8±1.5 4±0.5 4±0.5 8±1.5 8±1.5 4±0.5
3 4±0.5 16±2.0 8±1.5 8±1.5 5±0.5 16±1.5 16±1.5 4±0.5
4 8±0.5 16±1.5 8±1.0 5±0.5 4±0.5 16±1.5 4±0.5 4±0.5
5 64±2.0 32±2.0 32±2.0 4±0.5 4±0.5 64±2.0 64±2.0 64±2.0
197
Table 8. MICs of 1-5 from C. sativum against fungal strains
MIC (µg/mL) of compounds 1-5 against Fungal strains
Comp/
Organism
C.
albicans
C.
neoformans
M.
audouinii
A.
niger
T.
mentagrophytes
E.
floccosum
M.
canis
T.
rubrum
1 4±0.5 4±0.5 8±0.5 0 8±0.5 16±0.5 0 16±1.5
2 4±0.5 8±1.5 16±1.5 0 16±0.5 16±0.5 0 16±1.5
3 4±0.5 8±1.5 16±1.5 0 16±0.5 32±0.5 16±1.5 32±2.0
4 8±1.5 8±1.5 16±1.5 0 64±2.5 32±1.5 16±1.5 16±1.5
5 16±1.5 64±2.0 16±1.5 0 32±1.5 32±2.0 16±1.5 8±1.5
198
Table 9. MBCs of 1-5 from C. sativum against bacterial strains
MIC (µg/mL) of compounds 1-5 against Bacterial strains
Compd/
Organism
E. coli P.
mirabilis
P.
aeruginosa
M.
luteus
Entero
Coli
K.
pneumoniae
B.
cereus
S. aureus
1 8±1.5 16±1.5 16±1.5 8±1.5 0 8±1.5 9±1.5 8 ±1.5
2 8±1.5 16±1.5 16±1.5 9±1.5 0 16±1.5 16±1.5 8±1.5
3 8±1.5 33±1.5 16±1.5 16±1.5 0 32±1.5 33±1.5 8±1.5
4 17±1.5 32±1.5 16±1.5 0 0 33±1.5 9±1.5 9±1.5
5 123±1.5 65±1.5 65±1.5 0 0 124±1.5 125±1.5 124±1.5
.
199
Table 10. MFCs of 1-5 from C. sativum Seeds against fungal strains
MIC (µg/mL) of compounds 1-5 against Fungal strains
Cmpd C.
albicans
C.
neoformans
M.
audouinii
A.
niger
T.
mentagrophytes
E.
floccosum
M.
canis
T.
rubrum
1 9±1.5 9±1.5 17±1.5 0 17±1.5 31±1.5 0 31±1.5
2 9±1.5 16±1.5 31±1.5 0 31 31 0 31±1.5
3 9±1.5 16±1.5 31±1.5 0 31±1.5 63±1.5 32±1.5 63±1.5
4 16±1.5 16±1.5 31±1.5 0 122±1.5 61±1.5 3±1.52 31±1.5
5 32±1.5 112±1.5 31±1.5 0 62±1.5 61±1.5 32±1.5 16±1.5
200
Table 11. 1H-NMR (300 MHz, C5D5N) data of 6-9 isolated from C. sativum
Aglycone 6 7 8 9
H-C(1α) 2.01 ddd, (12.5, 3.5, 3.5) 2.08 ddd, (12.5, 3.5, 3.5) 2.09 ddd, (12.5, 3.5, 3.5) 2.02 ddd, (12.5, 3.5, 3.5)
H-C(1β) 1.41 dd, (12.5, 3.5) 1.43 dd, (12.5, 3.5) 1.44 dd, (12.5, 3.5) 1.40 dd, (12.5, 3.5)
H-2 4.46 ddd (3.0, 3.0, 12.0) 3.56 ddd (3.0, 3.0, 12.0) 4.45 ddd (3.0, 3.0, 12.0) 4.46 ddd (3.0, 3.0, 12.0)
H-3 4.58 d (3.0) 4.59 d (3.0) 4.65 d (3.0) 4.58 d (3.0)
H-5 1.87 d (12.0) 1.88 d (12.0) 1.86 d (12.0) 1.87 d (12.0)
H-C(6α) 1.56 dddd, (12.6, 5.5, 3.5,
3.5)
1.61 dddd, (12.5, 5.5, 3.5,
3.5)
1.58 dddd, (12.6, 5.5, 3.5,
3.5)
1.58 dddd, (12.6, 5.5, 3.5,
3.5)
H-C(6β) 1.37 ddd, (12.6, 5.5, 3.5) 1.33 ddd, (12.6, 5.3, 3.5) 1.39 ddd, (12.6, 5.4, 3.5) 1.33 ddd, (12.6, 5.5, 3.7)
H-C(7α) 1.65 ddd, (16.5, 6.6, 3.5) 1.68 ddd, (16.6, 6.5, 3.5) 1.69 ddd, (16.6, 6.5, 3.5) 1.65 ddd, (16.6, 6.5, 3.5)
H-C(7β) 1.49 dd, (12.5, 5.5) 1.46 dd, (12.5, 5.5) 1.48 dd, (12.5, 5.5) 1.47 dd, (12.5, 5.5)
H-C(9) 1.64 dd, (13.5, 6.5) 1.66 dd, (13.5, 6.5) 1.65 dd, (13.5, 6.5) 1.67 dd, (13.5, 6.5)
H-C(11α) 2.08 ddd, (8.3, 4.4, 2.5) 2.07 ddd, (8.5, 4.3, 2.5) 2.09 ddd, (8.5, 4.4, 2.5) 2.04 ddd, (8.5, 4.5, 2.5)
H-C(11β) 1.88 dd, (13.5, 4.5) 1.85 dd, (13.3, 4.5) 1.86 dd, (13.4, 4.5) 1.85 dd, (13.5, 4.4)
H-12 5.50 d (3.0) 5.49 d (3.0) 5.51 d (3.0) 5.50 d (3.0)
H-15 2.36 ddd (3.0, 13.5, 13.5) 2.36 ddd (3.0, 13.5, 13.5) 2.36 ddd (3.0, 13.5, 13.5) 2.36 ddd (3.0, 13.5, 13.5)
H-16 2.80 ddd (3.0, 13.5, 13.5) 2.82 ddd (3.0, 13.5, 13.5) 2.81 ddd (3.0, 13.5, 13.5) 2.78 ddd (3.0, 13.5, 13.5)
H-17 3.07 ddd (4.5, 13.5, 13.5) 3.08 ddd (4.5, 13.5, 13.5) 3.09 ddd (4.5, 13.5, 13.5) 3.10 ddd (4.5, 13.5, 13.5)
H-18 3.12 br s 3.12 br s 3.12 br s 3.12 br s
H-19 3.65 d (4.0) 4.54 d (4.0) 3.58 d (4.0) 4.62 d (4.0)
H-C(21α) 2.11 dddd, (13.2, 13.2,
4.5, 4.2)
2.14 dddd, (13.3, 13.1, 4.5,
4.2)
2.15 dddd, (13.3, 13.2,
4.5, 4.2)
2.12 dddd, (13.3, 13.2, 4.5,
4.2)
H-C(21β)
1.77 ddd, (13.4, 13.2, 3.3) 1.73 ddd, (13.5, 13.2, 3.5) 1.74 ddd, (13.5, 13.2, 3.7) 1.79 ddd,(13.5, 13.5, 3.5)
H-C
(22α)
2.10 ddd, (13.5, 13.5, 3.5) 2.06 ddd,(13.5, 13.5, 3.5) 2.05 ddd, (13.5, 13.5, 3.5) 2.12 ddd, (13.5, 13.5, 3.5)
H-C(22β) 1.51 dd, (13.5, 13.5) 1.45 dd, (13.5, 13.4) 1.41 dd, (13.5, 13.3) 1.48 dd, (13.5, 13.2)
H-23 1.66 s 1.64 s 1.67 s 1.69 s
Hα -24 4.13 d (11.5) 4.10 d (11.5) 4.15 d (11.5) 4.14 d (11.5)
Hβ -24 3.85 d (11.5) 3.85 d (11.5) 3.85 d (11.5) 3.85 d (11.5)
H-25 1.09 s 1.10 s 1.08 s 1.07 s
H-26 1.17 s 1.18 s 1.16 s 1.17 s
H-27 1.54 s 1.56 s 1.55 s 1.53 s
H-29 1.14 s 1.13 s 1.18 s 1.15 s
H-30 0.98 s 0.99 s 0.97 s 0.96 s
Glc
H-1 6.36 d (8.5) 6.37 d (8.5) 6.35 d (8.5) 6.34 d (8.5)
H-2 4.21 dd (8.5, 9.0) 4.20 dd (8.5, 9.0) 4.22 dd (8.5, 9.0) 4.19 dd (8.5, 9.0)
H-3 4.29 dd (9.0, 9.0) 4.28 dd (9.0, 9.0) 4.30 dd (9.0, 9.0) 4.31 dd (9.0, 9.0)
H-4 4.36 dd (9.0, 9.0) 4.37 dd (9.0, 9.0) 4.39 dd (9.0, 9.0) 4.34 dd (9.0, 9.0)
H-5 4.02 ddd (2.5, 4.5, 9.0) 4.03 ddd (2.5, 4.5, 9.0) 4.01 ddd (2.5, 4.5, 9.0) 4.04 ddd (2.5, 4.5, 9.0)
Hα -6 4.45 dd (2.5, 12.0) 4.48 dd (2.5, 12.0) 4.47 dd (2.5, 12.0) 4.49 dd (2.5, 12.0)
Hβ -6 4.39 dd (4.5, 12.0) 4.40 dd (4.5, 12.0) 4.38 dd (4.5, 12.0) 4.41 dd (4.5, 12.0)
201
Table 12. 1H-NMR (300 MHz, C5D5N) data of 10-13 isolated from C. sativum
Aglycone 10 11 12 13
H-C(1α) 2.03 ddd, (12.5, 3.5, 3.5) 2.06 ddd, (12.5, 3.5, 3.5) 2.08 ddd, (12.5, 3.5, 3.5) 2.03 ddd, (12.5, 3.5, 3.5)
H-C(1β) 1.39 dd, (12.5, 3.5) 1.42 dd, (12.5, 3.5) 1.49 dd, (12.5, 3.5) 1.38 dd, (12.5, 3.5)
H-2 4.76 ddd (3.0, 3.0, 12.0) 4.96 ddd (3.0, 3.0, 12.0) 4.45 ddd (3.0, 3.0, 12.0) 4.46 ddd (3.0, 3.0, 12.0)
H-3 4.68 d (3.0) 4.58 d (3.0) 4.98 d (3.0) 4.58 d (3.0)
H-5 1.87 d (12.0) 1.87 d (12.0) 1.87 d (12.0) 1.87 d (12.0)
H-C(6α) 1.63 dddd, (12.6, 5.5, 3.5,
3.5)
1.62 dddd, (12.5, 5.5, 3.5,
3.5)
1.55 dddd, (12.6, 5.5, 3.5,
3.5)
1.56 dddd, (12.6, 5.5, 3.5,
3.5)
H-C(6β) 1.34 ddd, (12.6, 5.5, 3.5) 1.36 ddd, (12.6, 5.3, 3.5) 1.37 ddd, (12.6, 5.4, 3.5) 1.35 ddd, (12.6, 5.5, 3.7)
H-C(7α) 1.64 ddd, (16.5, 6.6, 3.5) 1.68 ddd, (16.6, 6.5, 3.5) 1.69 ddd, (16.6, 6.5, 3.5) 1.67 ddd, (16.6, 6.5, 3.5)
H-C(7β) 1.48 dd, (12.5, 5.5) 1.44 dd, (12.5, 5.5) 1.47 dd, (12.5, 5.5) 1.47 dd, (12.5, 5.5)
H-C(9) 1.66 dd, (13.5, 6.5) 1.67 dd, (13.5, 6.5) 1.64 dd, (13.5, 6.5) 1.63 dd, (13.5, 6.5)
H-(11α) 2.09 ddd, (8.3, 4.4, 2.5) 2.08 ddd, (8.5, 4.3, 2.5) 2.05 ddd, (8.5, 4.4, 2.5) 2.06 ddd, (8.5, 4.5, 2.5)
H-C(11β) 1.89 dd, (13.5, 4.5) 1.83 dd, (13.3, 4.5) 1.82 dd, (13.4, 4.5) 1.86 dd, (13.5, 4.4)
H-12 5.50 d (3.0) 5.50 d (3.0) 5.53 d (3.0) 5.53 d (3.0)
H-15 2.36 ddd (3.0, 13.5, 13.5) 2.36 ddd (3.0, 13.5, 13.5) 2.36 ddd (3.0, 13.5, 13.5) 2.36 ddd (3.0, 13.5, 13.5)
H-16 2.80 ddd (3.0, 13.5, 13.5) 2.79 ddd (3.0, 13.5, 13.5) 2.81 ddd (3.0, 13.5, 13.5) 2.82 ddd (3.0, 13.5, 13.5)
H-17 3.07 ddd (4.5, 13.5, 13.5) 3.09 ddd (4.5, 13.5, 13.5) 3.10 ddd (4.5, 13.5, 13.5) 3.05 ddd (4.5, 13.5, 13.5)
H-18 3.12 br s 3.12 br s 3.12 br s 3.12 br s
H-19 3.57 d (4.0) 4.81 d (11.4) 4.79 d (11.5) 4.75 d (11.8.0)
H-C(21α) 2.07 dddd, (13.2, 13.2, 4.5,
4.2)
2.04 dddd, (13.3, 13.1, 4.5,
4.2)
2.05 dddd, (13.3, 13.2, 4.5,
4.2)
2.09 dddd, (13.3, 13.2, 4.5,
4.2)
H-C(21β)
1.75 ddd, (13.4, 13.2, 3.3) 1.77 ddd, (13.5, 13.2, 3.5) 1.75 ddd, (13.5, 13.2, 3.7) 1.74 ddd, (13.5, 13.5, 3.5)
H-(22α)
2.09 ddd, (13.5, 13.5, 3.5) 2.08 ddd, (13.5, 13.5, 3.5) 2.09 ddd, (13.5, 13.5, 3.5) 2.07 ddd, (13.5, 13.5, 3.5)
H-C(22β) 1.50 dd, (13.5, 13.5) 1.48 dd (13.5, 13.4) 1.44 dd (13.5, 13.3) 1.46 dd (13.5, 13.2)
H-23 1.66 s 1.67 s 1.69 s 1.70 s
Hα -24 4.13 d (11.5) 4.14 d (11.5) 4.16 d (11.5) 4.11 d (11.5)
Hβ -24 3.85 d (11.5) 3.85 d (11.5) 3.85 d (11.5) 3.85 d (11.5)
H-25 1.09 s 1.08 s 1.07 s 1.04 s
H-26 1.17 s 1.14 s 1.15 s 1.18 s
H-27 1.54 s 1.52 s 1.55 s 1.53 s
H-29 1.14 s 1.16 s 1.13 s 1.12 s
H-30 0.98 s 0.99 s 0.96 s 0.97 s
Me-CO 2.23 s 2.22 s 2.22 s
Glc
H-1 6.36 d (8.5) 6.33 d (8.5) 6.35 d (8.5) 6.41 d (8.5),
H-2 4.21 dd (8.5, 9.0) 4.26 dd (8.5, 9.0) 4.27 dd (8.5, 9.0) 4.28 dd (8.5, 9.0)
H-3 4.29 dd (9.0, 9.0) 4.31 dd (9.0, 9.0) 4.32 dd (9.0, 9.0) 4.30 dd (9.0, 9.0)
H-4 4.36 dd (9.0, 9.0) 4.34 dd (9.0, 9.0) 4.39 dd (9.0, 9.0) 4.33 dd (9.0, 9.0)
H-5 4.02 ddd (2.5, 4.5, 9.0) 4.05 ddd (2.5, 4.5, 9.0) 4.07 ddd (2.5, 4.5, 9.0) 4.01 ddd (2.5, 4.5, 9.0)
Hα -6 4.45 dd (2.5, 12.0) 4.43 dd (2.5, 12.0) 4.46 dd (2.5, 12.0) 4.48 dd (2.5, 12.0)
Hβ -6 4.39 dd (4.5, 12.0) 4.40 dd (4.5, 12.0 4.38 dd (4.5, 12.0) 4.37 dd (4.5, 12.0)
202
Table 13. 13
C-NMR (75 MHz, C5D5N) data of 6-13 isolated from C. sativum
C# 6 7 8 9 10 11 12 13
C-1 43.3 43.5 43.7 43.4 43.0 43.2 44.0 43.8
C-2 66.3 74.3 66.7 66.9 68.3 69.3 66.4 66.5
C-3 74.2 71.3 76.2 74.2 79.2 74.2 76.2 74.2
C-4 45.2 45.1 45.4 45.6 45.7 45.2 45.3 45.2
C-5 49.7 50.1 49.9 49.7 49.6 49.7 49.9 49.8
C-6 19.2 19.3 19.1 19.4 18.9 18.8 19.5 19.0
C-7 33.8 33.7 33.9 33.7 34.1 334.2 33.6 40.0
C-8 40.6 40.8 40.5 40.7 40.9 40.6 40.4 41.0
C-9 48.5 48.8 48.7 48.6 48.2 48.9 48.3 48.4
C-10 38.9 39.1 39.2 39.0 38.8 38.7 38.6 38.5
C-11 24.5 24.7 24.8 24.6 24.9 24.5 25.1 25.0
C-12 123.8 123.9 123.7 123.6 123.4 124.0 124.1 123.5
C-13 144.4 143.8 144.5 144.3 144.6 144.7 144.6 144.8
C-14 42.2 42.3 42.5 42.4 42.7 42.8 42.2 42.6
C-15 29.0 29.1 29.5 29.4 29.3 29.6 29.8 29.2
C-16 28.0 28.9 28.6 28.5 28.3 28.0 28.2 28.1
C-17 46.5 46.8 46.4 46.8 46.9 46.3 46.2 46.6
C-18 44.6 44.4 44.7 44.0 44.9 44.7 44.8 44.2
C-19 81.1 78.4 81.2 81.3 81.4 81.7 81.3 84.1
C-20 35.6 35.7 36.1 35.9 35.8 36.1 36.8 35.8
C-21 29.0 29.1 29.2 29.3 29.0 28.9 28.8 29.5
C-22 33.1 33.2 33.8 33.7 33.6 33.4 33.5 33.4
C-23 23.8 23.9 23.5 24.0 24.1 23.7 23.6 23.2
C-24 65.2 65.7 65.4 65.5 65.9 65.3 65.6 65.0
C-25 17.1 17.2 17.3 17.7 17.6 17.4 17.8 16.9
C-26 17.1 17.3 17.4 17.6 17.5 17.5 17.7 17.0
C-27 24.9 25.1 24.8 24.7 24.6 24.4 25.2 24.5
C-28 177.3 177.7 177.6 177.8 177.9 177.1 177.2 177.0
C-29 28.8 28.9 28.7 28.6 28.5 28.7 29.2 29.3
C-30 16.7 16.8 16.5 16.4 16.6 16.9 16.5 16.7
Me-CO 22.3 22.1 22.2
Me-CO 176.2 176.4 176.5
Glc
C-1 95.9 95.8 95.7 95.4 95.6 96.1 96.2 96.0
C-2 74.4 74.5 74.6 74.7 74.8 74.9 74.3 74.2
C-3 79.3 79.7 79.8 79.5 79.6 80.3 80.2 80.1
C-4 71.2 71.3 71.4 71.6 71.9 71.7 71.8 71.4
C-5 79.2 79.4 79.3 79.5 79.6 79.1 79.7 78.9
C-6 62.3 62.2 62.5 62.8 62.7 62.1 62.0 62.4
203
Table 14. IC50 values (µM) of Compounds 1-13 isolated from C. sativum L. for various cell lines
Com HL-60 SMMC-7721 A-549 MCF-7 SW-480
6 2.14± 0.08 10.27± 0.07 11.63± 0.02 12.73± 0.04 14.03± 0.02
7 2.19± 0.05 14.34± 0.02 16.69± 0.12 18.14± 0.06 21.48± 0.02
8 2.17± 0.04 15.06± 0.07 13.62± 0.02 17.68± 0.05 20.04± 0.02
9 3.16± 0.02 18.38± 0.02 20.73± 0.02 27.37± 0.04 24.73± 0.02
10 2.57± 0.12 19.62± 0.11 28.28± 0.05 24.84± 0.06 23.19± 0.02
11 2.87± 0.08 19.93± 0.02 38.19± 0.04 27.49± 0.05 25.79± 0.02
12 2.84± 0.07 22.63± 0.02 31.26± 0.07 26.06± 0.03 27.14± 0.02
13 3.96± 0.06 19.45± 0.05 19.93± 0.03 21.83± 0.04 29.43± 0.08
Std 1.04± 0.05 14.75± 0.04 13.61± 0.03 16.95± 0.07 19.68± 0.02
DDP ((MW300) cisplatin) was used a positive control.
204
FIGURES
205
Fig. 1. FTIR of essential oils obtained from C. sativum
206
Fig. 2. (i) COSY-450 and HOHAHA Bold-bond (ii) HMBC Interaction in 1-5
207
Fig. 3. NOESY Interaction in 1-5
208
Fig. 4. (i) COSY-450 and HOHAHA Bold-bond (ii) HMBC Interaction in 6-13
209
Fig. 5. ROESY interaction in 6-13
210
BIBLIOGRAPHY
211
REFERENCES
Abreu, V. G. C., Takahashi, J. A., Duarte, L. P., Piló-Veloso, D., Junior, P. A. S., Alves, R. O.,
Romanha, A. J., Alcântara, A. F. C. Evaluation of the bactericidal and trypanocidal
activities of triterpenes isolated from the leaves, stems, and flowers of Lychnophorα
pinαster. Brαziliαn Journal of Phαrmαcognosy, 21, 615 (2011).
Ali, S. S., Kasoju, N., Luthra, A., Singh, A., Sharanabasava, H., Sahu, A., Bora, U. Indian
medicinal herbs as sources of antioxidants, Food Res. Intl., 41, 1 (2008).
Amin, A. and Mousa, M., Merits of anti-cancer plants from the Arabian Gulf Region. Cancer
Therapy, 5, 55 (2007).
Bakkali, F., Averbeck, S., Averbeck, D., and Idaomar, M. Biological effects of essential oils - A
review. Food Chem. Toxicol., 46, 446 (2008).
Barrtta, M. T., Dorman H. J. D., Deams, S. G., Figueiredo, C., Barroso, J. G., Ruberto, G.
Antimicrobial and antioxidant properties of some commercial essential oils. Flav. Fragr. J.,
13, 235 (1998).
Bhuiyan, Md. N. I., Begum, J., and Sultana, M. Chemical composition of leaf and seed essential
oil of Coriandrum sativum L. from Bangladesh. Bangladesh J. Pharmacol., 4, 150 (2009).
Burdock, G. A., and Carabin, I. G. Safety assessment of Coriander (Coriandrum sativum (L.)
essential oil as a food ingredient. Food Chem. Toxicol., 47, 22 (2009).
Burt, S. Essential Oils: their antibacterial properties and potential applications in foods: a review.
Int. J. Food Microbiol., 94, 223 (2004).
Cantore, P. L., Lacobellis, N. S., DeMarco, A., Capasso, F., and Senatore, F. Antibacterial
activity of Coriandrum sativum L. and Foeniculum vulgare Miller var vulgare (Miller)
essential oils. J. Agri. Food Chem., 52, 7862 (2004).
212
Cao, S., Brodie, P. J., Callmander, M., Randrianaivo, R., Rakotobe, E., Rasamison, V. E.,
Kingston, D. G.I. Saponins and a lignan derivative of Terminalia tropophylla from the
Madagascar Dry Forest. Phytochem., 71, 95 (2010)
Chandrasekaran, M. and Venkatesalu, V. Antibacterial and antifungal activity of Syzygium
jambolanum seeds. J. Ethnopharmacol., 91, 105 (2004).
Chen, J., Chen, B., Tian, J. and Wu, F. E. Two new pentacyclic triterpenes from Sabia parviflora.
Chin. Chem. Letts., 13, 345 (2002).
Chen, W. and Viljoen, A. M. Geraniol - A review of a commercially important fragrance
material. South Afr. J. Bot., 76, 643 (2010).
Chopra, R. N., Nayar, S. L. and Chopra, L. C. (1956). Glossary of Indian Medicinal Plants.
Council for Scientific and Industrial Research, New Delhi, 58.
Caldwell, C.G., Franzblau, S.G., Suarez, E., and Timmermann, B.N. Oleanane triterpenes from
junellia tridens. J. Nat. Prod., 63, 1611 (2000).
Emamghoreishi, M., Khasaki, M. and Aazam, M. F. Coriandrum sativum: evaluation of its
anxiolytic effect in the elevated plus-maze. J. Ethnopharmacol., 96, 365 (2005).
Gershenzon, J. and Dudareva, N. The function of terpene natural products in the natural world.
Nat. Chem. Biol., 3, 408 (2007).
Gui-Sheng, Z., Nian-Yun, Y., Yu-Ping, T., Jin-Ao, D., Shu, J., Hui, Y., Sheng, G., Bing-Sheng,
S. and Zi-Qing, H. Chemical constituents from the aerial parts of Angelica sinensis and
their bioactivities.Chin. J. N. Med., 10, 295 (2012).
Hedge, I. C. and J. M. Lamond. (1972). Coriandrum L. Pp. 330-331 in Flora of Turkey. Vol. 4.
(P.H. Davis, D.F. Chamberlain and V.A. Matthews, eds.). Edinburgh University Press,
Edinburgh.
213
Hichri, F., Jannet, H. B., Cheriaa, J., Jegham, S., and Mighri, Z. Antibacterial activities of a few
prepared derivatives of oleanolic acid and of other natural triterpenic compounds. Comptes
Rendus Chimie, 6, 473 (2003).
James, J. T. and Dubery, I. A. Pentacyclic triterpenoids from the medicinal herb, Centella
asiatica (L.) Urban. Molecules, 14, 3922 (2009).
Janick, J., Fruits of the Bibles. HortScience, 42, 1072 (2007).
Juan, M. E., Planas, J. M., Ruiz-Gutierrez, V., Daniel, H., Wenzel, U. Antiproliferative and
apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from
olives, on HT-29 colon cancer cells. Br. J. Nutr., 100, 36 (2008).
Kainsa, S., Kumar, P., Rani, P., Medicinal plants of Asian origin having anticancer potential:
short review. Asian J. Biomed. Pharm. Sc., 2, 1 (2012).
Khan, N., Ahmed, M., Ahmed, A., Shaukat, S. S., Wahab, M., Ajaib, M., Siddiqui, M. F. and
Nasir, M. Important medicinal plants of Chitral Gol National Park (CGNP) Pakistan. Pak.
J. Bot., 43, 797 (2011).
Khan, S. W. and Khatoon, S. Ethnobotanical studies on some useful herbs of haramosh and
bugrote valleys in Gilgit, Northern areas of Pakistan. Pak. J. Bot., 40, 43 (2008).
Kilama, W. L. Health research ethics in public health: Trials and implementation of malaria
mosquito control strategies. Acta Tropica, 112, 37 (2009).
Kljuykov, E. and Ukrainskaja, U. Distribution of the Umbelliferae in Middle Asia and
Kazakhstan. Plant Div. Evol., 128, 547 (2010).
Koppula, S and Choi, D. K. Anethum graveolens Linn (Umbelliferae) extract attenuates stress-
induced urinary biochemical changes and improves cognition in scopolamineinduced
amnesic rats. Trop. J. Pharm. Res., 10, 47 (2011).
214
Li, X.-H., Shen, D.-D., Li, N., and Yu, S.-S. Bioactive triterpenoids from symplocos chinensis. J.
Asian Nat. Prod. Res., 5, 49 (2003).
Lu, J.-J., Bao, J.-L., Chen, X.-P., Huang, M., and Wang Y.-T. Alkaloids isolated from natural
herbs as the anticancer agents. Evidence-Based Complementary and Alternative Medicine,
2012, 1 (2012).
Maghraby, A. S., and Hassan, S. A. Effect of antioxidative properties of honey on schistosoma
mansoni-infected mice. Pol. J. Food Nutr. Sci., 14/55, 323 (2005).
Matthäus, B., and Angelini, L. G. Anti-nutritive constituents in oilseed crops from Italy,
Industrial Crops and Products, 21, 89 (2005).
Mbaze, L. M., Poumale, H. M. P., Wansi, J. D., Lado, J. A., Khan, S. N., Iqbal, M. C., Ngadjui,
B. T. and Laatsch, H., Phytochem., 68, 591 (2007).
Menglan, S., Meng-lan, S., Fading, P., Fa-ting, P., Zehui, P., Watson, M. F., Cannon, J. F. M.,
Holmes-Smith, I., Kljuykov, E. V., Phillippe, L. R., Pimenov, M. G. APIACEAE
(UMBELLIFERAE), Flora of China 14, 1-205 (2005).
Mouterde, P. (ed.). (1986). Nouvelle Flore du Liban et de la Syrie. Vol. 2. Dar El-Marchreq
Éditeurs, Beyrouth. Pp. 612-613.
Marwat, S. K., Khan, M. A., Khan, M. A., Rehman, F.,Ahmad, M., Zafar, M., Sultana, S.
Salvadora persica, Tamarix aphylla and Zizyphus mauritiana-Three Woody Plant Species
Mentioned in Holy Quran and Ahadith and Their Ethnobotanical Uses inNorth Western
Part (D.I. Khan) of Pakistan. Pak. J. Nutr., 8, 542 (2009).
Msaada, K., Hosni, K., Taarit, M. B., Chahed, T., Kchouk, M. E. and Marzouk, B. Changes on
essential oil composition of coriander (Coriandrum sativum L.) fruits during three stages of
maturity. Food Chem., 102, 1131 (2007).
215
Newman, D. J. and Cragg, G. M. Natural products as sources of new drugs over the last 25 years.
J. Nat. Prod., 70, 461(2007).
Nickavar, B. and Al-Sadat, A. F. Screening of antioxidant properties of seven Umbelliferae fruits
from Iran. Pak. J. Pharm. Sc., 22, 30 (2009).
Nirmala, M. J., Samundeeswari, A. and Sankar, P. D., Natural plant resources in anti-cancer
therapy-A review; Res. Plant Biol., 1, 1 (2011).
Olle, M. and Bender, I. The content of oils in umbelliferous crops and its formation. Agronomy
Research, 8 (Special Issue III), 687 (2010).
Orhan, I. E., Ozçelik, B., Kartal, M. and Kan, Y. Antimicrobial and antiviral eff ects of essential
oils from selected Umbelliferae and Labiatae plants and individual essential oil
components. Turk. J. Biol., 36, 239 (2012).
Pandey, A., Bigoniya, P., Raj, V. and Patel. K. K. Pharmacological screening of Coriandrum
sativum Linn. for hepatoprotective activity. J. Pharm. Bioallied Sc., 3, 435 (2011).
Perveen, A. and Qaiser, M. Pollen flora of Pakistan -XLVIII. Umbelliferae. Pak. J. Bot., 38, 1
(2006).
Pimenov, M. G. and Leonov, M. V (1993). The Genera of the Umbelliferae. (J. M. Lock ed.).
Whistable Litho, Whistable. 156pp.
Pimenov, M. G. and Leonov, M. V. The Asian Umbelliferae Biodiversity Database (ASIUM)
with Particular Reference to South-West Asian Taxa. Turk. J. Bot., 28, 139 (2004).
Radulovic, N., Dorđevic, N., Denic, M., Pinheiro, M. M., Fernandes, P. D., Boylan, F. A novel
toxic alkaloid from poison hemlock (Conium maculatum L., Apiaceae): identification,
synthesis and antinociceptive activity. Food Chem. Toxicol., 50, 274 (2012).
216
Ramadan, M. F. and Morsel, J. T. Analysis of glycolipids from coriander (Coriandrum sativum
L.), Black cumin (Nigella sativa L.) and niger (Guizotia abyssinica Cass.) oilseeds. Food
Chem., 80, 197 (2003).
Ramadan, M. F., Kroh, L. W. and Morsel, J. T. Radical scavenging activity of black cumin
(Nigella sativa L.), coriander (Coriandrum sativum L.), and niger (Guizotia abyssinica
Cass.) crude seed oils and oil fractions. J. Agric. Food Chem., 51, 6961 (2003).
Shoeb, M. Anticancer agents from medicinal plants. Bangladesh J. Pharmacol., 1: 35 (2006).
Singh, D., Singh, P., Gupta, A., Solanki, S., Sharma, E., Nema, R. Qualitative estimation of the
presence of bioactive compound in Centella asiatica: an important medicinal plant, Int. J L.
Sc., Med. Res., 2, 5 (2012).
Siripornvisal, S. 1, Thawornluk, P. 1 and Rungprom, W. 1. Screening for antifungal activity and
active components of crude extracts from 6 Umbelliferae. Agr. Sci. J. 42, 361(2011).
Sreelatha, S., Padma, P. R. and Umadevi, M. Protective effects of Coriandrum sativum extracts
on carbon tetrachloride-induced hepatotoxicity in rats. Food Chem. Toxicol., 47, 702
(2009).
Sriti, J., Msaada, K., Talou, T., Faye, M., Vilarem, G., Marzouk, B. Coupled extruder-headspace,
a new method for analysis of the essential oil components of Coriandrum sativum fruits.
Food Chem., 134, 2419 (2012).
Sriti, J., Wannes, W. A., Talou, T., Vilarem, G. and Marzouk, B. Chemical Composition and
antioxidant activities of tunisian and canadian coriander (Coriandrum sativum L.) fruit. J.
Essent. Oil Res., 23, 7 (2011).
217
Sriti, J., Wannesa, W. A., Taloub, T, Mhamdia, B., Hamdaouia, G. and Marzouka, B. Lipid, fatty
acid and tocol distribution of coriander fruit’s different parts. Industrial Crops and
Products, 31, 294 (2010).
Suguna, L., Sivakumar, P., Chandrakasan, G. Effects of Centella asiatica extract on dermal
wound healing in rats. Ind. J .Exp. Biol., 34, 1208 (1996).
Sule, M.I., Hassan, H.S., Pateh, U.U., Ambi, A.A. (2011).Triterpenoids from the leaves of Olax
mannii Oliv. Nigerian Journal of Basic and Applied Sciences, 19, 193 (2011).
Sun, H., Fang, W.-S., Wang, W.-Z., and Hu, C. Structure-activity relationships of oleanane- and
ursanetype triterpenoids. Botanical Studies, 47, 339 (2006).
Tenni, R., Zanaboni, G., De Agostini M. P., Rossi. A., Bendotti, C., Cetta, G. Effect of the
triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in
human skin fibroblast cultures. Ital. J. Biochem., 37, 69 (1988).
Vetter, J. Poison hemlock (Conium maculatum L). Food Chem. Toxicol., 42, 1373 (2004).
Wangensteen, H., Samuelsen, A. B. and Malterud, K. E. Antioxidant activity in extracts from
coriander. Food Chem., 88, 293 (2004).
Zhou, Z.-F., Chen, L.-Y., Shen, M., Ma, A.-D., Yang, X.-M., and Zou, F. Analysis of the
essential oils of Coriandrum sativum using GC-MS Coupled with chemometric resolution
methods. Chem. Pharm. Bull., 59, 28 (2011).
218
Published Papers
1. Muhammad Iqbal, Imam Bakhsh Baloch and Musa Kaleem Baloch. Synthesis and
Structural Characterization of Novel Monoesters of Succinic Anhydride with Aryl
Alcohols. Chemistry Journal, 2 (1), 2-19 (2012).
Available online at www.scientific-journals.co.uk
2. Muhammad Iqbal, Imam Bakhsh Baloch and Musa Kaleem Baloch. Preparation of
Novel Monoesters of Succinic Acid from Succinic Anhydride using p-Toluensulphonic
Acid as a Catalyst. Chemistry Journal, 2 (2), 87-94 (2012).
Available online at www.scientific-journals.co.uk
3. Muhammad Iqbal, Imam Bakhsh Baloch, Musa K. Baloch. An efficient method for the
preparation of benzyl γ-ketohexanoates. Chemical Papers, 67 (4) 444–455 (2013).
4. Muhammad Iqbal, Imam Bakhsh Baloch, Musa Kaleem Baloch, Muhammad Ayaz
Khan, Adnan Amin and Muhammad Akram. Bio-active Compounds from Coriandrum
sativum L. Seeds. Wulfenia Journal, 20 (1), 105-120, (2013).
5. Muhammad Iqbal, Imam Bakhsh Baloch and Musa Kaleem Baloch. Synthesis of Novel
γ-Ketoesters from Succinic Anhydride. Asian Journal of Chemistry, 25 (17), 9701-9703
(2013).
6. Muhammad Iqbal, Imam Bakhsh Baloch and Musa Kaleem Baloch. Evaluation of
antifungal and antibacterial activities of monoesters of succinic anhydride. Bull. Chem.
Soc. Ethiop., 28 (1), 131-136 (2014).